
<html lang="en"     class="pb-page"  data-request-id="bf49e827-8ce6-41b4-8dcf-fe0970de8c9a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5019302;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-5;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer" /></meta><meta name="dc.Creator" content="Yong  Ai" /></meta><meta name="dc.Creator" content="Fenghua  Kang" /></meta><meta name="dc.Creator" content="Zhangjian  Huang" /></meta><meta name="dc.Creator" content="Xiaowen  Xue" /></meta><meta name="dc.Creator" content="Yisheng  Lai" /></meta><meta name="dc.Creator" content="Sixun  Peng" /></meta><meta name="dc.Creator" content="Jide  Tian" /></meta><meta name="dc.Creator" content="Yihua  Zhang" /></meta><meta name="dc.Description" content="Seventeen CDDO–amino acid–NO donor trihybrids (4a–q) were designed and synthesized. Biological evaluation indicated that the most active compound 4c produced high levels of NO and inhibited the pro..." /></meta><meta name="Description" content="Seventeen CDDO–amino acid–NO donor trihybrids (4a–q) were designed and synthesized. Biological evaluation indicated that the most active compound 4c produced high levels of NO and inhibited the pro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 23, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5019302" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5019302" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5019302" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5019302" /></link>
        
    
    

<title>Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5019302" /></meta><meta property="og:title" content="Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0012.jpeg" /></meta><meta property="og:description" content="Seventeen CDDO–amino acid–NO donor trihybrids (4a–q) were designed and synthesized. Biological evaluation indicated that the most active compound 4c produced high levels of NO and inhibited the proliferation of drug-sensitive (HCT-8, IC50 = 0.294 μM) and drug-resistant (HCT-8/5-FU, IC50 = 0.232 μM) colon cancer cells, which were attenuated by an NO scavenger or typical substrate of PepT1. Furthermore, 4c triggered HCT-8 and HCT-8/5-FU cell apoptosis more strongly than CDDO-Me, inhibited the HIF-1α, Stat3, AKT, and ERK signaling, and induced the nitration of P-gp, MRP1, and BCRP proteins in HCT-8/5-FU cells. Finally, 4c had 4.36–5.53-fold less inhibitory activity against nontumor colon epithelial-like cells (CCD841, IC50 = 1.282 μM) in vitro and inhibited the growth of implanted human drug-resistant colon cancers in mice more potently than CDDO-Me. Together, 4c is a novel trihybrid with potent antitumor activity and may be a promising candidate for the treatment of drug-resistant colon cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5019302"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5019302">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5019302&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5019302&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5019302&amp;href=/doi/10.1021/jm5019302" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2452-2464</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501920g" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501940y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Ai">Yong Ai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fenghua++Kang">Fenghua Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhangjian++Huang">Zhangjian Huang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaowen++Xue">Xiaowen Xue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yisheng++Lai">Yisheng Lai</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sixun++Peng">Sixun Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jide++Tian">Jide Tian</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yihua++Zhang">Yihua Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California 90095, United States</span></div><div class="corresp-info"><strong>*</strong>For Y.Z.: phone, +86-25-83271015; fax, +86-25-83271015; E-mail, <a href="/cdn-cgi/l/email-protection#80faf9e8f4e7e4c0b1b6b3aee3efed"><span class="__cf_email__" data-cfemail="077d7e6f736063473631342964686a">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For Z.H.: phone, +86-25-83271072; E-mail, <a href="/cdn-cgi/l/email-protection#0f4a22626e6663356c7f7a6b6e677a6e61684f3e393c216c6062">E-mail:<span class="__cf_email__" data-cfemail="8ae9faffeeebe2ffebe4edcabbbcb9a4e9e5e7">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5019302&amp;href=/doi/10.1021%2Fjm5019302" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2452–2464</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 December 2014</li><li><span class="item_label"><b>Published</b> online</span>23 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5019302" title="DOI URL">https://doi.org/10.1021/jm5019302</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2452%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYong%2BAi%252C%2BFenghua%2BKang%252C%2BZhangjian%2BHuang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D5%26contentID%3Djm5019302%26title%3DSynthesis%2Bof%2BCDDO%25E2%2580%2593Amino%2BAcid%25E2%2580%2593Nitric%2BOxide%2BDonor%2BTrihybrids%2Bas%2BPotential%2BAntitumor%2BAgents%2Bagainst%2BBoth%2BDrug-Sensitive%2Band%2BDrug-Resistant%2BColon%2BCancer%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2464%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5019302"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1953</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">46</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5019302" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis of CDDO–Amino Acid–Nitric Oxide Donor Trihybrids as Potential Antitumor Agents against Both Drug-Sensitive and Drug-Resistant Colon Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Ai&quot;},{&quot;first_name&quot;:&quot;Fenghua&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Zhangjian&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Xiaowen&quot;,&quot;last_name&quot;:&quot;Xue&quot;},{&quot;first_name&quot;:&quot;Yisheng&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Sixun&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Jide&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Yihua&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2452-2464&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5019302&quot;},&quot;abstract&quot;:&quot;Seventeen CDDO–amino acid–NO donor trihybrids (4a–q) were designed and synthesized. Biological evaluation indicated that the most active compound 4c produced high levels of NO and inhibited the proliferation of drug-sensitive (HCT-8, IC50 = 0.294 μM) and drug-resistant (HCT-8/5-FU, IC50 = 0.232 μM) colon cancer cells, which were attenuated by an NO scavenger or typical substrate of PepT1. Furthermore, 4c triggered HCT-8 and HCT-8/5-FU cell apoptosis more strongly than CDDO-Me, inhibited the HIF-1α, Stat3, AKT, and ERK signaling, and induced the nitration of P-gp, MRP1, and BCRP proteins in HCT-8/5-FU cells. Finally, 4c had 4.36–5.53-fold less inhibitory activity against nontumor colon epithelial-like cells (CCD841, IC50 = 1.282 μM) in vitro and inhibited the growth of implanted human drug-resistant colon cancers in mice more potently than CDDO-Me. Together, 4c is a novel trihybrid with potent antitumor activity and may be a promising candidate for the treatment of drug-resistant colon cancer.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019302&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019302" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019302&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019302" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5019302&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019302" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5019302&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5019302&amp;href=/doi/10.1021/jm5019302" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5019302" /></input><a href="/doi/pdf/10.1021/jm5019302" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5019302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5019302%26sid%3Dliteratum%253Aachs%26pmid%3D25675144%26genre%3Darticle%26aulast%3DAi%26date%3D2015%26atitle%3DSynthesis%2Bof%2BCDDO%25E2%2580%2593Amino%2BAcid%25E2%2580%2593Nitric%2BOxide%2BDonor%2BTrihybrids%2Bas%2BPotential%2BAntitumor%2BAgents%2Bagainst%2BBoth%2BDrug-Sensitive%2Band%2BDrug-Resistant%2BColon%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D5%26spage%3D2452%26epage%3D2464%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291098" title="Antitumor activity">Antitumor activity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jmcmar.2015.58.issue-5/20150312/jmcmar.2015.58.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Seventeen CDDO–amino acid–NO donor trihybrids (<b>4a</b>–<b>q</b>) were designed and synthesized. Biological evaluation indicated that the most active compound <b>4c</b> produced high levels of NO and inhibited the proliferation of drug-sensitive (HCT-8, IC<sub>50</sub> = 0.294 μM) and drug-resistant (HCT-8/5-FU, IC<sub>50</sub> = 0.232 μM) colon cancer cells, which were attenuated by an NO scavenger or typical substrate of PepT1. Furthermore, <b>4c</b> triggered HCT-8 and HCT-8/5-FU cell apoptosis more strongly than CDDO-Me, inhibited the HIF-1α, Stat3, AKT, and ERK signaling, and induced the nitration of P-gp, MRP1, and BCRP proteins in HCT-8/5-FU cells. Finally, <b>4c</b> had 4.36–5.53-fold less inhibitory activity against nontumor colon epithelial-like cells (CCD841, IC<sub>50</sub> = 1.282 μM) in vitro and inhibited the growth of implanted human drug-resistant colon cancers in mice more potently than CDDO-Me. Together, <b>4c</b> is a novel trihybrid with potent antitumor activity and may be a promising candidate for the treatment of drug-resistant colon cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Multidrug resistance (MDR) is a leading cause for the failure of anticancer chemotherapy.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> MDR in cancer cells is attributed to many factors, such as overexpression of the ATP-binding cassette (ABC) transporters, which can export anticancer drugs out of the cells, leading to low levels of intracellular drugs and consequent drug ineffectiveness.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Three major ABC transporters implicated in cancer MDR are P-glycoprotein (P-gp/ABCB1/MDR1), multidrug resistance-associated protein 1 (MRP1/ABCC1), and breast cancer resistance protein (BCRP/ABCG2).<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> Currently, there is no ABC transporter inhibitor available in the clinic.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> Therefore, novel strategies are urgently needed to design and synthesize compounds with potent cytotoxicity against cancer cells with MDR.</div><div class="NLM_p">Nitric oxide (NO) is a signaling and effector molecule and plays an important role in various physiological and pathophysiological processes.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> High levels of NO have strong antitumor activity by inducing tumor cell apoptosis, inhibiting tumor metastasis, and sensitizing drug-resistant tumor cells to chemotherapy, radiation, and immunotherapy in vitro and in vivo.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> More importantly, NO-donating antitumor drugs usually do not induce drug resistance in tumor cells.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Furoxans, an important class of NO donors, are able to produce high levels of NO in vitro and inhibit the growth of tumors in vivo.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Previous studies have shown that doxorubicin/furoxan hybrids can generate high levels of NO in the cancer cells and react with superoxide to produce peroxynitrite anion, which can nitrate the tyrosine residue of many key proteins, including ABC transporters.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> We have also developed a variety of furoxan-based NO donating compounds such as oleanolic acid (OA)/furoxan,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> anilinopyrimidine/furoxan,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and bifendate/furoxan hybrids<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> with potent antitumor and/or anti-MDR activities. Hence, generation of furoxan-based hybrids is a promising strategy for overcoming the MDR in cancer therapy.</div><div class="NLM_p">OA is a well-known natural triterpenoid and has multiple pharmacological activities.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> To improve its potency, many synthetic OA derivatives (SOADs) have been prepared, including 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid (CDDO), its ester (CDDO-Me), amides (CDDO-Im), olean-28,13β-olide (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), and others.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26-29)</a> These SOADs have strong antitumor activity by inhibiting tumor cell proliferation and inducing cancer cell apoptosis.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Recent studies show that OA and its derivative methyl 3,11-dioxoolean-12-en-28-olate (DIOXOL, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) have moderate antitumor activity and can reverse the P-gp-mediated MDR.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of OA and SOADs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Peptide transporter 1 (PepT1) is an attractive target for development of antitumor drugs because of its high affinity to its broad substrates.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Physiologically, PepT1 is predominantly expressed in the intestinal epithelium and can effectively transport amino acids, peptides, peptide-like drugs, etc.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Pathologically, the PepT1 is highly expressed by tumor cells, including human colon cancer cells (Caco-2),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> pancreatic cancer cells (AsPc-1 and Capan-2),<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> sarcoma cells (HT-1080),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> prostatic cancer cells (PC-3),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> lung cancer cells (A549),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and ovarian adenocarcinoma cisplatin-sensitive (2008) and -resistant cells (C13),<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and others. However, the low levels of PepT1 are expressed in nontumor tissues.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38 ref39 ref40">(35-40)</a> Thus, the differential expression of PepT1 has been utilized for design and synthesis of selective anticancer agents, including the PepT1-targeting dihybrids of amino acid with OA, floxuridine, gemcitabine, cytarabine, and gold(III)-dithiocarbamato, respectively.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40-44)</a></div><div class="NLM_p last">In this context, we hypothesized that CDDO–amino acid–NO donor trihybrids could be effectively transported to cancer cells by the PepT1 to exert potent cytotoxicity against both drug-sensitive and drug-resistant colon cancer cells. Accordingly, we synthesized trihybrids <b>4a</b>–<b>q</b> by coupling the carboxyl group of CDDO with phenylsulfonyl-substituted furoxan through different amino acids, respectively, and evaluated their bioactivity in vitro and in vivo.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The strategies for the synthesis of the target compounds <b>4a</b>–<b>q</b> are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. (3-Phenylsulphonyl-4-hydyoxyalkoxyl)furoxans <b>2a</b>–<b>e</b> were synthesized through the reactions of 3,4-diphenylsulphonylfuroxan with different diols (butane-1,3-diol, butane-1,4-diol, 2-butyne-1,4-diol, hexane-1,6-diol, or 2,2′-oxidiethanol). The generated <b>2a</b>–<b>e</b> were reacted with <i>N</i>-protected amino acids (Boc-glycine, Boc-β-Ala-OH, Boc-<span class="smallcaps smallerCapital">l</span>-Pro-OH, Boc-<span class="smallcaps smallerCapital">l</span>-Ala-OH, and Boc-γ-aminobutyric acid), respectively, in the presence of 1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride (EDCI) and 4-dimethylamino-pyridine (DMAP) to afford the corresponding esters <b>3a</b>–<b>q</b>. The Boc group of <b>3a</b>–<b>q</b> was then removed by trifluoroacetic acid (TFA) to yield amino-containing intermediates, which were directly treated with the acyl chloride of CDDO prepared as reported previously<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> in the presence of triethylamine (TEA) to provide the target compounds <b>4a</b>–<b>q</b>. Their structures were characterized by IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, MS, and HRMS.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of CDDO–Amino Acid–NO Donor Trihybrids <b>4a</b>–<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) diol, THF, NaH, 0 °C, 15 min; (b) EDCI, DMAP, DCM, rt, 12 h; (c) TFA, DCM, rt, 1 h; (d) acyl chloride of CDDO, TEA, DCM, rt, 12 h.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Biological Activity</h3><div id="sec3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i6" class="anchor-spacer"></div><h4 class="article-section__title" id="_i6"> Assessment of in Vitro Antiproliferative Activity</h4><div class="NLM_p">Given that the target compounds we designed may be effectively transported to cancer cells by PepT1, we initially assessed the levels of PepT1 expression in drug-sensitive colon cancer HCT-8 and drug-resistant colon cancer HCT-8/5-FU cells as well as in nontransformed colon epithelial-like CCD841 cells by Western blot assay.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The results indicated that high levels of PepT1 were expressed by both HCT-8 and HCT-8/5-FU cells, but only little was detected in CCD841 cells (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure S1">Supporting Information, Figure S1</a>).</div><div class="NLM_p">Next, the antitumor activity of compounds <b>4a</b>–<b>q</b> against HCT-8 and HCT-8/5-FU were preliminarily screened by the MTT assay using CDDO-Me as a positive control. Compounds <b>4a</b>–<b>c</b>, <b>4p</b>, and <b>4q</b> (R<sub>1</sub> = 2-butyne-1,4-diol), and <b>4d</b>, <b>4g</b>, <b>4j</b>, and <b>4m</b> (R<sub>2</sub> = glycine) at 1 μM inhibited colon cancer proliferation by >90%, which were higher than that of CDDO-Me (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The other eight compounds, <b>4e</b>, <b>4f</b>, <b>4h</b>, <b>4i</b>, <b>4k</b>, <b>4l</b>, <b>4n</b>, and <b>4o</b>, displayed an antitumor potency comparable to CDDO-Me.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>4a</b>–<b>q</b> inhibit the proliferation of HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with, or without, the indicated compounds at 1 μM for 72 h, and the cell proliferation was measured by MTT. The inhibition (%) of each compound was determined. Data are present as the means (%) ± SD of each compound from three independent experiments. *<i>P</i> < 0.05 vs the CDDO-Me.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, the nine most potent compounds (<b>4a</b>-<b>d</b>, <b>4g</b>, <b>4j</b>, <b>4m</b>, <b>4p</b>, and <b>4q</b>) were further investigated for their antitumor activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>4c</b> displayed more potent activity (IC<sub>50</sub> = 0.294 and 0.232 μM) than CDDO-Me and 5-FU in HCT-8 and HCT-8/5-FU cells. It is notable that CDDO-Me had similar antitumor activities against both colon cancer and nontumor colon cells, however, <b>4c</b> displayed a 4.63–5.53-fold decrease in its antiproliferative activity on nontumor CCD841 cells (IC<sub>50</sub> = 1.282 μM), suggesting that <b>4c</b> may be a promising drug candidate for further investigation.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antiproliferative Activity of Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">HCT-8</th><th class="colsep0 rowsep0" align="center" char="±">HCT-8/5-FU</th><th class="colsep0 rowsep0" align="center" char="±">CCD841</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.441 ± 0.081<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.343 ± 0.044<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.425 ± 0.154<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.504 ± 0.098</td><td class="colsep0 rowsep0" align="char" char="±">0.381 ± 0.021<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.698 ± 0.109<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="char" char="±">0.294 ± 0.013<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">0.232 ± 0.010<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="±">1.282 ± 0.095<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="char" char="±">0.550 ± 0.067</td><td class="colsep0 rowsep0" align="char" char="±">0.380 ± 0.026<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.725 ± 0.114<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="char" char="±">0.383 ± 0.031<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.315 ± 0.053<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.121 ± 0.102<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="char" char="±">0.356 ± 0.054<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.339 ± 0.060<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.423 ± 0.081<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4m</b></td><td class="colsep0 rowsep0" align="char" char="±">0.872 ± 0.101</td><td class="colsep0 rowsep0" align="char" char="±">0.562 ± 0.087<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">3.129 ± 0.198<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4q</b></td><td class="colsep0 rowsep0" align="char" char="±">0.370 ± 0.052<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.276 ± 0.013<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.958 ± 0.069<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4p</b></td><td class="colsep0 rowsep0" align="char" char="±">0.379 ± 0.066<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">0.462 ± 0.088<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="±">1.472 ± 0.057<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDDO-Me</td><td class="colsep0 rowsep0" align="char" char="±">0.399 ± 0.047</td><td class="colsep0 rowsep0" align="char" char="±">0.363 ± 0.029</td><td class="colsep0 rowsep0" align="char" char="±">0.316 ± 0.019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-FU</td><td class="colsep0 rowsep0" align="char" char="±">0.91 ± 0.103</td><td class="colsep0 rowsep0" align="char" char="±">36.638 ± 2.319</td><td class="colsep0 rowsep0" align="char" char="±">-</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The compounds were dissolved in DMSO and diluted with culture medium into eight concentrations (0.015625, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 5 μM) of solution for each compound (final DMSO concentration in medium <0.4%). The cells (1 × 10<sup>4</sup> cells) were treated in triplicate with the indicated concentrations of each compound for 72 h to test their effects on the cell proliferation by the MTT assay. The values of IC<sub>50</sub> for each compound were calculated and data are expressed as mean IC<sub>50</sub> (μM) ± SD of each compound from three independent experiments. IC<sub>50</sub> is the drug concentration inhibiting 50% of the cell proliferation.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>P</i> < 0.01 vs the 5-FU.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>P</i> < 0.05 vs the CDDO-Me.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> The Role of NO in the Antitumor Activity of <b>4c</b></h4><div class="NLM_p">Compound <b>4c</b> was composed of CDDO moiety (compound <b>5</b>) and furoxan moiety (<b>2a</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), and their antitumor activity against HCT-8 and HCT-8/5-FU cells were also examined. The IC<sub>50</sub> values of <b>4c</b> for HCT-8 (0.294 μM) and HCT-8/5-FU cells (0.232 μM) were significantly less than that of individual moieties, <b>5</b> (IC<sub>50</sub> = 3.192 and 2.257 μM) and <b>2a</b> (IC<sub>50</sub> = 33.512 and 36.569 μM), and even the combination of <b>5</b> and <b>2a</b> (IC<sub>50</sub> = 2.447 and 1.863 μM), respectively. These results suggest that the antitumor activity of <b>4c</b> may be attributed to the synergic effects of CDDO and NO donor moieties as well as PepT1-mediated drug transportation in cancer cells.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of anticancer activity of trihybrid <b>4c</b> with that of <b>5</b>, <b>2a</b>, and an equimolar mixture of <b>5</b> and <b>2a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To verify the contribution of NO to the antitumor activity, the levels of intracellular NO released by the tested compounds were first detected. HCT-8, HCT-8/5-FU, and CCD841 cells were treated with 100 μM <b>4c</b>, <b>4q</b>, <b>4f</b>, <b>4i</b>, <b>4l</b>, or <b>5</b>, and the levels of intracellular NO were determined by a Griess assay (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). As expected, treatment with <b>5</b> resulted in little NO in both HCT-8 and HCT-8/5-FU cells. In contrast, treatment with individual tested compounds led to variable levels of NO production in both cancer cell lines. Interestingly, treatment with one of the more active compounds such as <b>4c</b> or <b>4q</b> caused higher levels of NO production in the cells, particularly in the drug-resistant HCT-8/5-FU cells, whereas less active compounds <b>4f</b>, <b>4i</b>, and <b>4l</b> produced lower levels of NO. The levels of intracellular NO by different compounds were positively correlated with their antitumor activities against HCT-8 and HCT-8/5-FU cells in vitro (<i>R</i> = 0.950, 0.962, respectively, <i>p</i> < 0.05, determined by Pearson’s correlation analysis). These results suggest that the active compounds may have a better ability to penetrate the membrane of HCT-8 and HCT-8/5-FU cells, leading to higher levels of NO production in colon cancer cells than the less active compounds. On the other hand, compounds <b>4c</b>, <b>4q</b>, <b>4f</b>, <b>4i</b>, and <b>4l</b> produced almost negligible amounts of NO in nontumor colon CCD841 cells, suggesting that PepT1-mediated transport of these compounds may be important for the high levels of NO production and antitumor activity of these compounds. These data also explained why <b>4c</b> had preferable inhibition on the proliferation of colon cancer cells.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of NO produced by the target compounds on colon cell proliferation. (A) Variable levels of NO (present as nitrite) produced by the indicated compounds. HCT-8, HCT-8/5-FU, and CCD841 cells were treated in triplicate with individual compounds at 100 μM for 150 min, and the concentrations of intracellular nitrite were determined by Griess assay. The individual values were determined by measuring the absorbance at 540 nm and calculated according to the standard curve. Data are expressed as the mean ± SD of each compound in individual types of cells from three experiments. ***<i>P</i> < 0.001 vs the CCD841 group, #<i>P</i> < 0.05 vs the HCT-8 group. (B) Effects of NO scavenging, carboxy-PTIO (PTIO) on the antiproliferative effect of <b>4c</b>. HCT-8, HCT-8/5-FU, and CCD841 cells were pretreated in triplicate with the indicated concentrations of carboxy-PTIO (0, 6.25, 12.5, 25, or 50 μM) for 1 h and treated with 0.25 μM <b>4c</b> for 24 h. The results are expressed as the percentage of cell growth inhibition relative to control cells without the scavenger. Data are the mean value ± SD obtained from three independent experiments. **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furthermore, the effect of NO on the antitumor activity of <b>4c</b> was investigated. HCT-8 and HCT-8/5-FU cells were pretreated with various concentrations of an NO scavenger of carboxy-PTIO for 1 h and then treated with 0.25 μM of <b>4c</b>. The effects of different treatments on the proliferation of HCT-8 and HCT-8/5-FU cells were determined by the MTT assay (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Treatment with <b>4c</b> alone remarkably inhibited the proliferation of HCT-8 and HCT-8/5-FU cells, and its inhibitory effects were reduced dose-dependently by pretreatment with different concentrations of carboxy-PTIO. These results suggest that NO produced by <b>4c</b> may contribute to its inhibition on the proliferation of drug-sensitive and drug-resistant colon cancer cells in vitro.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> PepT1-Mediated Cell Uptake is Crucial for the Antitumor Activity of These Compounds</h4><div class="NLM_p">To determine the importance of PepT1-mediated update of compound, we tested whether the dipeptide Gly-Sar, a high affinity of substrate for PepT1,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> could modulate the antitumor activity of <b>4c</b> in HCT-8 and HCT-8/5-FU cells. The two cancer cells were treated with different doses of <b>4c</b> and Gly-Sar, and the proliferation of cancer cells were determined using MTT assay. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A,B, addition of Gly-Sar (0, 0.75, or 1.5 μM) significantly mitigated the inhibitory effects of <b>4c</b> on the proliferation of HCT-8 and HCT-8/5-FU cells and their regulatory effects tended to be dose-dependent. Furthermore, analysis of the impact of Gly-Sar on the levels of NO production by <b>4c</b> indicated that pretreatment with Gly-Sar reduced the levels of NO production by <b>4c</b> in both HCT-8 and HCT-8/5-FU cells in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Therefore, the PepT1 on these cancer cells is crucial for the intracellular transportation and antitumor activity of <b>4c</b>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PepT1-mediated cell uptake is important for the antitumor activity of <b>4c</b>. HCT-8 (A) and HCT-8/5-FU (B) cells were pretreated with, or without, Gly-Sar (0.75 or 1.5 μM) for 24 h and treated with the indicated concentrations of <b>4c</b> for 72 h. The inhibition on the proliferation of cancer cells was determined by MTT. (C) Effects of Gly-Sar on the levels of NO (present as nitrite) produced by <b>4c</b>. HCT-8 and HCT-8/5-FU cells were pretreated with, or without, different concentrations of Gly-Sar (0.75, 1.5, 3, 6, 12, 24, 48, 96, and 192 μM) for 150 min and treated with <b>4c</b> at 150 μM for 150 min. The concentrations of intracellular nitrite were determined by Griess assay. Data are expressed as the means ± SD of each concentration of compounds in individual types of cells from three experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the Gly-Sar untreated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Induction of Cancer Cell Apoptosis in Vitro</h4><div class="NLM_p">Previous studies have shown that CDDO-Me can induce cancer cell apoptosis by modulating the expression of apoptosis-related regulators and signal events,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and high levels of NO can induce tumor cell apoptosis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Accordingly, the effect of <b>4c</b> on induction of tumor cell apoptosis was tested. HCT-8 and HCT-8/5-FU cells were treated with variable concentrations of <b>4c</b>, CDDO-Me, or vehicle (0.4% DMSO in medium) for 24 h, respectively. The cells were harvested and stained with Annexin V-FITC and propidium iodide (PI), and the percentages of apoptotic cells were determined by flow cytometry analysis. Treatment with <b>4c</b> induced apoptosis in both HCT-8 and HCT-8/5-FU cells in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), and the effects of higher doses of <b>4c</b> were significantly stronger than that of CDDO-Me in both HCT-8 and HCT-8/5-FU cells.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compounds <b>4c</b> and CDDO-Me induce colon cancer cell apoptosis in vitro. HCT-8 (A) and HCT-8/5-FU (B) cells were incubated with the indicated concentrations of <b>4c</b> or CDDO-Me for 24 h, and the percentages of apoptotic cells were determined by flow cytometry after staining them with Annexin V-FITC and propidium iodide (PI). Data are representative charts or expressed as the means ± SD of the percentages of apoptotic cells from three independent experiments. **<i>P</i> < 0.01 vs the CDDO-Me group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Effects of <b>4c</b> on the HIF-1α, Stat3, AKT, and ERK Signaling in HCT-8 and HCT-8/5-FU Cells</h4><div class="NLM_p">To gain more insights into the molecular mechanisms underlying the activity of <b>4c</b>, we examined the regulatory effects of <b>4c</b> on the HIF-1α, Stat3, AKT, and ERK signaling in HCT-8 and HCT-8/5-FU cells using CDDO-Me as a control. The cells were treated with various concentrations of <b>4c</b> or CDDO-Me. The expression and activation of HIF-1α, Stat3, AKT, and ERK were determined by Western blotting. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, treatment with <b>4c</b> significantly inhibited the HIF-1α expression and Stat3, AKT, and ERK phosphorylation in a dose-dependent manner, although it did not alter the levels of Stat3, AKT, and ERK expression in cancer cells. Similarly, treatment with CDDO-Me also significantly reduced the levels of HIF-1α expression and Stat 3, AKT, and ERK phosphorylation in both cell lines and the inhibitory effects of CDDO-Me on the Stat3 phosphorylation and HIF-1α expression in both cell lines were significantly less than that of <b>4c</b> while the inhibitory effect of CDDO-Me on the ERK phosphorylation in HCT-8/5-FU cells was significantly stronger than that of <b>4c</b>. Previous studies have shown that aberrant activation of Stat3 and AKT and high levels of HIF-1α expression are associated with the development of human colon cancer,<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45-47)</a> and CDDO-Me can inhibit the proliferation of cancer cells by down-regulating the Stat3 and AKT activation and HIF-1α expression in cancer cells.<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48-50)</a> Recent studies also show that high levels of ROS directly inhibit the Stat3 and AKT activation.<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51-53)</a> Accordingly, the strong inhibition of <b>4c</b> on the Stat3, AKT, and ERK activation may reflect the synergistic effect of high levels of ROS and CDDO activity in colon cancer cells. While oxidative stress and related ROS production usually promote the HIF-1α expression, we observed that treatment with <b>4c</b> significantly reduced the levels of HIF-1α expression in both colon cancer lines. The reduced levels of HIF-1α expression by <b>4c</b> may stem from ROS-mediated inactivation of Stat3, which can attenuate the Stat3-up-regulated PI3K/AKT/mTOR activation and downstream HIF-1α expression in colon cancer cells. The precise mechanisms underlying the action of <b>4c</b> remain to be further investigated.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>4c</b> and CDDO-Me on the HIF-1α, Stat3, AKT, and ERK signaling in HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with vehicle or the indicated compound for 24 h, and the relative levels of HIF-1α, Stat3, AKT, and ERK expression and phosphorylation were determined by Western blot assays using β-actin as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of HIF-1α, Stat3, AKT, and ERK expression and phosphorylation. (B) Quantitative analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated control. <sup>#</sup><i>P</i> < 0.05 vs the CDDO-Me group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Effect of <b>4c</b> on ABC-Transporter Expression</h4><div class="NLM_p">High levels of NO can react with superoxide to produce peroxynitrite anion, which can nitrate the tyrosine residue of many key proteins, including ABC transporters, attenuating MDR.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> To further understand the role of <b>4c</b> in inhibiting drug-resistant colon cancer cell proliferation, the impact of <b>4c</b> on the levels of Pgp, MRP1, and BCRP expression was determined by Western blotting. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>A, the relative levels of Pgp, MRP1, and BCRP expression in HCT-8/5-FU cells were significantly higher than that in HCT-8 cells. Furthermore, treatment with <b>4c</b>, but not CDDO-Me, significantly reduced the relative levels of Pgp, MRP1, and BCRP expression in a dose-dependent manner and these inhibitory effects were partially attenuated by pretreatment with the NO scavenger of carboxy-PTIO in HCT-8/5-FU cells. In addition, we also tested the impact of <b>4c</b> on the nitration of Pgp, MRP1, and BCRP in HCT-8/5-FU cells. HCT-8/5-FU cells were treated with, or without, different concentrations of <b>4c</b> or CDDO-Me, and the nitrated Pgp, MRP1, and BCRP proteins were precipitated by antinitrotyrosine antibody. Subsequently, the relative levels of nitrated Pgp, MRP1, and BCRP were determined by Western blotting using individual specific antibodies (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>B). Treatment with <b>4c</b>, but not CDDO-Me, increased the levels of nitrated Pgp, MRP1, and BCRP in a dose-dependent manner, which was partially attenuated by pretreatment with carboxy-PTIO in HCT-8/5-FU cells. Apparently, high levels of NO produced by <b>4c</b> were responsible for the nitration of Pgp, MRP1, and BCRP in HCT-8/5-FU cells.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nitration of drug efflux pumps by <b>4c</b> in HCT-8/5-FU cells. (A) Expression of ABC transporters in HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with, or without, the indicated concentrations of <b>4c</b> or CDDO-Me for 24 h, and the relative levels of Pgp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 to GAPDH were determined by Western blotting. In addition, the nitrated Pgp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 in the HCT-8/5-FU cell lysates were precipitated by antinitrotyrosine antibody and characterized by Western blotting using individual specific antibodies. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western analysis of the relative levels of ABC transporter expression. ***<i>P</i> < 0.001 vs the HCT-8 group. (B) Western blot analysis of the levels of nitrated ABC transporters. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs the PTIO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Safety Profile in Healthy Mice</h4><div class="NLM_p">To evaluate the safety of <b>4c</b>, the acute toxicity of <b>4c</b> was examined in healthy mice. Adult ICR mice at either gender were randomly treated by oral gavage with various doses of <b>4c</b> (dissolved in the vehicle consisting of cremophor-EL/DMSO/PBS (1:1:8)),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> based on our preliminary study, and the survival of the mice was monitored up to 14 days post treatment. Interestingly, <b>4c</b> did not cause any mouse death or abnormality in eating, drinking, body weight, or activity throughout the observation period even when the dose was raised up to 2000 mg/kg (2.38 × 10<sup>3</sup> μmol/kg) (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, data from other doses not shown), indicating a relative safety of <b>4c</b> in vivo.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Safety of <b>4c</b> in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±">body weight<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose mg/kg (μmol/kg)</th><th class="colsep0 rowsep0" align="center" char=".">no. of mice</th><th class="colsep0 rowsep0" align="center">mouse sex</th><th class="colsep0 rowsep0" align="center" char=".">total mortality (1–14 d) </th><th class="colsep0 rowsep0" align="center" char="±">day 0</th><th class="colsep0 rowsep0" align="center" char="±">day 7</th><th class="colsep0 rowsep0" align="center" char="±">day 14</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2000 (2.38 × 10<sup>3</sup>)</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char="±">19.8 ± 0.92</td><td class="colsep0 rowsep0" align="char" char="±">25 ± 1.05</td><td class="colsep0 rowsep0" align="char" char="±">30 ± 1.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2000 (2.38 × 10<sup>3</sup>)</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char="±">19.5 ± 0.85</td><td class="colsep0 rowsep0" align="char" char="±">26.7 ± 1.89</td><td class="colsep0 rowsep0" align="char" char="±">31.9 ± 1.97</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data shown are the means ± SD of body weights from each group of mice (<i>n</i> = 10).</p></div></div></div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Antitumor Activity of <b>4c</b> against the Growth of HCT-8/5-FU Xenograft Tumors in Mice</h4><div class="NLM_p">To evaluate the in vivo anticancer activity of <b>4c</b>, BALB/c nude mice were inoculated subcutaneously with drug-resistant colon carcinoma HCT-8/5-FU cells. After the establishment of solid tumor, the mice were randomly treated by gavage with CDDO-Me, <b>4c</b> at the indicated doses, or vehicle (cremophor-EL/DMSO/PBS (1:1:8))<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> daily for 21 consecutive days (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). It was found that all mice survived and the obvious abnormalities in the liver, kidney, lung, and heart in terms of the size, color, and weights in the control, <b>4c</b>, or CDDO-Me-treated mice were not observed although the body weights in the control, <b>4c</b>-, and CDDO-Me-treated groups of mice were somewhat reduced (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In addition, treatment with 15 mg/kg (17.8 μmol/kg) of <b>4c</b> significantly reduced the volumes of implanted colon tumors, while treatment with <b>4c</b> at 30 mg/kg (35.7 μmol/kg) further inhibited the growth of the implanted tumors (<i>P</i> < 0.01 vs the vehicle-treated control, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), indicating that the antitumor activity of <b>4c</b> tended to be dose-dependent. Furthermore, the tumor weights (0.48 ± 0.17 g) in the mice treated with <b>4c</b> at 30 mg/kg (35.7 μmol/kg) were significantly reduced by 60.83%, as compared with those of the vehicle-treated controls (1.24 ± 0.19 g, <i>P</i> < 0.01, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). More importantly, the antitumor activity of <b>4c</b> at 30 mg/kg (35.7 μmol/kg) was comparable with that of CDDO-Me at 30 mg/kg (59.4 μmol/kg). Therefore, <b>4c</b> had more potent antitumor activity against the growth of implanted human colon tumors than CDDO-Me in mice.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Inhibition of <b>4c</b> on the growth of implanted drug-resistant colon tumors in mice. Male BALB/c nude mice were inoculated with HCT-8/5-FU cells, and after establishment of solid tumors, the mice were randomly treated with the indicated doses of <b>4c</b>, CDDO-Me, or vehicle (cremophor-EL/DMSO/PBS (1:1:8)) daily and the tumor volumes were measured every other day through the observation period in a blinded manner. Data are expressed as the mean ± SD from each group of mice (<i>n</i> = 8 per group). **<i>P</i> < 0.01 vs the vehicle-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of <b>4c</b> on the Body and Tumor Weights in Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">body weight (g)</th><th class="colsep0 rowsep0" align="center" char="±"> </th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">group</th><th class="colsep0 rowsep0" align="center">dose mg/kg (μmol/kg)</th><th class="colsep0 rowsep0" align="center" char="±">day 1</th><th class="colsep0 rowsep0" align="center" char="±">day 21</th><th class="colsep0 rowsep0" align="center" char="±">tumor weight (g)</th><th class="colsep0 rowsep0" align="center" char=".">inhibitory ratio (%, w/w)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">control</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">20.8 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="±">18.2 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">1.24 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDDO-Me</td><td class="colsep0 rowsep0" align="left">30 (59.4)</td><td class="colsep0 rowsep0" align="char" char="±">22.4 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">16.7 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">0.51 ± 0.25<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">58.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">15 (17.8)</td><td class="colsep0 rowsep0" align="char" char="±">22.3 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">17.5 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.25<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">49.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">30 (35.7)</td><td class="colsep0 rowsep0" align="char" char="±">21.1 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">16.7 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">0.48 ± 0.17<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">60.83</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data shown are the means ± SD of tumor weights in mice and their body weights from each group of mice (<i>n</i> = 8).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>P</i> < 0.01 vs the vehicle-treated control.</p></div></div></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a series of trihybrids (<b>4a</b>–<b>q</b>) were designed and synthesized from CDDO, amino acid, and (phenylsulfonyl)furoxan and were biologically evaluated. The most active compound <b>4c</b> exhibited strong and preferable antitumor activity against both drug-sensitive HCT-8 and drug-resistant HCT-8/5-FU cells. Treatment with <b>4c</b> induced high levels of NO production in HCT-8 and HCT-8/5-FU cells but not in human nontumor colon epithelial-like CDD841 cells, and its antitumor activity was significantly attenuated by an NO scavenger or a known substrate of PepT1 in a dose-dependent manner. In addition, <b>4c</b> displayed more potent capacity to induce HCT-8 and HCT-8/5-FU cell apoptosis than CDDO-Me. Furthermore, treatment with <b>4c</b> inhibited the HIF-1α, Stat 3, AKT, and ERK signaling in HCT-8 and HCT-8/5-FU cells and reduced the relative levels of P-gp, MRP1, and BCRP by nitrating these cellular drug efflux proteins in HCT-8/5-FU cells. Moreover, <b>4c</b> was relatively safe to mice and inhibited the growth of implanted human colon tumors more potently than CDDO-Me in mice. Together, these data indicated that <b>4c</b>, a trihybrid of CDDO, amino acid, and NO donor moieties, had more potent antitumor activity preferably against human colon cancer than CDDO-Me. Our findings may provide a proof of principle for design of such trihybrids like <b>4c</b> as potent and selective anticolon cancer agents potentially to circumvent MDR.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Protocols</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemical Analysis</h3><div class="NLM_p last">Melting points were determined on a Mel-TEMP II melting point apparatus and were uncorrected. Infrared (IR) spectra (KBr) were recorded on a Nicolet Impact 410 instrument (KBr pellet). <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded with a Bruker Avance 300 MHz spectrometer at 300 K, using TMS as an internal standard. MS spectra were recorded on a Mariner Mass Spectrum (ESI) and high resolution mass spectrometry (HRMS) on Agilent Technologies LC/MSD TOF. Analytical and preparative TLC was performed on silica gel (200–300 mesh) GF/UV 254 plates, and the chromatograms were visualized under UV light at 254 and 365 nm. All solvents were reagent grade and, when necessary, were purified and dried by standard methods. Solutions after reactions and extractions were concentrated using a rotary evaporator operating at a reduced pressure of ca. 20 Torr. The purity of all tested compounds was characterized by HPLC analysis (LC-10A HPLC system consisting of LC-10ATvp pumps and an SPD-10Avp UV detector). Individual compounds with a purity of >95% were used for subsequent experiments (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). CDDO, acyl chloride of CDDO, and <b>2a</b>–<b>e</b> was prepared according to the method described previously.<a onclick="showRef(event, 'ref21 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref21 ref26 ref27">(21, 26, 27)</a> The procedure for the preparation of compound <b>5</b> was shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure S2">Supporting Information, Figure S2</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Preparation of Compounds <b>3a</b>–<b>q</b></h3><div class="NLM_p last">To a solution of Boc-amino acid (3.1 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (5 mL), <b>2a</b>–<b>e</b> (3.0 mmol), 1-(3-(dimethylamino)propyl)-3-ethylcarbodiimide hydrochloride (EDCI) (6 mmol), and 4-dimethylaminopyridine (DMAP) (0.3 mmol) were added, and the mixture was stirred at room temperature for 6–12 h. The reaction solution was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with brine and then dried with sodium sulfate, filtered, and evaporated in vacuo to give corresponding crude compound <b>3a</b>–<b>q</b> (93–96%), respectively, which was used in the next without further purification.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Preparation of Compounds <b>4a</b>–<b>q</b></h3><div class="NLM_p">A mixture of <b>3a</b>–<b>q</b> (2 mmol) and TFA (15 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was stirred at room temperature for 0.5 h. The reaction mixture was then cooled to 0 °C, and Et<sub>3</sub>N (20 mmol) and acyl chloride of CDDO (2 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was sequentially thus added dropwise and the mixture was allowed to stir at room temperature for 12 h. The reaction solution was quenched by adding water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The resulting crude product was purified by flash chromatography on silica gel column (PE:AcOEt = 7:3–1:1 v/v) to provide the title compounds <b>4a</b>–<b>q</b> (54–80%), respectively.</div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Compound <b>4a</b></h4><div class="NLM_p last">The title compound was obtained in 65% yield as a white solid: mp 119–121 °C. IR (KBr): 3129, 1729, 1689, 1663, 1615, 1549, 1399 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.09–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>H), 7.78–7.66 (m, 3H, 3 × ArH), 5.95 (s, 1H, C<sub>11</sub>-H), 5.09 (s, 2H, CH<sub>2</sub>O), 4.81 (s, 2H, CH<sub>2</sub>O), 4.53–4.50 (m, 1H, NCHCOO), 4.15–4.09 (m, 2H, NCH<sub>2</sub>), 3.24–3.22 (m, 1H, C<sub>13</sub>-H), 3.08–3.06 (m, 1H, C<sub>18</sub>-H), 1.48 (s, 3H, CH<sub>3</sub>), 1.36 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.88 (s, 3H, CH<sub>3</sub>), 0.86 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.5, 196.1, 175.4, 171.4, 165.4, 165.2, 157.6, 135.3, 130.4, 129.2, 129.2, 128.3, 128.1, 128.1, 123.4, 114.0, 113.9, 83.4, 78.1, 65.0, 61.1, 59.0, 58.1, 51.8, 49.3, 47.9, 47.3, 44.5, 42.0, 41.8, 35.8, 33.6, 32.9, 31.4, 31.2, 31.1, 29.3, 29.2, 28.8, 27.6, 26.1, 25.7, 24.6, 23.4, 22.2. 21.8, 21.0, 17.7. ESI-MS: 881 [M + H]<sup>+</sup>. HRMS: calculated for C<sub>48</sub>H<sub>56</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 903.3615, found 903.3635.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Compound <b>4b</b></h4><div class="NLM_p last">The title compound was obtained in 80% yield as a white solid: mp 102–104 °C. IR (KBr): 3131, 1739, 1685, 1661, 1617, 1549, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.09–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.79 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.65 (t, <i>J</i> = 7.6 Hz, 2H, 2 × ArH), 6.18 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 5.97 (s, 1H, C<sub>11</sub>-H), 5.11 (s, 2H, CH<sub>2</sub>O), 4.75 (s, 2H, CH<sub>2</sub>O), 3.06 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.91–2.87 (m, 1H, C<sub>18</sub>-H), 2.39 (t, <i>J</i> = 7.1 Hz, 2H, CH<sub>2</sub>COO), 1.48 (s, 3H, CH<sub>3</sub>), 1.33 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.5, 196.1, 176.8, 171.9, 168.2, 165.3, 157.6, 137.0, 135.3, 130.4, 129.2, 129.2, 128.2, 128.2, 123.5, 114.1, 113.9, 83.4, 78.2, 65.1, 58.1, 51.5, 49.0, 47.2, 46.0, 45.4, 44.5, 42.0, 41.6, 38.5, 35.6, 34.1, 33.6, 32.8, 31.4, 31.2, 30.9, 30.1, 29.2, 27.3, 26.1, 24.3, 22.6, 22.2, 21.2, 21.0, 17.7. ESI-MS: 869 [M + H]<sup>+</sup>, 891 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>47</sub>H<sub>56</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 891.3615, found 891.3633.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Compound <b>4c</b></h4><div class="NLM_p last">The title compound was obtained in 77% yield as a white solid: mp 120–122 °C. IR (KBr): 3129, 1758, 1685, 1660, 1618, 1548, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.15–8.09 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.4 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.7 Hz, 2H, 2 × ArH), 6.35 (t, <i>J</i> = 5.4 Hz,1H, CONH), 6.00 (s, 1H, C<sub>11</sub>-H), 5.10 (s, 2H, CH<sub>2</sub>O), 4.80 (s, 2H, CH<sub>2</sub>O), 4.13–4.09 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>COO), 3.14 (d, <i>J</i> = 4.6 Hz, 1H, C<sub>13</sub>-H), 2.97–2.94 (m, 1H, C<sub>18</sub>-H), 1.48 (s, 3H, CH<sub>3</sub>), 1.36 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.91 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 177.3, 169.0, 168.6, 165.6, 157.4, 137.5, 135.3, 129.3, 129.3, 128.1, 128.1, 123.5, 116.4, 114.0, 114.0, 82.9, 78.6, 58.1, 52.0, 49.0, 47.2, 46.1, 45.5, 44.5, 42.1, 41.7, 40.6, 35.5, 34.1, 33.5, 32.7, 31.4, 31.2, 30.1, 29.2, 28.8, 27.1, 26.4, 24.5, 22.6, 21.2, 21.0, 17.7. ESI-MS: 841 [M + H]<sup>+</sup>, 863 [M + Na]<sup>+</sup>, 879 [M + K]<sup>+</sup>. HRMS: calculated for C<sub>45</sub>H<sub>52</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 863.3302, found 863.3320.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Compound <b>4d</b></h4><div class="NLM_p last">The title compound was obtained in 74% yield as a white solid: mp 128–130 °C. IR (KBr): 3131, 1751, 1689, 1662, 1616, 1553, 1398 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.10–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 6.7 Hz, 1H, ArH), 7.66 (t, <i>J</i> = 6.9 Hz, 2H, 2 × ArH), 6.36 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 5.97 (s, 1H, C<sub>11</sub>-H), 4.52–4.50 (m, 2H, CH<sub>2</sub>O), 4.36–4.34 (m, 2H, CH<sub>2</sub>O), 4.11–4.08 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>COO), 3.14 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.98–2.94 (m, 1H, C<sub>18</sub>-H), 1.46 (s, 3H, CH<sub>3</sub>), 1.35 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.99 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 177.3, 169.7, 168.5, 165.7, 158.3, 137.3, 135.3,129.3, 129.3, 128.3, 128.3, 123.4, 114.0, 113.9, 110.0, 67.7, 60.9, 49.0, 47.2, 46.0, 45.5, 44.5, 42.0, 41.7, 40.7, 35.5, 34.1, 33.5, 32.7, 31.3, 31.3, 30.1, 29.2, 27.5, 27.1, 26.1, 24.4, 22.6, 22.2, 21.2, 21.0, 17.7. ESI-MS: 831 [M + H]<sup>+</sup>, 853 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>44</sub>H<sub>54</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 853.3458, found 853.3474.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Compound <b>4e</b></h4><div class="NLM_p last">The title compound was obtained in 63% yield as a white solid: mp 116–118 °C. IR (KBr): 3128, 1735, 1685, 1662, 1617, 1553, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.07–8.05 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.79 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.65 (t, <i>J</i> = 7.9, 7.6 Hz, 2H, 2 × ArH), 6.18 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 5.97 (s, 1H, C<sub>11</sub>-H), 4.53 (t, <i>J</i> = 6.0 Hz, 2H, CH<sub>2</sub>O), 4.29 (t, <i>J</i> = 6.0 Hz, 2H, CH<sub>2</sub>O), 3.41–3.29 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>), 3.06 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.91–2.87 (m, 1H, C<sub>18</sub>-H), 2.39 (t, <i>J</i> = 7.1 Hz, 2H, CH<sub>2</sub>COO), 2.25–2,20 (m, 2H, OCH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>O), 1.47 (s, 3H, CH<sub>3</sub>), 1.33 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 0.99 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 199.0, 196.6, 177.3, 173.2, 168.7, 166.0, 158.9, 137.9, 135.7, 129.7, 129.7, 128.6, 128.6, 124.0, 114.5, 114.5, 110.5, 68.1, 60.5, 49.5, 47.7, 46.5, 45.9, 45.0, 42.6, 42.1, 39.1, 36.0, 34.6, 34.1, 33.3, 31.8, 31.6, 31.6, 30.6, 29.7, 27.9, 27.8, 26.9, 24.8, 24.8, 23.1, 22.9, 21.7, 21.5, 18.2. ESI-MS: 859 [M + H]<sup>+</sup>, 881 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>46</sub>H<sub>58</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 881.3771, found 881.3787.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Compound <b>4f</b></h4><div class="NLM_p last">The title compound was obtained in 58% yield as a white solid: mp 122–124 °C. IR (KBr): 3128, 1743, 1689, 1664, 1613, 1553, 1398 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.07–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.77 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.63 (t, <i>J</i> = 7.8 Hz, 2H, 2 × ArH), 5.94 (s, 1H, C<sub>11</sub>-H), 4.53–4.51 (m, 3H, CH<sub>2</sub>O, NCHCOO), 4.16–4.06 (m, 2H, CH<sub>2</sub>O), 3.83–3.81 (m, 2H, NCH<sub>2</sub>), 3.26–3.22 (m, 1H, C<sub>13</sub>-H), 3.07–3.05 (m, 1H, C<sub>18</sub>-H), 1.46 (s, 3H, CH<sub>3</sub>), 1.34 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.15 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 0.91 (s, 3H, CH<sub>3</sub>), 0.88 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 175.3, 172.2, 168.3, 165.5, 158.3, 137.5, 135.2, 129.2, 129.2, 128.1, 128.1, 123.4, 114.0, 113.9, 110.4, 67.6, 61.3, 60.2, 49.3, 48.0, 47.3, 47.1, 45.5, 44.5, 42.0, 41.7, 35.8, 33.6, 32.9, 31.4, 31.1, 30.9, 30.1, 29.4, 29.2, 28.8, 27.7, 27.1, 26.2, 24.6, 22.9, 22.2, 21.9, 21.0, 17.7. ESI-MS: 871 [M + H]<sup>+</sup>, 893 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>47</sub>H<sub>58</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 893.3771, found 893.3790.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Compound <b>4g</b></h4><div class="NLM_p last">The title compound was obtained in 70% yield as a white solid: mp 110–112 °C. IR (KBr): 3130, 1744, 1685, 1662, 1616, 1549, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.13–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.0 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.7 Hz, 2H, 2 × ArH), 6.53 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 6.03 (s, 1H, C<sub>11</sub>-H), 4.46 (t, <i>J</i> = 5.3 Hz, 2H, CH<sub>2</sub>O), 4.24 (t, <i>J</i> = 6.1 Hz, 2H, CH<sub>2</sub>O), 4.13–4.08 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>COO), 3.17 (d, <i>J</i> = 3.9 Hz, 1H, C<sub>13</sub>-H), 2.99–2.95 (m, 1H, C<sub>18</sub>-H), 1.47 (s, 3H, CH<sub>3</sub>), 1.36 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.98 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.8, 196.3, 177.3, 169.8, 168.5, 165.8, 158.4, 137.4, 135.3, 129.2, 129.2, 128.0, 128.0, 123.4, 114.1, 113.8, 110.1, 70.4, 63.9, 48.9, 47.1, 46.0, 45.4, 44.5, 42.1, 41.7, 40.1, 35.5, 34.1, 33.5, 32.7, 31.3, 31.1, 30.1, 29.2, 27.1, 26.1, 24.6, 24.5, 24.4, 22.6, 22.6, 21.2, 21.0, 17.7. ESI-MS: 845 [M + H]<sup>+</sup>, 867 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>45</sub>H<sub>56</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 867.3615, found 867.3630.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Compound <b>4h</b></h4><div class="NLM_p last">The title compound was obtained in 74% yield as a white solid: mp 137–139 °C. IR (KBr): 3129, 1738, 1685, 1658, 1618, 1553, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.11–8.05 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.79 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.65 (t, <i>J</i> = 7.9 Hz, 2H, 2 × ArH), 6.32 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 6.00 (s, 1H, C<sub>11</sub>-H), 4.47 (t, <i>J</i> = 6.0 Hz, 2H, CH<sub>2</sub>O), 4.19 (t, <i>J</i> = 6.2 Hz, 2H, CH<sub>2</sub>O), 3.33 (q, <i>J</i> = 6.0 Hz, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 3.07 (d, <i>J</i> = 4.3 Hz, 1H, C<sub>13</sub>-H), 2.93–2.89 (m, 1H, C<sub>18</sub>-H), 2.39 (t, <i>J</i> = 7.2 Hz, 2H, CH<sub>2</sub>COO), 1.48 (s, 3H, CH<sub>3</sub>), 1.33, (s, 3H, CH<sub>3</sub>) 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 0.99 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 176.9, 173.0, 168.3, 165.5, 158.4, 137.3, 135.2, 130.4, 129.2, 129.2, 128.0, 128.0, 123.5, 113.9, 113.9, 70.5, 63.3, 49.0, 47.1, 45.9, 45.4, 44.5, 42.1, 41.6, 38.7, 35.5, 34.1, 33.5, 32.8, 31.2, 31.1, 30.1, 29.2, 27.2, 26.4, 26.1, 24.7, 24.5, 24.2, 22.6, 22.4, 21.2, 21.0, 18.7, 17.7. ESI-MS: 873 [M + H]<sup>+</sup>. HRMS: calculated for C<sub>47</sub>H<sub>60</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 895.4084, found 895.4102.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Compound <b>4i</b></h4><div class="NLM_p last">The title compound was obtained in 54% yield as a white solid: mp 115–117 °C. IR (KBr): 3130, 1737, 1688, 1658, 1614, 1546, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.06–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.77 (t, <i>J</i> = 7.3 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.3 Hz, 2H, 2 × ArH), 5.94 (s, 1H, C<sub>11</sub>-H), 4–52–4.44 (m, 3H, CH<sub>2</sub>O, NCHCOO), 4.21–4.19 (m, 2H, CH<sub>2</sub>O), 3.83–3.80 (m, 2H, NCH<sub>2</sub>), 3.26–3.22 (m, 1H, C<sub>13</sub>-H), 3.13–3.10 (m, 1H, C<sub>18</sub>-H), 1.47 (s, 3H, CH<sub>3</sub>), 1.36 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.91 (s, 3H, CH<sub>3</sub>), 0.88 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.6, 196.2, 175.2, 172.3, 168.2, 165.5, 158.4, 137.5, 135.2, 129.2, 129.2, 128.0, 128.0, 123.4, 113.9, 113.9, 110.0, 65.0, 63.4, 61.3, 49.3, 47.9, 47.2, 47.0, 45.5, 44.5, 42.0, 41.7, 35.8, 33.6, 32.9, 31.4, 31.2, 30.1, 29.4, 29.2, 28.8, 27.5, 27.1, 26.1, 25.7, 24.6, 23.9, 23.4, 22.2, 21.8, 21.0, 17.7. ESI-MS: 885 [M + H]<sup>+</sup>, 907 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>48</sub>H<sub>60</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 907.3928, found 907.3943.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Compound <b>4j</b></h4><div class="NLM_p last">The title compound was obtained in 72% yield as a white solid: mp 109–111 °C. IR (KBr): 3129, 1747, 1689, 1662, 1616, 1553, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.07–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.63 (t, <i>J</i> = 7.9, 7.6 Hz, 2H, 2 × ArH), 6.41 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 6.00 (s, 1H, C<sub>11</sub>-H), 4.43 (t, <i>J</i> = 6.4 Hz, 2H, CH<sub>2</sub>O), 4.16 (t, <i>J</i> = 6.5 Hz, 2H, CH<sub>2</sub>O), 4.05 (t, <i>J</i> = 6.7 Hz, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>COO), 3.16 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.99–2.94 (m, 1H, C<sub>18</sub>-H), 1.48 (s, 3H, CH<sub>3</sub>), 1.36 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.99 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 177.2, 169.8, 168.5, 165.6, 158.5, 137.6, 135.2, 129.2, 129.2, 128.0, 128.0, 123.5, 114.0, 113.9, 110.0, 70.9, 64.6, 49.0, 47.2, 46.0, 45.4, 44.5, 42.1, 41.7, 40.7, 35.5, 34.1, 33.5, 32.7, 31.3, 31.2, 30.1, 29.2, 28.8, 27.9, 27.8, 27.1, 26.1, 24.9, 24.8, 24.4, 22.6, 21.2, 21.0, 17.7. ESI-MS: 873 [M + H]<sup>+</sup>, 895 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>47</sub>H<sub>60</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 895.3928, found 895.3946.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Compound <b>4k</b></h4><div class="NLM_p last">The title compound was obtained in 67% yield as a white solid: mp 108–110 °C. IR (KBr): 3128, 1729, 1685, 1662, 1616, 1553, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.07–8.05 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.80 (t, <i>J</i> = 9.3 Hz, 1H, ArH), 7.63 (t, <i>J</i> = 8.0, 7.5 Hz, 2H, 2 × ArH), 6.16 (t, <i>J</i> = 5.6, 1H, CONH), 5.97 (s, 1H, C<sub>11</sub>-H), 4.43 (t, <i>J</i> = 6.4 Hz, 2H, CH<sub>2</sub>O), 4.11 (t, <i>J</i> = 6.6 Hz, 2H, CH<sub>2</sub>O), 3.35–3.28 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 3.07 (t, <i>J</i> = 4.3 Hz, 1H, C<sub>13</sub>-H), 2.92–2.87 (m, 1H, C<sub>18</sub>-H), 2.37 (t, <i>J</i> = 7.1 Hz, 2H, CH<sub>2</sub>COO), 1.48 (s, 3H, CH<sub>3</sub>), 1.33 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.6, 196.2, 176.8, 173.0, 168.1, 165.6, 158.5, 137.5, 135.2, 129.2, 129.2, 128.0, 128.0, 123.5, 114.0, 113.9, 110.0, 70.9, 63.9, 48.9, 47.1, 45.9, 45.4, 44.5, 42.1, 41.6, 38.7, 35.5, 34.1, 33.5, 32.8, 31.3, 31.2, 31.1, 30.1, 29.2, 27.9, 27.8, 27.3, 26.0, 25.0, 24.8, 24.3, 24.2, 22.6, 22.5, 21.2, 21.0, 17.7. ESI-MS: 901 [M + H]<sup>+</sup>, 923 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>49</sub>H<sub>64</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 923.4241, found 923.4258.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Compound <b>4l</b></h4><div class="NLM_p last">The title compound was obtained in 63% yield as a white solid: mp 120–122 °C; IR (KBr): 3129, 1738, 1685, 1663, 1613, 1553, 1399 cm<sup>–1</sup>; <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.07–8.04 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.63 (t, <i>J</i> = 7.9 Hz, 2H, 2 × ArH), 5.93 (s, 1H, C<sub>11</sub>-H), 4.52–4.50 (m, 1H, NCHCOO), 4.43 (t, <i>J</i> = 6.4 Hz, 2H, CH<sub>2</sub>O), 4.13 (t, <i>J</i> = 6.4 Hz, 2H, CH<sub>2</sub>O), 3.83–3.80 (m, 2H, NCH<sub>2</sub>), 3.26–3.21 (m, 1H, C<sub>13</sub>-H), 3.13–3.10 (m, 1H, C<sub>18</sub>-H), 1.47 (s, 3H, CH<sub>3</sub>), 1.35 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.13 (s, 3H, CH<sub>3</sub>), 1.02 (s, 3H, CH<sub>3</sub>), 0.85 (s, 3H, CH<sub>3</sub>) ppm; <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.7, 196.2, 175.1, 172.3, 168.0, 165.5, 158.5, 137.6, 135.2, 129.2, 129.2, 128.0, 128.0, 123.4, 114.0, 113.9, 110.2, 70.9, 64.1, 61.3, 49.2, 47.9, 47.2, 47.0, 45.5, 44.5, 42.0, 41.8, 35.7, 33.7, 32.9, 31.2, 31.1, 30.1, 29.3, 29.2, 28.0, 27.8, 27.6, 27.1, 26.1, 25.7, 24.9, 24.8, 24.5, 23.3, 22.2, 21.7, 21.0, 17.7; ESI-MS: 913 [M + H]<sup>+</sup>, 935 [M + Na]<sup>+</sup>; HRMS: calculated for C<sub>50</sub>H<sub>64</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 935.4241, found 935.4261.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Compound <b>4m</b></h4><div class="NLM_p last">The title compound was obtained in 66% yield as a white solid: mp 118–120 °C. IR (KBr): 3128, 1747, 1691, 1658, 1620, 1552, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.08–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.4 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.8, 7.3 Hz, 2H, 2 × ArH), 6.36 (t, <i>J</i> = 5.4 Hz, 1H, CONH), 5.96 (s, 1H, C<sub>11</sub>-H), 4.58–4.56 (m, 2H, CH<sub>2</sub>O), 4.35–4.33 (m, 2H, CH<sub>2</sub>O), 4.11–4.09 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>COO), 3.92–3.90 (m, 2H, CH<sub>2</sub>O), 3.81–3.79 (m, 2H, CH<sub>2</sub>O), 3.14 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.98–2.94 (m, 1H, C<sub>18</sub>-H), 1.47 (s, 3H, CH<sub>3</sub>), 1.34 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.18 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.98 (s, 3H, CH<sub>3</sub>), 0.90 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.5, 196.8, 177.2, 169.7, 168.2, 165.4, 157.4, 137.5, 135.2, 129.2, 129.2, 128.1, 128.1, 123.5, 114.0, 113.9, 110.0, 70.0, 68.7, 67.8, 63.4, 48.9, 47.2, 46.0, 45.4, 44.5, 42.0, 41.7, 40.6, 35.5, 33.5, 32.7, 31.3, 31.2, 30.1, 29.2, 28.8, 27.2, 26.1, 24.4, 22.7, 22.6, 21.2, 21.0, 17.7. ESI-MS: 863 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>45</sub>H<sub>56</sub>N<sub>4</sub>O<sub>11</sub>SNa [M + Na]<sup>+</sup> 883.3564, found 883.3583.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Compound <b>4n</b></h4><div class="NLM_p last">The title compound was obtained in 59% yield as a white solid: mp 126–128 °C. IR (KBr): 3128, 1729, 1685, 1662, 1611, 1555, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.08–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78 (t, <i>J</i> = 7.1 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.7 Hz, 2H, 2 × ArH), 6.19 (t, <i>J</i> = 5.5 Hz, 1H, CONH), 5.96 (s, 1H, C<sub>11</sub>-H), 4.58 (t, <i>J</i> = 4.1 Hz, 2H, CH<sub>2</sub>O), 4.29 (t, <i>J</i> = 4.4 Hz, 2H, CH<sub>2</sub>O), 3.92 (t, <i>J</i> = 4.3 Hz, 2H, CH<sub>2</sub>O), 3.80 (t, <i>J</i> = 4.7 Hz, 2H, CH<sub>2</sub>O), 3.32–3.28 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 3.08 (d, <i>J</i> = 4.2 Hz, 1H, C<sub>13</sub>-H), 2.92–2.88 (m, 1H, C<sub>18</sub>-H), 2.40 (t, <i>J</i> = 6.9 Hz, 2H, CH<sub>2</sub>COO), 1.47 (s, 3H, CH<sub>3</sub>), 1.32 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.99 (s, 3H, CH<sub>3</sub>), 0.89 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.5, 196.1, 176.8, 172.9, 168.1, 165.4, 158.4, 137.4, 135.2, 129.2, 129.2, 128.1, 128.1, 127.4, 123.5, 114.0, 113.9, 70.0, 68.9, 67.8, 63.0, 48.9, 47.2, 45.9, 45.4, 44.5, 42.0, 41.6, 38.6, 35.5, 34.1, 33.6, 32.8, 31.3, 31.2, 31.2, 30.1, 29.2, 27.3, 26.1, 24.3, 24.2, 22.6, 22.5, 21.2, 21.0, 17.7. ESI-MS: 889 [M + H]<sup>+</sup>, 911 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>47</sub>H<sub>60</sub>N<sub>4</sub>O<sub>11</sub>SNa [M + Na]<sup>+</sup> 911.3877, found 911.3898.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Compound <b>4o</b></h4><div class="NLM_p last">The title compound was obtained in 63% yield as a white solid: mp 122–124 °C. IR (KBr): 3129, 1738, 1691, 1661, 1616, 1549, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.08–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.77 (t, <i>J</i> = 7.5 Hz, 1H, ArH), 7.64 (t, <i>J</i> = 7.4 Hz, 2H, 2 × ArH), 5.93 (s, 1H, C<sub>11</sub>-H), 4.61–4.57 (m, 3H, NCHCOO, CH<sub>2</sub>O), 4.32–4.27 (m, 2H, CH<sub>2</sub>O), 3.96–3.90 (m, 2H, CH<sub>2</sub>O), 3.81–3.79 (m, 4H, CH<sub>2</sub>O, NCH<sub>2</sub>), 3.15–3.13 (m, 1H, C<sub>13</sub>-H), 3.09–3.06 (m, 1H, C<sub>18</sub>-H), 1.44 (s, 3H, CH<sub>3</sub>), 1.33 (s, 3H, CH<sub>3</sub>), 1.25 (s, 3H, CH<sub>3</sub>), 1.24 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.01 (s, 3H, CH<sub>3</sub>), 0.91 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.6, 196.1, 175.2, 172.2, 168.0, 165.4, 158.4, 137.5, 135.2, 129.2, 129.2, 128.1, 128.1, 127.4, 123.4, 114.0, 113.9, 70.0, 68.9, 67.8, 63.2, 61.2, 49.3, 47.9, 47.3, 47.0, 45.5, 44.5, 42.0, 41.8, 35.7, 33.7, 32.9, 31.2, 31.1, 30.1, 29.3, 29.2, 27.6, 27.1, 26.1, 25.7, 24.5, 23.4, 21.8, 21.5, 21.0, 17.7. ESI-MS: 901 [M + H]<sup>+</sup>, 923 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>48</sub>H<sub>60</sub>N<sub>4</sub>O<sub>11</sub>SNa [M + Na]<sup>+</sup> 923.3877, found 923.3893.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Compound <b>4p</b></h4><div class="NLM_p last">The title compound was obtained in 73% yield as a white solid: mp 132–134 °C. IR (KBr): 3130, 1744, 1691, 1662, 1616, 1549, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.09–8.05 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.79–7.62 (m, 3H, 3 × ArH), 6.37–6.36 (m, 1H, CONH), 5.94 (s, 1H, C<sub>11</sub>-H), 5.12 (s, 2H, CH<sub>2</sub>O), 4.75 (s, 2H, CH<sub>2</sub>O), 3.58–3.56 (m, 2H, NH<u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 3.04–3.05 (m, 1H, C<sub>13</sub>-H), 2.91 (m, 1H, C<sub>18</sub>-H), 2.60–2.61 (m, 2H, CH<sub>2</sub>COO), 1.48 (s, 3H, CH<sub>3</sub>), 1.33 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.16 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.88 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 198.9, 196.6, 177.3, 171.6, 168.6, 165.8, 158.4, 135.8, 131.0, 129.7, 129.7, 128.8, 128.7, 128.7, 123.9, 114.5, 114.4, 83.7, 78.9, 58.6, 52.1, 49.4, 47.7, 46.4, 45.9, 45.0, 42.5, 42.1, 36.0, 35.1, 34.6, 33.9, 33.2, 31.8, 31.7, 30.6, 29.7, 27.7, 27.0, 26.6, 24.7, 23.1, 23.0, 21.7, 21.6, 18.2. ESI-MS: 877 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>46</sub>H<sub>54</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup>877.3458, found 877.3473.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Compound <b>4q</b></h4><div class="NLM_p last">The title compound was obtained in 68% yield as a white solid: mp 129–131 °C. IR (KBr): 3129, 1747, 1689, 1662, 1616, 1549, 1400 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 8.09–8.06 (m, 3H, 2 × ArH, C<sub>1</sub>-H), 7.78–7.64 (m, 3H, 3 × ArH), 6.22–6.19 (m, 1H, CONH), 5.99 (s, 1H, C<sub>11</sub>-H), 5.10 (s, 2H, CH<sub>2</sub>O), 4.81 (s, 2H, CH<sub>2</sub>O), 4.63–4.61 (m, 1H, NH<u class="uu">CH</u>(CH<sub>3</sub>)COO), 3.14–3.08 (m, 1H, C<sub>13</sub>-H), 2.94–2.91 (m, 1H, C<sub>18</sub>-H), 1.49 (s, 3H, CH<sub>3</sub>), 1.34 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.26 (s, 3H, CH<sub>3</sub>), 1.18 (s, 3H, CH<sub>3</sub>), 1.00 (s, 3H, CH<sub>3</sub>), 0.88 (s, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 M Hz, CDCl<sub>3</sub>, 25 °C, TMS): δ 199.0, 196.6, 177.0, 172.5, 168.7, 165.9, 157.0, 135.8, 130.9, 129.7, 129.7, 128.8, 128.7, 128.7, 124.0, 114.5, 114.4, 83.4, 79.0, 65.8, 58.5, 52.7, 49.5, 47.7, 46.4, 45.9, 45.0, 42.5, 42.1, 36.0, 35.9, 34.6, 34.0, 33.2, 31.9, 31.8, 30.6, 29.7, 27.6, 27.0, 26.6, 24.7, 23.1, 21.7, 21.6, 18.2. ESI-MS: 877 [M + Na]<sup>+</sup>. HRMS: calculated for C<sub>46</sub>H<sub>54</sub>N<sub>4</sub>O<sub>10</sub>SNa [M + Na]<sup>+</sup> 877.3458, found 877.3481.</div></div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> MTT Assay</h3><div class="NLM_p last">The effects of different trihybrids and CDDO-Me on the proliferation of human colon cancer and nontumor cells were investigated by the MTT assay. The compounds were dissolved in DMSO and diluted with culture medium into eight concentrations (0.015625, 0.03125, 0.0625, 0.125, 0.25, 0.5, 1, and 5 μM) of solution for each compound (final DMSO concentration in medium <0.4%). HCT-8, HCT-8/5-FU, or nontumor CCD841 cells (1.0 × 10<sup>4</sup> cells/well) were cultured in 10% fetal bovine serum (FBS) DMEM medium (Invitrogen) as the complete medium in 96-well cell plates overnight and treated in triplicate with, or without, different concentrations of individual compounds for 72 h. During the last 4 h culture, the cells were exposed to MTT (5 mg/mL, Signma), and the resulting formazan crystals were dissolved in 150 μL of DMSO and measured using an microplate reader (Tecan) at 570 nm. Inhibition rate (%) = [(<i>A</i><sub>control</sub> – <i>A</i><sub>treated</sub>)/<i>A</i><sub>control</sub>] × 100%.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Nitrite Measurement in Vitro</h3><div class="NLM_p last">The levels of intracellular NO generated by individual compounds were determined by the colorimetric assay using the nitrite colorimetric assay kit (Beyotime, China), according to the manufacturer’s instructions. Briefly, HCT-8 or HCT-8/5FU or CCD841 cells (1 × 10<sup>6</sup>/well) were treated with 100 or 150 μM of each compound for 150 min in the presence or absence of different concentrations of a PpeT1 substrate of Gly-Sar. Furthermore, some experiments were performed after pretreatment of cells with different concentrations of a NO scavenger of PITO for 150 min. Subsequently, the cells were harvested and their cell lysates were prepared and then mixed with Griess reagent for 10 min at 37 °C, followed by measurement at 540 nm by an microplate reader. The cells treated with 0.4% DMSO in medium were used as negative controls for the background levels of nitrite production, while sodium nitrite at different concentrations was prepared as the positive control for the establishment of a standard curve.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Flow Cytometry Analysis of Apoptotic Cells</h3><div class="NLM_p last">HCT-8 and HCT-8/5-FU cells (1 × 10<sup>5</sup>/well) were cultured in complete medium in six-well plates for 24 h and treated in duplicate with different concentrations of <b>4c</b> or CDDO-Me for 24 h. The control cells wre treated with vehicle (0.4% DMSO in complete medium). The cells were harvested, washed, and stained with propidium iodide (PI) and FITC-Annexin-V in the dark for 15 min using the FITC-AnnexinV Kit (BD PharMingen). The percentages of apoptotic cells were determined by flow cytometry on an FACS Calibur flow cytometer (Becton Dickinson).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Western Blotting Analysis</h3><div class="NLM_p last">HCT-8 or HCT-8/5-FU (1 × 10<sup>6</sup> cells/well) were cultured in 6 cm dishes for 24 h and were treated in duplicate with 0.25, 0.5, or 1 μM <b>4c</b> or 1 μM CDDO-Me in the presence of absence of PTIO for 24 h. The cells were harvested and lysed. After protein quantification using the BCA protein assay kit (Beyotime, China), the cell lysates (20 μg/lane) were separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE, 7.5% gel) and transferred onto polyvinylidenedifluoride (PVDF) membranes. After the membranes were blocked in 5% fat-free milk for 1 h, the target proteins were probed with anti-Pgp, anti-MRP1, anti-BCRP, anti-HIF-1α, anti-AKT, antiphospho-AKT (Ser473), anti-ERK, antiphospho-ERK (Thr202/Tyr204), anti-Stat3, antiphoshpo-Stat3, anti-GAPDH, and anti-β-actin antibodies (Cell Signaling, Boston, MA). The bound antibodies were detected using horseradish peroxidase (HRP)-conjugated second antibodies and visualized by the enhanced chemiluminescent reagent. The relative levels of interesting protein expression and phosphorylation were determined by densitometric scanning using ImageJ software. In addition, the relative levels of PepT1, Pgp, MRP1, and BCRP expression in the unmanipulated cells were also determined by Western blotting using specific antibodies.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Analysis of Nitrated Drug Transporters</h3><div class="NLM_p last">Some HCT-8/5-FU cell lysates were incubated with antinitrotyrosine antibody (Cambridge, MA, USA) and protein G microbeads (Cambridge, MA, USA) overnight at 4 °C with gently shocking. After centrifugation, the microbeads were washed extensively and the immune precipitated nitrolized proteins were eluted. Subsequently, the contents of nitrated Pgp, MRP1, and BCRP were characterized by Western blotting using anti-Pgp, anti-MRP1, and anti-BCRP, respectively.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Acute Toxicity of <b>4c</b> in Mice</h3><div class="NLM_p last">Both genders of ICR mice at 7 weeks of age were purchased from Slac Laboratory Animal Co. of the China Academy of Science (SLACCAS, Shanghai, China), and were housed in a specific pathogen free facility. The mice were randomly treated by oral gavage with a single dose of <b>4c</b> at 500, 1000, 1500, and 2000 mg/kg (0.60 × 10<sup>3</sup>, 1.19 × 10<sup>3</sup>, 1.79 × 10<sup>3</sup>, and 2.38 × 10<sup>3</sup> μmol/kg), respectively. The mice were monitored for their survival, behaviors, the amounts of water and food consumption, body weights, and activity up to 14 days post treatment. The experimental protocols were evaluated and approved by the Ethics Committee of the China Pharmaceutical University.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Mouse Tumor Xenograft Model</h3><div class="NLM_p last">Male athymic BALB/c nude mice at 3–5 weeks old were obtained from SLACCAS and housed in an individual ventilated cage under controlled environmental conditions in an AAALAC-accredited facility. The mice at 6–8 weeks old were inoculated subcutaneously with HCT-8/5-FU cells (2 × 10<sup>6</sup>/mouse) in the right flank. After establishment of solid tumors at an average volume of 180–200 mm<sup>3</sup> (9–11 days postimplantation), the animals were randomly treated by gavage with vehicle alone (0.2 mL) consisting of cremophor-EL/DMSO/PBS (1:1:8),<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> 15 mg/kg (17.8 μmol/kg) or 30 mg/kg (35.7 μmol/kg) <b>4c</b>, or 30 mg/kg (59.4 μmol/kg) CDDO-Me in vehicle daily for 21 consecutive days. Tumor volumes were measured every other day using a vernier caliper and calculated using the following formula: tumor volume (mm<sup>3</sup>) = <i>W</i><sup>2</sup> (<i>L</i>/2), where <i>W</i> = width and <i>L</i> = length (mm).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm5019302">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34012" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34012" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Preparative procedures and spectral data for compound <b>5</b> and HPLC spectra for the purities of compounds <b>4a</b>–<b>q</b> (PEF and CSV). This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019302/suppl_file/jm5019302_si_001.pdf">jm5019302_si_001.pdf (807.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019302/suppl_file/jm5019302_si_002.csv">jm5019302_si_002.csv (3.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5019302" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhangjian Huang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f9bcd494989095c39a898c9d98918c98979eb9c8cfcad79a9694">E-mail:<span class="__cf_email__" data-cfemail="fc9f8c89989d94899d929bbccdcacfd29f9391">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yihua Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c060514081b183c4d4a4f521f1311"><span class="__cf_email__" data-cfemail="cab0b3a2beadae8afbfcf9e4a9a5a7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Ai</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fenghua Kang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaowen Xue</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yisheng Lai</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sixun Peng</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines, China
Pharmaceutical University, Nanjing 210009, PR China</span>; 
    <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jide Tian</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular and Medical Pharmacology, University
of California, Los Angeles, California 90095, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d674e3846-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by grants from the National Natural Science Foundation of China (nos. 81273378, 21372261, 81202408, and No. 21472244).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">CDDO-Me</td><td class="NLM_def"><p class="first last">methyl-2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate</p></td></tr><tr><td class="NLM_term">CDDO-Im</td><td class="NLM_def"><p class="first last">1-[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">w/w</td><td class="NLM_def"><p class="first last">weight per unit weight (weight-to-weight ratio)</p></td></tr><tr><td class="NLM_term">PTIO</td><td class="NLM_def"><p class="first last">2-phenyl-4,4,5,5,-tetramethylimidazoline-1-oxyl 3-oxide</p></td></tr><tr><td class="NLM_term">BOC</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">AKT (protein kinase B)</td><td class="NLM_def"><p class="first last">a serine/threonine protein kinase</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular regulated kinase</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">Stat3</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription 3</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">human hypoxia inducible factor 1 alpha</p></td></tr><tr><td class="NLM_term">etc</td><td class="NLM_def"><p class="first last">and so forth</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-[4,5-dimethyl-thiazol-2-yl]-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluoro- 2,4(1<i>H</i>,3<i>H</i>)-pyrimidinedione</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 53 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lhiqHWZEfzOAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szak%C3%A1csauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0lhiqHWZEfzOAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homolya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Váradi, A.</span><span> </span><span class="NLM_article-title">Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=1179-1236&author=B.+Sarkadiauthor=L.+Homolyaauthor=G.+Szak%C3%A1csauthor=A.+V%C3%A1radi&title=Human+multidrug+resistance+ABCB+and+ABCG+transporters%3A+participation+in+a+chemoimmunity+defense+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHomolya%26aufirst%3DL.%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26atitle%3DHuman%2520multidrug%2520resistance%2520ABCB%2520and%2520ABCG%2520transporters%253A%2520participation%2520in%2520a%2520chemoimmunity%2520defense%2520system%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26spage%3D1179%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R.</span><span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+Coleauthor=G.+Bhardwajauthor=J.+Gerlachauthor=J.+Mackieauthor=C.+Grantauthor=K.+Almquistauthor=A.+Stewartauthor=E.+Kurzauthor=A.+Duncanauthor=R.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0li8lMGD7SzRVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DAlmquist%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DDuncan%26aufirst%3DA.%26aulast%3DDeeley%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Uchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, M.</span><span> </span><span class="NLM_article-title">Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fsj.bjc.6690186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=10098753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A280%3ADyaK1M7ps1eruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=1168-1173&author=S.+Uchidaauthor=Y.+Shimadaauthor=G.+Watanabeauthor=Z.+G.+Liauthor=T.+Hongauthor=M.+Miyakeauthor=M.+Imamura&title=Motility-related+protein+%28MRP-1%2FCD9%29+and+KAI1%2FCD82+expression+inversely+correlate+with+lymph+node+metastasis+in+oesophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma</span></div><div class="casAuthors">Uchida S; Shimada Y; Watanabe G; Li Z G; Hong T; Miyake M; Imamura M</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1168-73</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers.  The suppression of cell motility by MRP-1/CD9 may cause suppression of the metastasis.  As we could not find any reports concerning the expression of MRP-1/CD9 and KAI1/CD82 in oesophageal cancers we investigated their expression in oesophageal specimens.  We conducted immunohistochemical staining for MRP1/CD9 against 108 cases of oesophageal squamous cell carcinoma using anti-MRP-1/CD9 monoclonal antibody M31-15, and for KAI1/CD82 against 104 cases using anti-KAI1/CD82 monoclonal antibody C33.  To investigate the gradual expression of MRP-1/CD9 and KAI1/CD82, 24 oesophageal dysplasias were immunohistochemically stained using the same method and then investigated.  The expression of both MRP-1/CD9 and KAI1/CD82 were positive on the cell membranes of normal oesophageal epithelial cells, but reduced or negative in the cancer cells.  Reduced MRP-1/CD9 expressions significantly correlated to tumour depth (P = 0.0009).  We found a significantly greater number of reduced or negative expression of MRP-1/CD9 and KAI1/CD82 in lymph node metastatic cases (P = 0.0003 and P= 0.0129, respectively), but not in distant metastatic cases.  The 5-year survival rate of MRP-1/CD9-negative and reduced patients was significantly worse than those of positive patients (n = 108, curative cases, RO).  Few cases remained KAI1/CD82-positive (9.6%; 10/104) in oesophageal cancer.  Twenty (83.3%) and twenty-two (91.7%) cases out of 24 dysplasias were defined as KAI1/CD82-positive and MRP1/CD9-positive, respectively.  The decrease in MRP-1/CD9 and KAI1/CD82 expression may facilitate lymph node metastasis in oesophageal squamous cell carcinomas.  Knowing the status of the expression of MRP-1/CD9 appears helpful in predicting the prognosis for each patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0HVn8r3Ac0YhLSh9fo81bfW6udTcc2eaqTRI3mDKacrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7ps1eruw%253D%253D&md5=2ec1da90bf54cf62b063ce1d4c316d3d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690186%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DS.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%2BG.%26aulast%3DHong%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DM.%26atitle%3DMotility-related%2520protein%2520%2528MRP-1%252FCD9%2529%2520and%2520KAI1%252FCD82%2520expression%2520inversely%2520correlate%2520with%2520lymph%2520node%2520metastasis%2520in%2520oesophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D79%26spage%3D1168%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0li8lMGD7SzRVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Eckford, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3011</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0lgcRtg8KnEpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannock, I. F.</span><span> </span><span class="NLM_article-title">Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1007%2Fs10555-012-9402-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=23093326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=211-227&author=M.+Yuauthor=A.+Ocanaauthor=I.+F.+Tannock&title=Reversal+of+ATP-binding+cassette+drug+transporter+activity+to+modulate+chemoresistance%3A+why+has+it+failed+to+provide+clinical+benefit%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?</span></div><div class="casAuthors">Yu, Man; Ocana, Alberto; Tannock, Ian F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">211-227</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Enhanced drug extrusion from cells due to the overexpression of the ATP-binding cassette (ABC) drug transporters inhibits the cytotoxic effects of structurally diverse and mechanistically unrelated anticancer agents and is a major cause of multidrug resistance (MDR) of human malignancies.  Multiple compds. can suppress the activity of these efflux transporters and sensitize resistant tumor cells, but despite promising preclin. and early clin. data, they have yet to find a role in oncol. practice.  Based on the knowledge of the structure, function, and distribution of MDR-related ABC transporters and the results of their preclin. and clin. evaluation, we discuss probable reasons why these inhibitors have not improved the outcome of therapy for cancer patients.  We also outline new MDR-reversing strategies that directly target ABC transporters or circumvent relevant signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBAZK6a3syH7Vg90H21EOLACvtfcHk0lgcRtg8KnEpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFWit78%253D&md5=76bbcfcf06b4b4274310f9f48a8cf3cd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10555-012-9402-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-012-9402-8%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOcana%26aufirst%3DA.%26aulast%3DTannock%26aufirst%3DI.%2BF.%26atitle%3DReversal%2520of%2520ATP-binding%2520cassette%2520drug%2520transporter%2520activity%2520to%2520modulate%2520chemoresistance%253A%2520why%2520has%2520it%2520failed%2520to%2520provide%2520clinical%2520benefit%253F%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2013%26volume%3D32%26spage%3D211%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">The role of nitric oxide in tumour progression</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16794635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=521-534&author=D.+Fukumuraauthor=S.+Kashiwagiauthor=R.+K.+Jain&title=The+role+of+nitric+oxide+in+tumour+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide in tumour progression</span></div><div class="casAuthors">Fukumura, Dai; Kashiwagi, Satoshi; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumors and are known to exert both pro- and anti-tumor effects.  We summarize our current understanding of the role of NO in tumor progression, esp. in relation to angiogenesis and vascular functions.  We also discuss potential strategies for cancer treatment that modulate NO prodn. and/or its downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorTlzSMm-9dbVg90H21EOLACvtfcHk0lgcRtg8KnEpEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D&md5=ee546d1b8e37e216ef373374ba15209c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1910%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520nitric%2520oxide%2520in%2520tumour%2520progression%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D521%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baritaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K.</span><span> </span><span class="NLM_article-title">Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=152-157&author=B.+Bonavidaauthor=S.+Baritakiauthor=S.+Huerta-Yepezauthor=M.+I.+Vegaauthor=D.+Chatterjeeauthor=K.+Yeung&title=Novel+therapeutic+applications+of+nitric+oxide+donors+in+cancer%3A+roles+in+chemo-+and+immunosensitization+to+apoptosis+and+inhibition+of+metastases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DBaritaki%26aufirst%3DS.%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DM.%2BI.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DYeung%26aufirst%3DK.%26atitle%3DNovel%2520therapeutic%2520applications%2520of%2520nitric%2520oxide%2520donors%2520in%2520cancer%253A%2520roles%2520in%2520chemo-%2520and%2520immunosensitization%2520to%2520apoptosis%2520and%2520inhibition%2520of%2520metastases%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D152%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viarisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costamagna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescarmona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span> </span><span class="NLM_article-title">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+oxide+reverts+the+resistance+to+doxorubicin+in+human+colon+cancer+cells+by+inhibiting+the+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0lj6F6bqlWNfgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520reverts%2520the%2520resistance%2520to%2520doxorubicin%2520in%2520human%2520colon%2520cancer%2520cells%2520by%2520inhibiting%2520the%2520drug%2520efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Sullivan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. H.</span><span> </span><span class="NLM_article-title">Chemosensitization of cancer by nitric oxide</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.2174%2F138161208784246225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=18473858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslKrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1113-1123&author=R.+Sullivanauthor=C.+H.+Graham&title=Chemosensitization+of+cancer+by+nitric+oxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitization of cancer by nitric oxide</span></div><div class="casAuthors">Sullivan, Richard; Graham, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1113-1123</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent evidence from exptl. and clin. studies links the development of intratumoral hypoxia and oxidative stress with malignant progression.  Cellular adaptation induced by these environmental stresses is also assocd. with the emergence of drug resistant populations.  This adaptation is most likely a multifactorial process involving coordination of various stress-induced signaling pathways, including those regulated by hypoxia-inducible factor-1 (HIF-1) and nuclear factor κB (NF-κB) together with their down-stream targets linked to resistance mechanisms.  Exptl. data suggest that treatment of human cancer cells with nitric oxide (NO) and NO mimetic agents can effectively restore the sensitivity of resistant populations to the cytotoxic effects of chemotherapeutics both in vitro and in vivo.  Furthermore, preliminary results from Phase II clin. trials evaluating NO as an adjuvant to chemotherapy are promising.  The present review highlights the significance of intratumoral hypoxia and oxidative stress in the emergence of multidrug resistance, and summarizes the latest data demonstrating the chemosensitizing ability of NO.  To date, the specific mechanisms through which NO restores sensitivity to anticancer agents are not clearly understood.  However, the data suggest that chemosensitization is likely to involve NO-mediated activities assocd. with both prevention and inhibition of cellular drug resistance mechanisms.  Potential mechanisms contributing to the chemosensitizing activity of NO include vascular changes that promote increased blood delivery and tumor oxygenation, antioxidant effects and down-regulation of the glutathione detoxification/redox buffering system, inhibition of key transcription factors such as HIF-1 and NF-κB, as well as inhibition of drug efflux transporters and DNA repair enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKEY49it3dbVg90H21EOLACvtfcHk0lj6F6bqlWNfgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslKrsrw%253D&md5=e0a4aa6a7c684d5e8cc68e2c88dffe09</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208784246225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784246225%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DR.%26aulast%3DGraham%26aufirst%3DC.%2BH.%26atitle%3DChemosensitization%2520of%2520cancer%2520by%2520nitric%2520oxide%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1113%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=537-542&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=S.+J.+Knox&title=Novel+nitric+oxide+generating+compound+glycidyl+nitrate+enhances+the+therapeutic+efficacy+of+chemotherapy+and+radiotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DNovel%2520nitric%2520oxide%2520generating%2520compound%2520glycidyl%2520nitrate%2520enhances%2520the%2520therapeutic%2520efficacy%2520of%2520chemotherapy%2520and%2520radiotherapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D537%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hutchens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manevich, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, D. M.</span><span> </span><span class="NLM_article-title">Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=719-729&author=S.+Hutchensauthor=Y.+Manevichauthor=L.+Heauthor=K.+D.+Tewauthor=D.+M.+Townsend&title=Cellular+resistance+to+a+nitric+oxide+releasing+glutathione+S-transferase+P-activated+prodrug%2C+PABA%2FNO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutchens%26aufirst%3DS.%26aulast%3DManevich%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26atitle%3DCellular%2520resistance%2520to%2520a%2520nitric%2520oxide%2520releasing%2520glutathione%2520S-transferase%2520P-activated%2520prodrug%252C%2520PABA%252FNO%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D719%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Aguirre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arredondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basombrío, M. A.</span><span> </span><span class="NLM_article-title">Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=54-59&author=G.+Aguirreauthor=M.+Boianiauthor=H.+Cerecettoauthor=M.+Fern%C3%A1ndezauthor=M.+Gonz%C3%A1lezauthor=E.+Le%C3%B3nauthor=C.+Pintosauthor=S.+Raymondoauthor=C.+Arredondoauthor=J.+P.+Pachecoauthor=M.+A.+Basombr%C3%ADo&title=Furoxan+derivatives+as+cytotoxic+agents%3A+preliminary+in+vivo+antitumoral+activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguirre%26aufirst%3DG.%26aulast%3DBoiani%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DLe%25C3%25B3n%26aufirst%3DE.%26aulast%3DPintos%26aufirst%3DC.%26aulast%3DRaymondo%26aufirst%3DS.%26aulast%3DArredondo%26aufirst%3DC.%26aulast%3DPacheco%26aufirst%3DJ.%2BP.%26aulast%3DBasombr%25C3%25ADo%26aufirst%3DM.%2BA.%26atitle%3DFuroxan%2520derivatives%2520as%2520cytotoxic%2520agents%253A%2520preliminary%2520in%2520vivo%2520antitumoral%2520activity%2520studies%26jtitle%3DPharmazie%26date%3D2006%26volume%3D61%26spage%3D54%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9343</span><span class="NLM_x">–</span> <span class="NLM_lpage">9356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500613m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9343-9356&author=M.+Liuauthor=X.+Chenauthor=Y.+Huangauthor=P.+Fengauthor=Y.+Guoauthor=G.+Yangauthor=Y.+Chen&title=Hybrids+of+phenylsulfonylfuroxan+and+coumarin+as+potent+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm500613m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500613m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DHybrids%2520of%2520phenylsulfonylfuroxan%2520and%2520coumarin%2520as%2520potent%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9343%26epage%3D9356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">Nitric oxide donor doxorubicins accumulate into doxorubicin-resistant human colon cancer cells inducing cytotoxicity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100302t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=494-497&author=K.+Chegaevauthor=C.+Rigantiauthor=L.+Lazzaratoauthor=B.+Rolandoauthor=S.+Guglielmoauthor=I.+Campiaauthor=R.+Frutteroauthor=A.+Bosiaauthor=A.+Gasco&title=Nitric+oxide+donor+doxorubicins+accumulate+into+doxorubicin-resistant+human+colon+cancer+cells+inducing+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml100302t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100302t%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520donor%2520doxorubicins%2520accumulate%2520into%2520doxorubicin-resistant%2520human%2520colon%2520cancer%2520cells%2520inducing%2520cytotoxicity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D494%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span> </span><span class="NLM_article-title">Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5475</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100066y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5467-5475&author=R.+Frutteroauthor=M.+Crosettiauthor=K.+Chegaevauthor=S.+Guglielmoauthor=A.+Gascoauthor=F.+Berardiauthor=M.+Nisoauthor=R.+Perroneauthor=M.+A.+Panaroauthor=N.+A.+Colabufo&title=Phenylsulfonylfuroxans+as+modulators+of+multidrug-resistance-associated+protein-1+and+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100066y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100066y%26sid%3Dliteratum%253Aachs%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCrosetti%26aufirst%3DM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DPanaro%26aufirst%3DM.%2BA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26atitle%3DPhenylsulfonylfuroxans%2520as%2520modulators%2520of%2520multidrug-resistance-associated%2520protein-1%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5467%26epage%3D5475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800167u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4834-4838&author=L.+Chenauthor=Y.+Zhangauthor=X.+Kongauthor=E.+Lanauthor=Z.+Huangauthor=S.+Pengauthor=D.+L.+Kaufmanauthor=J.+Tian&title=Design%2C+synthesis%2C+and+antihepatocellular+carcinoma+activity+of+nitric+oxide+releasing+derivatives+of+oleanolic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800167u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800167u%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BL.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antihepatocellular%2520carcinoma%2520activity%2520of%2520nitric%2520oxide%2520releasing%2520derivatives%2520of%2520oleanolic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4834%26epage%3D4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4748</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400463q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4738-4748&author=C.+Hanauthor=Z.+Huangauthor=C.+Zhengauthor=L.+Wanauthor=L.+Zhangauthor=S.+Pengauthor=K.+Dingauthor=H.+Jiauthor=J.+Tianauthor=Y.+Zhang&title=Novel+hybrids+of+%28phenylsulfonyl%29furoxan+and+anilinopyrimidine+as+potent+and+selective+epidermal+growth+factor+receptor+inhibitors+for+intervention+of+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400463q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400463q%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520hybrids%2520of%2520%2528phenylsulfonyl%2529furoxan%2520and%2520anilinopyrimidine%2520as%2520potent%2520and%2520selective%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520for%2520intervention%2520of%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4738%26epage%3D4748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=801-805&author=X.+Tangauthor=X.+Guauthor=H.+Aiauthor=G.+Wangauthor=H.+Pengauthor=Y.+Laiauthor=Y.+Zhang&title=Synthesis+and+evaluation+of+nitric+oxide-releasing+DDB+derivatives+as+potential+Pgp-mediated+MDR+reversal+agents+in+MCF-7%2FAdr+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520nitric%2520oxide-releasing%2520DDB%2520derivatives%2520as%2520potential%2520Pgp-mediated%2520MDR%2520reversal%2520agents%2520in%2520MCF-7%252FAdr%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Gu, X.; Huang, Z.; Ren, Z.; Tang, X.; Peng, S.; Peng, H.; Lu, B.; Tian, J.; Zhang, Y.</span><span> </span><span class="NLM_article-title">Discovery of novel nitric oxide-donating DDB derivatives as potential anti-tumor agents against multidrug resistant leukemia</span>. J. Med. Chem. (submitted).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gu%2C+X.%3B+Huang%2C+Z.%3B+Ren%2C+Z.%3B+Tang%2C+X.%3B+Peng%2C+S.%3B+Peng%2C+H.%3B+Lu%2C+B.%3B+Tian%2C+J.%3B+Zhang%2C+Y.+Discovery+of+novel+nitric+oxide-donating+DDB+derivatives+as+potential+anti-tumor+agents+against+multidrug+resistant+leukemia.+J.+Med.+Chem.+%28submitted%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520nitric%2520oxide-donating%2520DDB%2520derivatives%2520as%2520potential%2520anti-tumor%2520agents%2520against%2520multidrug%2520resistant%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liby, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yore, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopchuk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span> </span><span class="NLM_article-title">New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/doi/10.1021/np100826q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=537-545&author=M.+B.+Spornauthor=K.+T.+Libyauthor=M.+M.+Yoreauthor=L.+Fuauthor=J.+M.+Lopchukauthor=G.+W.+Gribble&title=New+synthetic+triterpenoids%3A+potent+agents+for+prevention+and+treatment+of+tissue+injury+caused+by+inflammatory+and+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.; Yore, Mark M.; Fu, Liangfeng; Lopchuk, Justin M.; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We review the original rational for the development and the chem. of a series of new synthetic oleanane triterpenoids (SO), based on oleanolic acid (I) as a starting material.  Many of the new compds. that have been made, such as 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ["CDDO", (II; R = H)], are highly potent (activities found at levels below 1 nM) anti-inflammatory agents, as measured by their ability to block the cellular synthesis of the enzyme inducible nitric oxide synthase (iNOS) in activated macrophages.  Details of the org. synthesis of new SO and their chem. mechanisms of biol. activity are reviewed, as is formation of biotin conjugates for investigation of protein targets.  Finally, we give a brief summary of important biol. activities of SO in many organ systems in numerous animal models.  Clin. investigation of a new SO [Me 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate, "CDDO-Me", bardoxolone Me, (II; R = Me)] is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXWMDf2Fxc3LVg90H21EOLACvtfcHk0lhVUoGOzDgwyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D&md5=a6b2efe5faaba6151472b0f5f654940e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fnp100826q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100826q%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLopchuk%26aufirst%3DJ.%2BM.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DNew%2520synthetic%2520triterpenoids%253A%2520potent%2520agents%2520for%2520prevention%2520and%2520treatment%2520of%2520tissue%2520injury%2520caused%2520by%2520inflammatory%2520and%2520oxidative%2520stress%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D537%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rounds, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favaloro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span> </span><span class="NLM_article-title">Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4233</span><span class="NLM_x">–</span> <span class="NLM_lpage">4246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4233-4246&author=T.+Hondaauthor=B.+V.+Roundsauthor=L.+Boreauthor=H.+J.+Finlayauthor=F.+G.+Favaloroauthor=N.+Suhauthor=Y.+Wangauthor=M.+B.+Spornauthor=G.+W.+Gribble&title=Synthetic+oleanane+and+ursane+triterpenoids+with+modified+rings+A+and+C%3A+a+series+of+highly+active+inhibitors+of+nitric+oxide+production+in+mouse+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0002230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002230%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DRounds%26aufirst%3DB.%2BV.%26aulast%3DBore%26aufirst%3DL.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DFavaloro%26aufirst%3DF.%2BG.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DSynthetic%2520oleanane%2520and%2520ursane%2520triterpenoids%2520with%2520modified%2520rings%2520A%2520and%2520C%253A%2520a%2520series%2520of%2520highly%2520active%2520inhibitors%2520of%2520nitric%2520oxide%2520production%2520in%2520mouse%2520macrophages%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4233%26epage%3D4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favaloro, F. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Place, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span> </span><span class="NLM_article-title">A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1027-1030&author=T.+Hondaauthor=Y.+Hondaauthor=F.+G.+Favaloroauthor=G.+W.+Gribbleauthor=N.+Suhauthor=A.+E.+Placeauthor=M.+H.+Rendiauthor=M.+B.+Sporn&title=A+novel+dicyanotriterpenoid%2C+2-cyano-3%2C12-dioxooleana-1%2C9%2811%29-dien-28-onitrile%2C+active+at+picomolar+concentrations+for+inhibition+of+nitric+oxide+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DFavaloro%26aufirst%3DF.%2BG.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPlace%26aufirst%3DA.%2BE.%26aulast%3DRendi%26aufirst%3DM.%2BH.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DA%2520novel%2520dicyanotriterpenoid%252C%25202-cyano-3%252C12-dioxooleana-1%252C9%252811%2529-dien-28-onitrile%252C%2520active%2520at%2520picomolar%2520concentrations%2520for%2520inhibition%2520of%2520nitric%2520oxide%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">DDQ-promoted dehydrogenation from natural rigid polycyclic acids or flexible alkyl acids to generate lactones by a radical ion mechanism</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9495</span><span class="NLM_x">–</span> <span class="NLM_lpage">9497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=9495-9497&author=Y.+Dingauthor=Z.+Huangauthor=J.+Yinauthor=Y.+Laiauthor=S.+Zhangauthor=Z.+Zhangauthor=L.+Fangauthor=S.+Pengauthor=Y.+Zhang&title=DDQ-promoted+dehydrogenation+from+natural+rigid+polycyclic+acids+or+flexible+alkyl+acids+to+generate+lactones+by+a+radical+ion+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDDQ-promoted%2520dehydrogenation%2520from%2520natural%2520rigid%2520polycyclic%2520acids%2520or%2520flexible%2520alkyl%2520acids%2520to%2520generate%2520lactones%2520by%2520a%2520radical%2520ion%2520mechanism%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D9495%26epage%3D9497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells</span> <span class="citation_source-journal">Food Chem. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.fct.2013.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=24211866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyksb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=38-47&author=Z.+Zhangauthor=C.+Zhangauthor=Y.+Dingauthor=Q.+Zhaoauthor=L.+Yangauthor=J.+Lingauthor=L.+Liuauthor=H.+Jiauthor=Y.+Zhang&title=The+activation+of+p38+and+JNK+by+ROS%2C+contribute+to+OLO-2-mediated+intrinsic+apoptosis+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Zhang, Zhenzhen; Zhang, Chao; Ding, Ye; Zhao, Qian; Yang, Lifang; Ling, Jingjing; Liu, Ling; Ji, Hui; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, we describe that a novel synthesized compd., olean-28,13β-olide 2 (OLO-2), exhibits selective cytotoxic activity via inducing apoptosis in human hepatocellular carcinoma (HCC) cell lines but not normal human hepatic cells in vitro.  Exposure of human HCC HepG2 cells to OLO-2 results in significant loss of mitochondrial transmembrane potential (ΔΨm), the release of cytochrome c, the recruitment of B-cell lymphoma 2 (Bcl-2) assaciated X protein (Bax) and the downregulation of Bcl-2.  The apoptosis induced by OLO-2 is assocd. with the activation of caspase-3/9 and the nuclear translocation of apoptosis inducing factor (AIF).  Moreover, the increase of phosphorylated p38 and c-Jun N-terminal kinase (JNK) is obsd.  OLO-2-induced the externalization of phosphatidyl-serine (PS) and the loss of ΔΨm are blocked by p38 inhibitor SB203580 or JNK inhibitor SP600125.  In addn., OLO-2 provokes the generation of reactive oxygen species (ROS) in HepG2 cells, while the antioxidant N-acetyl cysteine (NAC) almost completely blocks OLO-2-induced apoptosis and the activation of p38 and JNK.  Taken together, the present study demonstrates that OLO-2 exhibits its cytotoxic activity through intrinsic apoptosis via ROS generation and the activation of p38 and JNK.  Its potential to be a candidate of anti-cancer agent is worth being further investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXRBGw2Zdia7Vg90H21EOLACvtfcHk0lg57nWVLlIwaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyksb3F&md5=5362d1e3697281c504adfc9b39b7d195</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2013.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2013.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520activation%2520of%2520p38%2520and%2520JNK%2520by%2520ROS%252C%2520contribute%2520to%2520OLO-2-mediated%2520intrinsic%2520apoptosis%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2014%26volume%3D63%26spage%3D38%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Liby, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yore, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span> </span><span class="NLM_article-title">Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer</span> <span class="citation_source-journal">Nature Rev. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc2129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=17446857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=357-369&author=K.+T.+Libyauthor=M.+M.+Yoreauthor=M.+B.+Sporn&title=Triterpenoids+and+rexinoids+as+multifunctional+agents+for+the+prevention+and+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer</span></div><div class="casAuthors">Liby, Karen T.; Yore, Mark M.; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-369</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Synthetic oleanane triterpenoids and rexinoids are two new classes of multifunctional drugs.  They are neither conventional cytotoxic agents, nor are they monofunctional drugs that uniquely target single steps in signal transduction pathways.  Synthetic oleanane triterpenoids have profound effects on inflammation and the redox state of cells and tissues, as well as being potent anti-proliferative and pro-apoptotic agents.  Rexinoids are ligands for the nuclear receptor transcription factors known as retinoid X receptors.  Both classes of agents can prevent and treat cancer in exptl. animals.  These drugs have unique mol. and cellular mechanisms of action and might prove to be synergistic with std. anti-cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngXAsiGtLhrVg90H21EOLACvtfcHk0lg57nWVLlIwaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7g%253D&md5=70f20e84e8ad6d4bbe03316432bb5b97</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrc2129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2129%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DTriterpenoids%2520and%2520rexinoids%2520as%2520multifunctional%2520agents%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer.%26date%3D2007%26volume%3D7%26spage%3D357%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Braga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayres-Saraiva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattass, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, M. A. M.</span><span> </span><span class="NLM_article-title">Oleanolic acid inhibits the activity of the multidrugresistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.canlet.2006.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16889888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2007&pages=147-152&author=F.+Bragaauthor=D.+Ayres-Saraivaauthor=C.+R.+Gattassauthor=M.+A.+M.+Capella&title=Oleanolic+acid+inhibits+the+activity+of+the+multidrugresistance+protein+ABCC1+%28MRP1%29+but+not+of+the+ABCB1+%28P-glycoprotein%29%3A+possible+use+in+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy</span></div><div class="casAuthors">Braga, F.; Ayres-Saraiva, D.; Gattass, C. R.; Capella, M. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of oleanolic acid (OA) on ABCB1 and ABCC1 activities were studied in a cell line constitutively expressing both proteins.  It was obsd. that OA did not alter ABCB1 activity, but inhibited the activity of ABCC1 protein.  This inhibition was reversible and only occurred in the presence of OA.  In addn., OA did not alter the expression of ABCC1 mRNA.  These results suggest that OA could be a good choice in the treatment of MDR tumors, either as a chemotherapy itself in tumors bearing ABCB1, or as an adjuvant in the chemotherapy of ABCC1 expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtV1rl85BULVg90H21EOLACvtfcHk0lg57nWVLlIwaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVWmu7Y%253D&md5=6a5c8b351bb5dfd598b367de6ee8111f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DF.%26aulast%3DAyres-Saraiva%26aufirst%3DD.%26aulast%3DGattass%26aufirst%3DC.%2BR.%26aulast%3DCapella%26aufirst%3DM.%2BA.%2BM.%26atitle%3DOleanolic%2520acid%2520inhibits%2520the%2520activity%2520of%2520the%2520multidrugresistance%2520protein%2520ABCC1%2520%2528MRP1%2529%2520but%2520not%2520of%2520the%2520ABCB1%2520%2528P-glycoprotein%2529%253A%2520possible%2520use%2520in%2520cancer%2520chemotherapy%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D248%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Paszel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubiś, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarczyk-Cwynar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaprutko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczmarek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczyńska, M.</span><span> </span><span class="NLM_article-title">Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2FS1734-1140%2811%2970714-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=22358098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1yjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1500-1517&author=A.+Paszelauthor=B.+Rubi%C5%9Bauthor=B.+Bednarczyk-Cwynarauthor=L.+Zaprutkoauthor=M.+Kaczmarekauthor=J.+Hofmannauthor=M.+Rybczy%C5%84ska&title=Oleanolic+acid+derivative+methyl+3%2C11-dioxoolean-12-en-28-olate+targets+multidrug+resistance+related+to+ABCB1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid derivative methyl 3,11-dioxoolean-l2-en-28-olate targets multidrug resistance related to ABCB1</span></div><div class="casAuthors">Paszel, Anna; Rubis, Blazej; Bednarczyk-Cwynar, Barbara; Zaprutko, Lucjusz; Kaczmarek, Mariusz; Hofmann, Johann; Rybczynska, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1500-1517</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) in leukemia patients is a great incentive to the development of new drugs.  In a search for potential multidrug resistance modulators we tested a group of oleanolic acid (OA) analogs modified at C-3, C-11, C-12 and C-28 using an exptl. model consisting of three human acute lymphoblastic leukemia cell lines (CCRF-CEM and the multidrug resistant sublines CCRF-VCR1000 and CCRF-ADR5000).  The most effective compd., Me 3,11-dioxoolean-12-en-28-olate (DIOXOL) was more potent in cell viability inhibition than its precursor - OA, and showed similar or even higher activity in the drug resistant than in the wild-type cells.  Resistance factor (RF) values obtained for CCRF-VCR1000 and CCRF-ADR-5000 cells using MTT assay were 0.7 and 0.8 (24 h of treatment) and after 72 h of treatment 0.9 and 1.1, resp.  Moreover, 5 μM DIOXOL significantly reduced the expression of the ABCB1 gene in MDR cells by around 30%, and also decreased the level of P-gp protein.  Compared to untreated control cells, DIOXOL treatment resulted in a significant P-gp decrease (30% in CCRF-ADR5000 and 50% in CCRF-VCR1000), that was detected by western blot and confirmed by flow cytometry anal.  Moreover, DIOXOL (at 10 μM) significantly inhibited P-gp transport function by more than twofold comparing to control, untreated cells that was demonstrated using rhodamine 123-based functional test.  The compd. exhibited synergistic activity with ABCB1 substrate - adriamycin in CCRF-VCR1000 cells, indicating partial but significant MDR reversing ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopKNB6BK_Xi7Vg90H21EOLACvtfcHk0lg4AKV9C2v_lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1yjs7k%253D&md5=4f50a0ae9fd29e151011925208833e48</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2811%2970714-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252811%252970714-9%26sid%3Dliteratum%253Aachs%26aulast%3DPaszel%26aufirst%3DA.%26aulast%3DRubi%25C5%259B%26aufirst%3DB.%26aulast%3DBednarczyk-Cwynar%26aufirst%3DB.%26aulast%3DZaprutko%26aufirst%3DL.%26aulast%3DKaczmarek%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DRybczy%25C5%2584ska%26aufirst%3DM.%26atitle%3DOleanolic%2520acid%2520derivative%2520methyl%25203%252C11-dioxoolean-12-en-28-olate%2520targets%2520multidrug%2520resistance%2520related%2520to%2520ABCB1%26jtitle%3DPharmacol.%2520Rep.%26date%3D2011%26volume%3D63%26spage%3D1500%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, K.</span><span> </span><span class="NLM_article-title">Recent advances in structural biology of peptide transporters</span> <span class="citation_source-journal">Curr. Top. Membr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2FB978-0-12-394316-3.00008-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2012&pages=257-274&author=T.+Teradaauthor=K.+Inui&title=Recent+advances+in+structural+biology+of+peptide+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in structural biology of peptide transporters</span></div><div class="casAuthors">Terada, Tomohiro; Inui, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Membranes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">Co-Transport Systems</span>),
    <span class="NLM_cas:pages">257-274</span>CODEN:
                <span class="NLM_cas:coden">CTMEET</span>;
        ISSN:<span class="NLM_cas:issn">1063-5823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Peptide transporters localized at brush-border membranes of intestinal and renal epithelial cells mediate the membrane transport of di- and tripeptides, and play important roles in protein absorption and the conservation of peptide-bound amino nitrogen.  Peptide-like drugs that show structural similarities to di- and tripeptides are also recognized by peptide transporters.  The energy for transport of small peptides and peptide-like drugs is provided by the proton gradient across the cell membrane.  Since the cloning of H+/peptide cotransporter (PEPT1, SLC15A1), there have been advances in the mol. biol., biochem., biophysics and structural detn. of PEPT1.  By integrating these advances, much effort has been made to understand the relationship between structure and function.  In silico exptl. strategies are classified as (1) construction of kinetic models, (2) computer modeling of PEPT1 structure and (3) homol. modeling of PEPT1 with crystal structures of bacterial transporters.  The hypotheses regarding the structure-function relationship produced by these strategies have been confirmed by in vitro mutagenesis including cysteine-scanning mutagenesis.  Recently, the crystal structure of PepTSo, a functionally similar prokaryotic homolog of the mammalian peptide transporters from Shewanella oneidensis, was classified, and the previous hypotheses regarding the structure-function relationship of PEPT1 have been re-evaluated.  This review highlights the recent advances in our knowledge of the structural biol. of PEPT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHja7umCppMLVg90H21EOLACvtfcHk0lg4AKV9C2v_lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFeisbk%253D&md5=5cee6ce36a7db3feb34fd5139b988d11</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394316-3.00008-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394316-3.00008-9%26sid%3Dliteratum%253Aachs%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520structural%2520biology%2520of%2520peptide%2520transporters%26jtitle%3DCurr.%2520Top.%2520Membr.%26date%3D2012%26volume%3D70%26spage%3D257%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Meredith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sword, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P. D.</span><span> </span><span class="NLM_article-title">Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">3723</span><span class="NLM_x">–</span> <span class="NLM_lpage">3728</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1046%2Fj.1432-1327.2000.01405.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=10848990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVKgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=3723-3728&author=D.+Meredithauthor=C.+S.+Templeauthor=N.+Guhaauthor=C.+J.+Swordauthor=C.+A.+Boydauthor=I.+D.+Collierauthor=K.+M.+Morganauthor=P.+D.+Bailey&title=Modified+amino+acids+and+peptides+as+substrates+for+the+intestinal+peptide+transporter+PepT1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1</span></div><div class="casAuthors">Meredith, David; Temple, Catherine S.; Guha, Nishan; Sword, Corinna J.; Boyd, C. A. Richard; Collier, Ian D.; Morgan, Keith M.; Bailey, Patrick D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3723-3728</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The binding affinities of a no. of amino-acid and peptide derivs. by the mammalian intestinal peptide transporter PepT1 were investigated, using the Xenopus laevis expression system.  A series of blocked amino acids, namely N-acetyl-Phe (Ac-Phe), Phe-amide (Phe-NH2), N-acetyl-Phe-amide (Ac-Phe-NH2) and the parent compd. Phe, was compared for efficacy in inhibiting the uptake of the peptide [3H]-D-Phe-L-Gln.  In an equiv. set of expts., the blocked peptides Ac-Phe-Tyr, Phe-Tyr-NH2 and Ac-Phe-Tyr-NH2 were compared with the parent compd. Phe-Tyr.  Comparing amino acids and derivs., only Ac-Phe was an effective inhibitor of peptide uptake (Ki = 1.81 ± 0.37 mM).  Ac-Phe-NH2 had a very weak interaction with PepT1 (Ki = 16.8 ± 5.64 mM); neither Phe nor Phe-NH2 interacted with PepT1 with measurable affinity.  With the dipeptide and derivs., unsurprisingly the highest affinity interaction was with Phe-Tyr (Ki = 0.10 ± 0.04 mM).  The blocked C-terminal peptide Phe-Tyr-NH2 also interacted with PepT1 with a relatively high affinity (Ki = 0.94 ± 0.38 mM).  Both Ac-Phe-Tyr and Ac-Phe-Tyr-NH2 interacted weakly with PepT1 (Ki = 8.41 ± 0.11 and 9.97 ± 4.01 mM, resp.).  The results suggest that the N-terminus is the primary binding site for both dipeptides and tripeptides.  Addnl. expts. with four stereoisomers of Ala-Ala-Ala support this conclusion, and lead us to propose that a histidine residue is involved in binding the C-terminus of dipeptides.  In addn., a substrate binding model for PepT1 is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ_S7-o5ew37Vg90H21EOLACvtfcHk0lg4AKV9C2v_lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVKgtb8%253D&md5=247bbe953d9fa273ff1494b41c59c15b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01405.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01405.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeredith%26aufirst%3DD.%26aulast%3DTemple%26aufirst%3DC.%2BS.%26aulast%3DGuha%26aufirst%3DN.%26aulast%3DSword%26aufirst%3DC.%2BJ.%26aulast%3DBoyd%26aufirst%3DC.%2BA.%26aulast%3DCollier%26aufirst%3DI.%2BD.%26aulast%3DMorgan%26aufirst%3DK.%2BM.%26aulast%3DBailey%26aufirst%3DP.%2BD.%26atitle%3DModified%2520amino%2520acids%2520and%2520peptides%2520as%2520substrates%2520for%2520the%2520intestinal%2520peptide%2520transporter%2520PepT1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D3723%26epage%3D3728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Nielsen, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frokjaer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffansen, B.</span><span> </span><span class="NLM_article-title">Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2001&pages=129-138&author=C.+U.+Nielsenauthor=R.+Andersenauthor=B.+Brodinauthor=S.+Frokjaerauthor=M.+E.+Taubauthor=B.+Steffansen&title=Dipeptide+model+prodrugs+for+the+intestinal+oligopeptide+transporter.+Affinity+for+and+transport+via+hPepT1+in+the+human+intestinal+Caco-2+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DC.%2BU.%26aulast%3DAndersen%26aufirst%3DR.%26aulast%3DBrodin%26aufirst%3DB.%26aulast%3DFrokjaer%26aufirst%3DS.%26aulast%3DTaub%26aufirst%3DM.%2BE.%26aulast%3DSteffansen%26aufirst%3DB.%26atitle%3DDipeptide%2520model%2520prodrugs%2520for%2520the%2520intestinal%2520oligopeptide%2520transporter.%2520Affinity%2520for%2520and%2520transport%2520via%2520hPepT1%2520in%2520the%2520human%2520intestinal%2520Caco-2%2520cell%2520line%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2001%26volume%3D76%26spage%3D129%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gonzalez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covitz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrsny, R. J.</span><span> </span><span class="NLM_article-title">An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=519-525&author=D.+E.+Gonzalezauthor=K.+M.+Covitzauthor=W.+Sadeeauthor=R.+J.+Mrsny&title=An+oligopeptide+transporter+is+expressed+at+high+levels+in+the+pancreatic+carcinoma+cell+lines+AsPc-1+and+Capan-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DD.%2BE.%26aulast%3DCovitz%26aufirst%3DK.%2BM.%26aulast%3DSadee%26aufirst%3DW.%26aulast%3DMrsny%26aufirst%3DR.%2BJ.%26atitle%3DAn%2520oligopeptide%2520transporter%2520is%2520expressed%2520at%2520high%2520levels%2520in%2520the%2520pancreatic%2520carcinoma%2520cell%2520lines%2520AsPc-1%2520and%2520Capan-2%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D519%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, A.</span><span> </span><span class="NLM_article-title">Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4118-4122&author=T.+Nakanishiauthor=I.+Tamaiauthor=Y.+Saiauthor=T.+Sasakiauthor=A.+Tsuji&title=Carrier-mediated+transport+of+oligopeptides+in+the+human+fibrosarcoma+cell+line+HT1080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DI.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DA.%26atitle%3DCarrier-mediated%2520transport%2520of%2520oligopeptides%2520in%2520the%2520human%2520fibrosarcoma%2520cell%2520line%2520HT1080%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4118%26epage%3D4122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span> </span><span class="NLM_article-title">Expression profile and functional activity of peptide transporters in prostate cancer cells</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300364k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=477-487&author=W.+Taiauthor=Z.+Chenauthor=K.+Cheng&title=Expression+profile+and+functional+activity+of+peptide+transporters+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression Profile and Functional Activity of Peptide Transporters in Prostate Cancer Cells</span></div><div class="casAuthors">Tai, Wanyi; Chen, Zhijin; Cheng, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptide transporters are expressed predominantly in intestinal and renal epithelial cells.  The functional expression of peptide transporters is also identified in other types of tissues, such as glia cells, macrophages, and the epithelia of the bile duct, the lungs, and the mammary glands.  However, their presence and role are poorly understood in carcinomas.  We explored the expression profile and functional activity of peptide transporters in the prostate cancer cell lines LNCaP, PC-3, and DU145.  Quant. real time RT-PCR (qRT-PCR) and Western blot were used to evaluate the expression profile of peptide transporter 1 (PEPT1), peptide transporter 2 (PEPT2), peptide histidine transporter 1 (PHT1), and peptide histidine transporter 2 (PHT2) in these cells.  LNCaP expresses high levels of PEPT2 and PHT1, while PC-3 demonstrates strong expression of PEPT1 and PHT1.  DU145 shows only weak expression of PEPT1 and PHT1.  Functional activities were studied in these cell lines using radiolabeled glycylsarcosine ([3H]Gly-Sar) and l-histidine ([3H]-l-histidine).  The uptake of [3H]Gly-Sar and [3H]-l-histidine was time- and pH-dependent.  A kinetic study showed that the uptake of Gly-Sar and l-histidine is saturable over the tested concn. range.  The binding affinity (Km) and the maximal velocity (Vmax) exhibited in the three cell lines were consistent with the expression profiles we obsd. in qRT-PCR and Western blot anal.  A competitive inhibition study revealed that peptide transporters in prostate cancer cells exhibited broad substrate specificity with a preference for hydrophobic dipeptides, such as Leu-Leu.  Fluorescence microscopy study revealed that the fluorescent dipeptide probe d-Ala-Lys-AMCA (a substrate of peptide transporters) specifically accumulated in the cytoplasm of LNCaP and PC-3, but not DU145 cells.  Inhibiting the peptide transporter activity by Gly-Sar suppressed the growth of LNCaP and PC-3 cells.  Our study indicated that PC-3 cells can be established as a new cell culture model for PEPT1 study, and LNCaP can be used as a model for PEPT2 study.  Moreover, our results suggested that peptide transporters are overexpressed in prostate cancer cells and can be adopted as a promising target for tumor-specific drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobyrL-hsv-GLVg90H21EOLACvtfcHk0ljyXP1Kg2AMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrN&md5=b637c4df34fcb8e0b1f6258645119f32</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fmp300364k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300364k%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DK.%26atitle%3DExpression%2520profile%2520and%2520functional%2520activity%2520of%2520peptide%2520transporters%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D477%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Endter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span> </span><span class="NLM_article-title">RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1211%2Fjpp.61.05.0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19405996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVemsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=583-591&author=S.+Endterauthor=D.+Francombeauthor=C.+Ehrhardtauthor=M.+Gumbleton&title=RT-PCR+analysis+of+ABC%2C+SLC+and+SLCO+drug+transporters+in+human+lung+epithelial+cell+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models</span></div><div class="casAuthors">Endter, Sibylle; Francombe, Danielle; Ehrhardt, Carsten; Gumbleton, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">583-591</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Carrier-mediated transport mechanisms play crucial roles in drug absorption and elimination processes, as well as in the transport of endogenous mols. affecting cellular regulation and function.  In this study the authors used RT-PCR anal. to characterize the mRNA transcript expression of a wide range of membrane carrier transporters in several in-vitro lung epithelial cell models.  Transporters studied included: 11 ATP-binding cassette (ABC) transporters, 11 solute carrier (SLC) transporters and 9 solute carrier org. anion (SLCO) transporters.  The cell culture models included both established cell lines (A549, Calu-3, 16HBE14o-, BEAS-2B) and freshly isolated lung epithelial cells in primary culture (human bronchial and alveolar epithelial cells).  The expression profiles of several clin. relevant drug transporters were characterized using RT-PCR anal.  The authors' results showed differential transporter expression in cell culture models from different regions of the lung and also highlighted disparities when comparing lung cell lines with primary cell culture models.  Differences in transporter expression between cell models of pulmonary and gastrointestinal origin were also noted.  The information will guide and validate the use of in-vitro lung epithelial cell lines in the study of pulmonary administered drugs and candidate mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri1P0ptS20-rVg90H21EOLACvtfcHk0ljyXP1Kg2AMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVemsg%253D%253D&md5=18353b05e3c635c257a5baf95429202b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1211%2Fjpp.61.05.0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.61.05.0006%26sid%3Dliteratum%253Aachs%26aulast%3DEndter%26aufirst%3DS.%26aulast%3DFrancombe%26aufirst%3DD.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DGumbleton%26aufirst%3DM.%26atitle%3DRT-PCR%2520analysis%2520of%2520ABC%252C%2520SLC%2520and%2520SLCO%2520drug%2520transporters%2520in%2520human%2520lung%2520epithelial%2520cell%2520models%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2009%26volume%3D61%26spage%3D583%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kouodom, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celegato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fregona, D.</span><span> </span><span class="NLM_article-title">Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2212</span><span class="NLM_x">–</span> <span class="NLM_lpage">2226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2212-2226&author=M.+N.+Kouodomauthor=L.+Ronconiauthor=M.+Celegatoauthor=C.+Nardonauthor=L.+Marchioauthor=Q.+P.+Douauthor=D.+Aldinucciauthor=F.+Formaggioauthor=D.+Fregona&title=Toward+the+selective+delivery+of+chemotherapeutics+into+tumor+cells+by+targeting+peptide+transporters%3A+tailored+gold-based+anticancer+peptidomimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKouodom%26aufirst%3DM.%2BN.%26aulast%3DRonconi%26aufirst%3DL.%26aulast%3DCelegato%26aufirst%3DM.%26aulast%3DNardon%26aufirst%3DC.%26aulast%3DMarchio%26aufirst%3DL.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DAldinucci%26aufirst%3DD.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DFregona%26aufirst%3DD.%26atitle%3DToward%2520the%2520selective%2520delivery%2520of%2520chemotherapeutics%2520into%2520tumor%2520cells%2520by%2520targeting%2520peptide%2520transporters%253A%2520tailored%2520gold-based%2520anticancer%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2212%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs</span> <span class="citation_source-journal">J. Med, Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1116-1120&author=L.+Fangauthor=M.+Wangauthor=S.+Gouauthor=X.+Liuauthor=H.+Zhangauthor=F.+Gao&title=Combination+of+amino+acid%2Fdipeptide+with+nitric+oxide+donating+oleanolic+acid+derivatives+as+PepT1+targeting+antitumor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span></div><div class="casAuthors">Fang, Lei; Wang, Meng; Gou, Shaohua; Liu, Xuying; Zhang, Huan; Cao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1116-1120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of the cytotoxic effect of nitric oxide (NO) and PepT1 for mol.-targeted drug delivery, a series of amino acid/dipeptide diester prodrugs of NO-donating oleanolic acid derivs. were designed and synthesized.  Two prodrugs 6a and 8a showed potent cytotoxcity, which is probably due to their high PepT1 affinity and NO-releasing ability.  Furthermore, the aq. soly. of the prodrugs was also significantly enhanced because of the hydrophilic amino acid/dipeptide promoiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9pR7AdIqo7Vg90H21EOLACvtfcHk0liPtrdps6yV_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D&md5=34d4a03853bb2b0bc6400f85c885ff4c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401634d%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DCombination%2520of%2520amino%2520acid%252Fdipeptide%2520with%2520nitric%2520oxide%2520donating%2520oleanolic%2520acid%2520derivatives%2520as%2520PepT1%2520targeting%2520antitumor%2520prodrugs%26jtitle%3DJ.%2520Med%252C%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1116%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Tsume, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. l.</span><span> </span><span class="NLM_article-title">Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp800008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFSkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=717-727&author=Y.+Tsumeauthor=J.+M.+Hilfingerauthor=G.+l.+Amidon&title=Enhanced+cancer+cell+growth+inhibition+by+dipeptide+prodrugs+of+floxuridine%3A+increased+transporter+affinity+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability</span></div><div class="casAuthors">Tsume, Yasuhiro; Hilfinger, John M.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptide monoester prodrugs of floxuridine were synthesized, and their chem. stability in buffers, resistance to glycosidic bond metab., affinity for PEPT1, enzymic activation and permeability in cancer cells were detd. and compared to those of mono amino acid monoester floxuridine prodrugs.  Prodrugs contg. glycyl moieties were the least stable in pH 7.4 buffer (t1/2 < 100 min).  The activation of all floxuridine prodrugs was 2- to 30-fold faster in cell homogenates than their hydrolysis in buffer, suggesting enzymic action.  The enzymic activation of dipeptide monoester prodrugs contg. arom. promoieties in cell homogenates was 5- to 20-fold slower than that of other dipeptide and most mono amino acid monoester prodrugs (t1/2 ∼ 40 to 100 min).  All prodrugs exhibited enhanced resistance to glycosidic bond metab. by thymidine phosphorylase compared to parent floxuridine.  In general, the 5'-O-dipeptide monoester floxuridine prodrugs exhibited higher affinity for PEPT1 than the corresponding 5'-O-mono amino acid ester prodrugs.  The permeability of dipeptide monoester prodrugs across Caco-2 and Capan-2 monolayers was 2- to 4-fold higher than the corresponding mono amino acid ester prodrug.  Cell proliferation assays in AsPC-1 and Capan-2 pancreatic ductal cell lines indicated that the dipeptide monoester prodrugs were equally as potent as mono amino acid prodrugs.  The transport and enzymic profiles of 5'-L-phenylalanyl-L-tyrosyl-floxuridine, 5'-L-phenylalanyl-L-glycyl-floxuridine, and 5'-L-isoleucyl-L-glycyl-floxuridine suggest their potential for increased oral uptake, delayed enzymic bioconversion and enhanced resistance to metab. to 5-fluorouracil, as well as enhanced uptake and cytotoxic activity in cancer cells, attributes that would facilitate prolonged systemic circulation for enhanced therapeutic action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALEnhYGvnZrVg90H21EOLACvtfcHk0liPtrdps6yV_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFSkurc%253D&md5=9646d4140b600e263fb95a76152e5631</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fmp800008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp800008c%26sid%3Dliteratum%253Aachs%26aulast%3DTsume%26aufirst%3DY.%26aulast%3DHilfinger%26aufirst%3DJ.%2BM.%26aulast%3DAmidon%26aufirst%3DG.%2Bl.%26atitle%3DEnhanced%2520cancer%2520cell%2520growth%2520inhibition%2520by%2520dipeptide%2520prodrugs%2520of%2520floxuridine%253A%2520increased%2520transporter%2520affinity%2520and%2520metabolic%2520stability%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D717%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp049888e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlKgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=157-167&author=X.+Songauthor=P.+L.+Lorenziauthor=C.+P.+Landowskiauthor=B.+S.+Vigauthor=J.+M.+Hilfingerauthor=G.+L.+Amidon&title=Amino+acid+ester+prodrugs+of+the+anticancer+agent+gemcitabine%3A+synthesis%2C+bioconversion%2C+metabolic+bioevasion%2C+and+hPEPT1-mediated+transport"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Ester Prodrugs of the Anticancer Agent Gemcitabine: Synthesis, Bioconversion, Metabolic Bioevasion, and hPEPT1-Mediated Transport</span></div><div class="casAuthors">Song, Xueqin; Lorenzi, Philip L.; Landowski, Christopher P.; Vig, Balvinder S.; Hilfinger, John M.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gemcitabine, a clin. effective nucleoside anticancer agent, is a polar drug with low membrane permeability and is administered i.v.  Further, extensive degrdn. of gemcitabine by cytidine deaminase to an inactive metabolite in the liver affects its activity adversely.  Thus, strategies that provide both enhanced transport and high metabolic bioevasion would potentially lead to oral alternatives that may be clin. useful.  The objective of this study was to evaluate whether amino acid ester prodrugs of gemcitabine would (a) facilitate transport across intestinal membranes or across cells that express hPEPT1 and (b) provide resistance to deamination by cytidine deaminase.  3'-Monoester, 5'-monoester, and 3',5'-diester prodrugs of gemcitabine utilizing aliph. (L-valine, D-valine, and L-isoleucine) and arom. (L-phenylalanine and D-phenylalanine) amino acids as promoieties were synthesized and evaluated for their affinity and direct hPEPT1-mediated transport in HeLa/hPEPT1 cells.  All prodrugs exhibited enhanced affinity (IC50: 0.14-0.16 mM) for the transporter.  However, only the 5'-L-valyl and 5'-L-isoleucyl monoester prodrugs exhibited (a) increased uptake (11.25- and 5.64-fold, resp.) in HeLa/hPEPT1 cells compared to HeLa cells and (b) chem. stability in buffers, that were comparable to valacyclovir, a com. marketed oral amino acid ester prodrug.  The widely disparate enzymic bioconversion profiles of the 5'-L-valyl and 5'-L-isoleucyl prodrugs in Caco-2 cell homogenates along with their significant resistance to deamination by cytidine deaminase suggest that the disposition of gemcitabine following oral administration would be controlled by the rate of bioconversion following transport across the intestinal epithelial membrane.  The combined results also suggest that it may be possible to modulate these characteristics by the choice of the amino acid moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aZvHr6U9tbVg90H21EOLACvtfcHk0liPtrdps6yV_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlKgtr4%253D&md5=c53342f57966396d26c6ded0daa46321</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fmp049888e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp049888e%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLandowski%26aufirst%3DC.%2BP.%26aulast%3DVig%26aufirst%3DB.%2BS.%26aulast%3DHilfinger%26aufirst%3DJ.%2BM.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DAmino%2520acid%2520ester%2520prodrugs%2520of%2520the%2520anticancer%2520agent%2520gemcitabine%253A%2520synthesis%252C%2520bioconversion%252C%2520metabolic%2520bioevasion%252C%2520and%2520hPEPT1-mediated%2520transport%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2005%26volume%3D2%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span> </span><span class="NLM_article-title">Synthesis, transport and pharmacokinetics of 5′-amino acid ester prodrugs of 1-β-<span class="smallcaps smallerCapital">d</span>-arabinofuranosylcytosine</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp800200a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFM%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=315-325&author=Y.+Sunauthor=J.+Sunauthor=S.+Shiauthor=Y.+Jingauthor=S.+Yinauthor=Y.+Chenauthor=G.+Liauthor=Y.+Xuauthor=Z.+He&title=Synthesis%2C+transport+and+pharmacokinetics+of+5%E2%80%B2-amino+acid+ester+prodrugs+of+1-%CE%B2-d-arabinofuranosylcytosine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Transport and Pharmacokinetics of 5'-Amino Acid Ester Prodrugs of 1-β-D-Arabinofuranosylcytosine</span></div><div class="casAuthors">Sun, Yongbing; Sun, Jin; Shi, Shiliang; Jing, Yongkui; Yin, Shiliang; Chen, Ying; Li, Gang; Xu, Youjun; He, Zhonggui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">315-325</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytarabine (1-β-D-arabinofuranosylcytosine, ara-C, 1) suffers from low oral bioavailability due to low intestinal membrane permeability and poor metabolic stability, and i.v. infusion is usually adopted as the clin. std. dosing administration.  To develop an oral alternative for 1 and utilize the intestinal oligopeptide transporter 1 (PepT1), a series of 5'-amino acid ester derivs. of 1 was synthesized to clarify which modification was the most suitable to increase the oral bioavailability of 1.  Their apical-to-basolateral permeability across Caco-2 cells and the antiproliferative activity with HL-60 cells were screened. 5'-Valyl prodrug 2 demonstrated the highest permeability and was selected for further study.  Glycylsarcosine (gly-sar, a typical substrate of PepT1) uptake by Caco-2 cells can be inhibited by 2 in a concn.-dependent manner, and IC50 for 2 was 2.18 ± 0.12 mM.  The uptake of 2 was markedly increased in the long-term leptin-treated Caco-2 cells compared with the control Caco-2 cells, and was significantly inhibited by the excess of gly-sar, but not by L-valine.  A dose-proportional pharmacokinetics was obsd. in rats when 5, 15, 30 mg/kg doses of 2 (calcd. as 1) were orally administered.  The oral abs. bioavailability of 1 was 60.0% and 21.8% after 2 and 1 were orally administered to rats 30 mg/kg, resp.  Following oral administration of 15 mg/kg, the absorption and bioactivation of 2 were extensive and rapid, over 98% of prodrug hydrolysis occurring before appearance in the portal vein.  The in vivo dispositions of 1-β-D-arabinofuranosyluracil (ara-U), a deaminated product of 1, were investigated.  Oral administration of 2 resulted in an increased 1/ara-U ratio (2.76) in the blood, much higher than that (1.25) after 1 orally taken.  Overall, these results demonstrated that the PepT1-mediated absorption of 2 and the increased metabolic stability resulted in a dramatic increase in the oral bioavailability of 1 in rats and further corroborated the thought that prodrug design strategy targeting intestinal PepT1 was an important and promising strategy to improve oral bioavailability of poorly absorbed drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MXf_lWyLGbVg90H21EOLACvtfcHk0lgcZu_hrKDHQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFM%253D&md5=b0c0eb744c81107c794d9f2f7d4077af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fmp800200a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp800200a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26atitle%3DSynthesis%252C%2520transport%2520and%2520pharmacokinetics%2520of%25205%25E2%2580%25B2-amino%2520acid%2520ester%2520prodrugs%2520of%25201-%25CE%25B2-d-arabinofuranosylcytosine%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D315%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells</span> <span class="citation_source-journal">Neoplasia.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=287-297&author=H.+Xiongauthor=Z.+Zhangauthor=X.+Tianauthor=D.+Sunauthor=Q.+Liangauthor=Y.+Zhangauthor=R.+Luauthor=Y.+Chenauthor=J.+Fang&title=Inhibition+of+JAK1%2C+2%2FSTAT3+signaling+induces+apoptosis%2C+cell+cycle+arrest%2C+and+reduces+tumor+cell+invasion+in+colorectal+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520JAK1%252C%25202%252FSTAT3%2520signaling%2520induces%2520apoptosis%252C%2520cell%2520cycle%2520arrest%252C%2520and%2520reduces%2520tumor%2520cell%2520invasion%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DNeoplasia.%26date%3D2008%26volume%3D10%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derijard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabandhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueber, A. O.</span><span> </span><span class="NLM_article-title">Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.canlet.2014.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=25199763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGgsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2014&pages=355-364&author=L.+Zhuauthor=B.+Derijardauthor=K.+Chakrabandhuauthor=B.+S.+Wangauthor=H.+Z.+Chenauthor=A.+O.+Hueber&title=Synergism+of+PI3K%2FAkt+inhibition+and+Fas+activation+on+colon+cancer+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death</span></div><div class="casAuthors">Zhu, Liang; Derijard, Benoit; Chakrabandhu, Krittalak; Wang, Bing-Shun; Chen, Hong-Zhuan; Hueber, Anne-Odile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fas and PI3K/Akt signaling pathways pivotally impact on cancer cell death and survival resp. and are considered as promising targets for innovative anticancer therapies.  To better characterize the combination effect of PI3K/Akt inhibitors and Fas agonists and understand the profile of the interaction between PI3K/Akt and Fas signaling, we qual. and quant. evaluated the combination effect of PI3K/Akt inhibitors LY294002, Akt inhibitor VIII and FasL.  At the concn. that can block cell cycle progression and DNA synthesis but not elicit apoptosis, these inhibitors potentiate FasL to induce apoptosis.  At higher concns., when the PI3K/Akt inhibitors induce apoptosis, they synergize FasL to induce apoptosis.  In addn., PI3K/Akt inhibition significantly facilitates the Fas-mediated apoptotic signaling.  Understanding the combination effects between PI3K/Akt inhibition and Fas activation not only leads to rational design of effective combination therapy of PI3K/Akt inhibitors but also improve our knowledge about the impact of PI3K-Akt pathway on Fas signaling and the potential modulation of innate immune system by PI3K-Akt-targeting drugs in anticancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5zxVgOhhPALVg90H21EOLACvtfcHk0lgcZu_hrKDHQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGgsLjL&md5=25fe3dfa7ed997777c59217e1556dea9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDerijard%26aufirst%3DB.%26aulast%3DChakrabandhu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%2BS.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DHueber%26aufirst%3DA.%2BO.%26atitle%3DSynergism%2520of%2520PI3K%252FAkt%2520inhibition%2520and%2520Fas%2520activation%2520on%2520colon%2520cancer%2520cell%2520death%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D354%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sheffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob-Hirsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechavi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Orazi, G.</span><span> </span><span class="NLM_article-title">Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1191-1202&author=M.+Shefferauthor=A.+J.+Simonauthor=J.+Jacob-Hirschauthor=G.+Rechaviauthor=E.+Domanyauthor=D.+Givolauthor=G.+D%E2%80%99Orazi&title=Genome-wide+analysis+discloses+reversal+of+the+hypoxia-induced+changes+of+gene+expression+in+colon+cancer+cells+by+zinc+supplementation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffer%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DJacob-Hirsch%26aufirst%3DJ.%26aulast%3DRechavi%26aufirst%3DG.%26aulast%3DDomany%26aufirst%3DE.%26aulast%3DGivol%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Orazi%26aufirst%3DG.%26atitle%3DGenome-wide%2520analysis%2520discloses%2520reversal%2520of%2520the%2520hypoxia-induced%2520changes%2520of%2520gene%2520expression%2520in%2520colon%2520cancer%2520cells%2520by%2520zinc%2520supplementation%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1191%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Liby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risingsong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royce, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letterio, J. J.</span><span> </span><span class="NLM_article-title">The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">–</span> <span class="NLM_lpage">4293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1158%2F1078-0432.CCR-06-0215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16857804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4288-4293&author=K.+Libyauthor=N.+Voongauthor=C.+R.+Williamsauthor=R.+Risingsongauthor=D.+B.+Royceauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=J.+J.+Letterio&title=The+synthetic+triterpenoid+CDDO-imidazolide+suppresses+STAT+phosphorylation+and+induces+apoptosis+in+myeloma+and+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells</span></div><div class="casAuthors">Liby, Karen; Voong, Nga; Williams, Charlotte R.; Risingsong, Renee; Royce, Darlene B.; Honda, Tadashi; Gribble, Gordon W.; Sporn, Michael B.; Letterio, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14, Pt. 1</span>),
    <span class="NLM_cas:pages">4288-4293</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Excessive activity of the transcription factors known as signal transducers and activators of transcription (STAT) contributes to the development and progression of malignancy in many organs.  It is, therefore, important to develop new drugs to control the STATs, particularly their phosphorylation state, which is required for their transcriptional activity.  Myeloma and lung cancer cells were treated with the new synthetic triterpenoid CDDO-Imidazolide, and STAT phosphorylation and apoptosis were evaluated by immunoblotting and fluorescence-activated cell sorting anal.  We now report that CDDO-Imidazolide, previously shown to be a potent agent for control of inflammation, cell proliferation, and apoptosis, rapidly (within 30-60 min) and potently (at nanomolar levels) suppresses either constitutive or interleukin-6-induced STAT3 and STAT5 phosphorylation in human myeloma and lung cancer cells.  Furthermore, in these cells, CDDO-Imidazolide also up-regulates crit. inhibitors of STATs, such as suppressor of cytokine signaling-1 and SH2-contg. phosphatase-1 (a tyrosine phosphatase).  Moreover, gene array studies reported here show that CDDO-Imidazolide potently regulates the transcription of important genes that are targets of the STATs.  Our new data thus show that CDDO-Imidazolide is a potent suppressor of STAT signaling and provide a further mechanistic basis for future clin. use of this agent to control inflammation or cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7ur0Wz3rJbVg90H21EOLACvtfcHk0lhWvQmTFHGNTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSmsLY%253D&md5=2bac90a0068414beb2af3af3a4577d18</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0215%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DVoong%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLetterio%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520synthetic%2520triterpenoid%2520CDDO-imidazolide%2520suppresses%2520STAT%2520phosphorylation%2520and%2520induces%2520apoptosis%2520in%2520myeloma%2520and%2520lung%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4288%26epage%3D4293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbab, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divine, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulchavsky, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, S. C.</span><span> </span><span class="NLM_article-title">Prevention of prostate cancer with oleanane synthetic triterpenoid CDDO-Me in the TRAMP mouse model of prostate cancer</span> <span class="citation_source-journal">Cancers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3353</span><span class="NLM_x">–</span> <span class="NLM_lpage">3369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=3353-3369&author=X.+Gaoauthor=D.+Deebauthor=Y.+Liuauthor=A.+S.+Arbabauthor=G.+W.+Divineauthor=S.+A.+Dulchavskyauthor=S.+C.+Gautam&title=Prevention+of+prostate+cancer+with+oleanane+synthetic+triterpenoid+CDDO-Me+in+the+TRAMP+mouse+model+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DDeeb%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DArbab%26aufirst%3DA.%2BS.%26aulast%3DDivine%26aufirst%3DG.%2BW.%26aulast%3DDulchavsky%26aufirst%3DS.%2BA.%26aulast%3DGautam%26aufirst%3DS.%2BC.%26atitle%3DPrevention%2520of%2520prostate%2520cancer%2520with%2520oleanane%2520synthetic%2520triterpenoid%2520CDDO-Me%2520in%2520the%2520TRAMP%2520mouse%2520model%2520of%2520prostate%2520cancer%26jtitle%3DCancers%26date%3D2011%26volume%3D3%26spage%3D3353%26epage%3D3369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Qi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span> </span><span class="NLM_article-title">Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2399</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=24604140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlyru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=2399-2406&author=R.+Qiauthor=W.+Jinauthor=J.+Wangauthor=Q.+Yiauthor=M.+Yuauthor=S.+Xuauthor=W.+Jin&title=Oleanolic+acid+enhances+the+radiosensitivity+of+tumor+cells+under+mimetic+hypoxia+through+the+reduction+in+intracellular+GSH+content+and+HIF-1%CE%B1+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression</span></div><div class="casAuthors">Qi, Rongxin; Jin, Wenwen; Wang, Juan; Yi, Qiyi; Yu, Maohu; Xu, Shiguo; Jin, Wensen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2399-2406</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">We previously found that oleanolic acid (OA), a naturally pentacyclic triterpenoid, enhances the radiosensitizing effect on tumor cells.  However, it is unclear whether or not OA enhances the radiosensitivity of hypoxic cells.  Therefore, the aim of the present study was to further observe the influence of OA on hypoxic tumor cells, and the relative mechanism was also investigated.  The radiosensitivity of rat glioma C6 cells and human lung cancer A549 cells with different treatments, under mimetic hypoxia, was evaluated by clonogenic assay.  A micronucleus (MN) test, meanwhile, was utilized to observe the alteration in intracellular DNA damage.  For detg. the mechanism involved in the OA influence on the radiosensitivity of hypoxic cells, we detd. the levels of intracellular reduced glutathione (GSH) using the glutathione reductase/5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) recycling assay.  Simultaneously, the activities of γ-glutamylcysteine synthetase (γ-GCS) and GSH synthase (GSS), both enzymes for GSH synthesis, were tested using appropriate methods.  Due to the involvement of hypoxia inducible factor-1α (HIF-1α) in the resistence of hypoxic cells to radiation damage, its levels were also obsd. by western blot method.  The results from this study demonstrated that the clonogenic growth of irradiated cells was increased under mimetic hypoxia while the refractory effect of hypoxic cells to radiation was decreased following OA treatment.  Moreover, the (MN) frequencies in the hypoxic cells treated with OA were augmented after irradn. compared with the cells without OA treatment.  In the subsequent expt., OA significantly reduced the biosynthesis of intracellular GSH via the attenuation of γ-GCS activity.  Addnl., there was an obvious redn. in HIF-1α expression in irradiated cells treated with OA at different concns.  In conclusion, OA significantly enhanced the radiosensitivity of tumor cells under mimetic hypoxia, through the redn. in intracellular GSH content and HIF-1α expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx09I9pwrcnLVg90H21EOLACvtfcHk0lhWvQmTFHGNTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlyru7o%253D&md5=0f56c48b3c9b0840ea1cd7afa953e023</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DW.%26atitle%3DOleanolic%2520acid%2520enhances%2520the%2520radiosensitivity%2520of%2520tumor%2520cells%2520under%2520mimetic%2520hypoxia%2520through%2520the%2520reduction%2520in%2520intracellular%2520GSH%2520content%2520and%2520HIF-1%25CE%25B1%2520expression%26jtitle%3DOncol.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D2399%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Dixit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koul, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, E.</span><span> </span><span class="NLM_article-title">Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.freeradbiomed.2009.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19409983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=364-374&author=D.+Dixitauthor=V.+Sharmaauthor=S.+Ghoshauthor=N.+Koulauthor=P.+K.+Mishraauthor=E.+Sen&title=Manumycin+inhibits+STAT3%2C+telomerase+activity%2C+and+growth+of+glioma+cells+by+elevating+intracellular+reactive+oxygen+species+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation</span></div><div class="casAuthors">Dixit, Deobrat; Sharma, Vivek; Ghosh, Sadashib; Koul, Nitin; Mishra, Prakash Kumar; Sen, Ellora</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">364-374</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The poor prognosis of glioblastoma multiforme and lack of effective therapy have necessitated the identification of new treatment strategies.  The authors have previously reported that elevation of oxidative stress induces apoptosis of glioma cells.  Because the farnesyltransferase inhibitor manumycin is known to induce reactive oxygen species (ROS) generation, the authors evaluated the effects of manumycin on glioma cells.  Manumycin induced glioma cell apoptosis by elevating ROS generation.  Treatment with the ROS inhibitor N-acetylcysteine blocked manumycin-induced apoptosis, caspase-3 activity, and PARP expression, indicating the involvement of increased ROS in the proapoptotic activity of manumycin.  This heightened ROS level was accompanied by a concurrent decrease in antioxidants such as superoxide dismutase (SOD-1) and thioredoxin (TRX-1).  SOD-1 overexpression protects glioma cells from manumycin-induced apoptosis.  In addn., small interfering RNA-mediated knockdown of SOD-1 and TRX-1 expression also increased ROS generation and sensitivity of glioma cells to manumycin-induced cell death.  Interestingly, suppressing ROS generation prevented manumycin-induced Ras inhibition.  This study reports for the first time that Ras inhibition by manumycin is due to heightened ROS levels.  The authors also report for the first time that manumycin inhibits the phosphorylation of signal transducer and activator of transcription 3 and telomerase activity in a ROS-dependent manner, which plays a crucial role in glioma resistance to apoptosis.  In addn. manumycin (i) induced the DNA-damage repair response, (ii) affected cell-cycle-regulatory mols., and (iii) impaired the colony-forming ability of glioma cells in a ROS-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprefJOXA98SrVg90H21EOLACvtfcHk0lhWvQmTFHGNTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotl2lsbs%253D&md5=2425f2472440ceae2551b5d7d2e2c37e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2009.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2009.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DDixit%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DKoul%26aufirst%3DN.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSen%26aufirst%3DE.%26atitle%3DManumycin%2520inhibits%2520STAT3%252C%2520telomerase%2520activity%252C%2520and%2520growth%2520of%2520glioma%2520cells%2520by%2520elevating%2520intracellular%2520reactive%2520oxygen%2520species%2520generation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2009%26volume%3D47%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span> </span><span class="NLM_article-title">Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1191&author=C.+Fanauthor=W.+Zhengauthor=X.+Fuauthor=X.+Liauthor=Y.+S.+Wongauthor=T.+Chen&title=Enhancement+of+auranofin-induced+lung+cancer+cell+apoptosis+by+selenocystine%2C+a+natural+inhibitor+of+TrxR1+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DEnhancement%2520of%2520auranofin-induced%2520lung%2520cancer%2520cell%2520apoptosis%2520by%2520selenocystine%252C%2520a%2520natural%2520inhibitor%2520of%2520TrxR1%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">He, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C. M.</span><span> </span><span class="NLM_article-title">A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">12532</span><span class="NLM_x">–</span> <span class="NLM_lpage">12536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCisrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12532-12536&author=L.+Heauthor=T.+Chenauthor=Y.+Youauthor=H.+Huauthor=W.+Zhengauthor=W.+L.+Kwongauthor=T.+Zouauthor=C.+M.+Che&title=A+cancer-targeted+nanosystem+for+delivery+of+gold%28III%29+complexes%3A+enhanced+selectivity+and+apoptosis-inducing+efficacy+of+a+gold%28III%29+porphyrin+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Cancer-Targeted Nanosystem for Delivery of Gold(III) Complexes: Enhanced Selectivity and Apoptosis-Inducing Efficacy of a Gold(III) Porphyrin Complex</span></div><div class="casAuthors">He, Lizhen; Chen, Tianfeng; You, Yuanyuan; Hu, Hao; Zheng, Wenjie; Kwong, Wai-Lun; Zou, Taotao; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12532-12536</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Construction of delivery systems for anticancer gold complexes to decrease their toxicity while maintaining efficacy is a key strategy to optimize and develop anticancer gold medicines.  Herein, we describe cancer-targeted mesoporous silica nanoparticles (MSN) for delivery of a gold(III) porphyrin complex (Au-1 <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="b3d2f3fee0fd">[email protected]</a>(R)) to enhance its anticancer efficacy and selectivity between cancer and normal cells.  Encapsulation of Au-1 a within mesoporous silica nanoparticles amplifies its inhibitory effects on thioredoxin reductase (TrxR), resulting in a loss of redox balance and overprodn. of reactive oxygen species (ROS).  Elevated cellular oxidative stress activates diversified downstream ROS-mediated signaling pathways, leading to enhanced apoptosis-inducing efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2JVwDP2syrVg90H21EOLACvtfcHk0lila1wbmEJ2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCisrjP&md5=311dbf02f970ea5792601738b9d33cb5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DKwong%26aufirst%3DW.%2BL.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520cancer-targeted%2520nanosystem%2520for%2520delivery%2520of%2520gold%2528III%2529%2520complexes%253A%2520enhanced%2520selectivity%2520and%2520apoptosis-inducing%2520efficacy%2520of%2520a%2520gold%2528III%2529%2520porphyrin%2520complex%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12532%26epage%3D12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 46 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Moonhyun Choi, Sohyeon Park, Kyungtae Park, Hyejoong Jeong, <span class="NLM_string-name hlFld-ContribAuthor">Jinkee Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Delivery Using Biocompatible Perfluorocarbon Microemulsion for Antibacterial Effect. </span><span class="cited-content_cbyCitation_journal-name">ACS Biomaterials Science & Engineering</span><span> <strong>2019,</strong> <em>5 </em>
                                    (3)
                                     , 1378-1383. <a href="https://doi.org/10.1021/acsbiomaterials.9b00016" title="DOI URL">https://doi.org/10.1021/acsbiomaterials.9b00016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsbiomaterials.9b00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsbiomaterials.9b00016%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Biomaterials%2520Science%2520%2526%2520Engineering%26atitle%3DNitric%252BOxide%252BDelivery%252BUsing%252BBiocompatible%252BPerfluorocarbon%252BMicroemulsion%252Bfor%252BAntibacterial%252BEffect%26aulast%3DChoi%26aufirst%3DMoonhyun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D30012019%26date%3D13022019%26date%3D30012019%26volume%3D5%26issue%3D3%26spage%3D1378%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yalan Guo, Yujie Wang, Haihong Li, Ke Wang, Qi Wan, Jia Li, Yubo Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Ying Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives as Potent Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 502-506. <a href="https://doi.org/10.1021/acsmedchemlett.8b00125" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BNitric%252BOxide%252BDonors%252Bof%252BPhenylsulfonylfuroxan%252Band%252B3-Benzyl%252BCoumarin%252BDerivatives%252Bas%252BPotent%252BAntitumor%252BAgents%26aulast%3DGuo%26aufirst%3DYalan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26032018%26date%3D20042018%26date%3D26042018%26date%3D20042018%26volume%3D9%26issue%3D5%26spage%3D502%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Yi  Mou</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Xu</span>, <span class="hlFld-ContribAuthor ">Di  Zhao</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>, <span class="hlFld-ContribAuthor ">Yuwen  Xu</span>, <span class="hlFld-ContribAuthor ">Cen  Chen</span>, <span class="hlFld-ContribAuthor ">Ping  Li</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Jide  Tian</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8847-8857. <a href="https://doi.org/10.1021/acs.jmedchem.7b00971" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00971</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00971%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BDerivative%252Bof%252BBardoxolone%252BMethyl%252BImproves%252BSafety%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetic%252BNephropathy%26aulast%3DHuang%26aufirst%3DZhangjian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01072017%26date%3D19102017%26date%3D09112017%26date%3D10102017%26volume%3D60%26issue%3D21%26spage%3D8847%26epage%3D8857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Junjie  Fu</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (18)
                                     , 7617-7635. <a href="https://doi.org/10.1021/acs.jmedchem.6b01672" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01672%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitric%252BOxide%252BDonor-Based%252BCancer%252BTherapy%25253A%252BAdvances%252Band%252BProspects%26aulast%3DHuang%26aufirst%3DZhangjian%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13112016%26date%3D23052017%26date%3D28092017%26date%3D15052017%26volume%3D60%26issue%3D18%26spage%3D7617%26epage%3D7635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Ai</span>, <span class="hlFld-ContribAuthor ">Bin  Zhu</span>, <span class="hlFld-ContribAuthor ">Caiping  Ren</span>, <span class="hlFld-ContribAuthor ">Fenghua  Kang</span>, <span class="hlFld-ContribAuthor ">Jinlong  Li</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Yisheng  Lai</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Jide  Tian</span>, and <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of New Monocarbonyl Ligustrazine–Curcumin Hybrids for Intervention of Drug-Sensitive and Drug-Resistant Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (5)
                                     , 1747-1760. <a href="https://doi.org/10.1021/acs.jmedchem.5b01203" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01203%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNew%252BMonocarbonyl%252BLigustrazine%2525E2%252580%252593Curcumin%252BHybrids%252Bfor%252BIntervention%252Bof%252BDrug-Sensitive%252Band%252BDrug-Resistant%252BLung%252BCancer%26aulast%3DAi%26aufirst%3DYong%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D30072015%26date%3D26022016%26date%3D10032016%26date%3D18022016%26volume%3D59%26issue%3D5%26spage%3D1747%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaofeng  Dai</span>, <span class="hlFld-ContribAuthor ">Danjun  Wang</span>, <span class="hlFld-ContribAuthor ">Jianying  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Programmed cell death, redox imbalance, and cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Apoptosis</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.1007/s10495-021-01682-0" title="DOI URL">https://doi.org/10.1007/s10495-021-01682-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10495-021-01682-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10495-021-01682-0%26sid%3Dliteratum%253Aachs%26jtitle%3DApoptosis%26atitle%3DProgrammed%252Bcell%252Bdeath%25252C%252Bredox%252Bimbalance%25252C%252Band%252Bcancer%252Btherapeutics%26aulast%3DDai%26aufirst%3DXiaofeng%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fenqin  Zhao</span>, <span class="hlFld-ContribAuthor ">Jinyu  Li</span>, <span class="hlFld-ContribAuthor ">Kexin  Yue</span>, <span class="hlFld-ContribAuthor ">Beibei  Song</span>, <span class="hlFld-ContribAuthor ">Erying  Sun</span>, <span class="hlFld-ContribAuthor ">Xinru  Cheng</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Lin  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Cell Lines Studies of Oleanolic Acid—Hydrogen Sulfide Donor Hybrids. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (8)
                                     , 3364. <a href="https://doi.org/10.3390/app11083364" title="DOI URL">https://doi.org/10.3390/app11083364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11083364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11083364%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCell%252BLines%252BStudies%252Bof%252BOleanolic%252BAcid%2525E2%252580%252594Hydrogen%252BSulfide%252BDonor%252BHybrids%26aulast%3DZhao%26aufirst%3DFenqin%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D8%26spage%3D3364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxan  Calvo</span>, <span class="hlFld-ContribAuthor ">Antoine  Le Tellier</span>, <span class="hlFld-ContribAuthor ">Thomas  Nauser</span>, <span class="hlFld-ContribAuthor ">David  Rombach</span>, <span class="hlFld-ContribAuthor ">Darryl  Nater</span>, <span class="hlFld-ContribAuthor ">Dmitry  Katayev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthese, Charakterisierung und Reaktivität eines Nitrooxylierungsreagenzes basierend auf einer hypervalenten Iodverbindung. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (39)
                                     , 17312-17319. <a href="https://doi.org/10.1002/ange.202005720" title="DOI URL">https://doi.org/10.1002/ange.202005720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202005720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202005720%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthese%25252C%252BCharakterisierung%252Bund%252BReaktivit%2525C3%2525A4t%252Beines%252BNitrooxylierungsreagenzes%252Bbasierend%252Bauf%252Beiner%252Bhypervalenten%252BIodverbindung%26aulast%3DCalvo%26aufirst%3DRoxan%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D39%26spage%3D17312%26epage%3D17319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roxan  Calvo</span>, <span class="hlFld-ContribAuthor ">Antoine  Le Tellier</span>, <span class="hlFld-ContribAuthor ">Thomas  Nauser</span>, <span class="hlFld-ContribAuthor ">David  Rombach</span>, <span class="hlFld-ContribAuthor ">Darryl  Nater</span>, <span class="hlFld-ContribAuthor ">Dmitry  Katayev</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, and Reactivity of a Hypervalent‐Iodine‐Based Nitrooxylating Reagent. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (39)
                                     , 17162-17168. <a href="https://doi.org/10.1002/anie.202005720" title="DOI URL">https://doi.org/10.1002/anie.202005720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202005720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202005720%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252Band%252BReactivity%252Bof%252Ba%252BHypervalent%2525E2%252580%252590Iodine%2525E2%252580%252590Based%252BNitrooxylating%252BReagent%26aulast%3DCalvo%26aufirst%3DRoxan%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D39%26spage%3D17162%26epage%3D17168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhixian  Shi</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Cheng  Chen</span>, <span class="hlFld-ContribAuthor ">Yujin  Wang</span>, <span class="hlFld-ContribAuthor ">Zhichao  Lei</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Novel NO-releasing scopoletin derivatives induce cell death via mitochondrial apoptosis pathway and cell cycle arrest. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112386. <a href="https://doi.org/10.1016/j.ejmech.2020.112386" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112386%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BNO-releasing%252Bscopoletin%252Bderivatives%252Binduce%252Bcell%252Bdeath%252Bvia%252Bmitochondrial%252Bapoptosis%252Bpathway%252Band%252Bcell%252Bcycle%252Barrest%26aulast%3DShi%26aufirst%3DZhixian%26date%3D2020%26volume%3D200%26spage%3D112386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  M. F. Gonçalves</span>, <span class="hlFld-ContribAuthor ">David  S. P. Cardoso</span>, <span class="hlFld-ContribAuthor ">Maria-José  U. Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (15)
                                     , 3364. <a href="https://doi.org/10.3390/molecules25153364" title="DOI URL">https://doi.org/10.3390/molecules25153364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25153364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25153364%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOvercoming%252BMultidrug%252BResistance%25253A%252BFlavonoid%252Band%252BTerpenoid%252BNitrogen-Containing%252BDerivatives%252Bas%252BABC%252BTransporter%252BModulators%26aulast%3DM.%2BF.%2BGon%25C3%25A7alves%26aufirst%3DBruno%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D15%26spage%3D3364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Chaoguo  Cao</span>, <span class="hlFld-ContribAuthor ">Dan  Luo</span>, <span class="hlFld-ContribAuthor ">Suke  Lan</span>, <span class="hlFld-ContribAuthor ">Meng  Luo</span>, <span class="hlFld-ContribAuthor ">Huifang  Shan</span>, <span class="hlFld-ContribAuthor ">Xinyu  Ma</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Liu</span>, <span class="hlFld-ContribAuthor ">Su  Yu</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhong</span>, <span class="hlFld-ContribAuthor ">Rui  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112336. <a href="https://doi.org/10.1016/j.ejmech.2020.112336" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112336</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112336%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%2525283%25252C5-dimethoxy-4-%252528%252528%2525284-methoxyphenethyl%252529amino%252529methyl%252529phenoxy%252529-N-phenylaniline%252Bas%252Ba%252Bnovel%252Bc-myc%252Binhibitor%252Bagainst%252Bcolorectal%252Bcancer%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DYang%26aufirst%3DJie%26date%3D2020%26volume%3D198%26spage%3D112336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Liye  Wang</span>, <span class="hlFld-ContribAuthor ">Zuoxu  Xie</span>, <span class="hlFld-ContribAuthor ">Shuang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Zhou</span>, <span class="hlFld-ContribAuthor ">Meiyan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric Oxide (NO) and NO Synthases (NOS)-Based Targeted Therapy for Colon Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 1881. <a href="https://doi.org/10.3390/cancers12071881" title="DOI URL">https://doi.org/10.3390/cancers12071881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12071881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12071881%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNitric%252BOxide%252B%252528NO%252529%252Band%252BNO%252BSynthases%252B%252528NOS%252529-Based%252BTargeted%252BTherapy%252Bfor%252BColon%252BCancer%26aulast%3DWang%26aufirst%3DHao%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D7%26spage%3D1881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>, <span class="hlFld-ContribAuthor ">Vladimir  Dobričić</span>, <span class="hlFld-ContribAuthor ">Loretta  Lazzarato</span>, <span class="hlFld-ContribAuthor ">Elena  Gazzano</span>, <span class="hlFld-ContribAuthor ">Miguel  Machuqueiro</span>, <span class="hlFld-ContribAuthor ">Ilza  Pajeva</span>, <span class="hlFld-ContribAuthor ">Ivanka  Tsakovska</span>, <span class="hlFld-ContribAuthor ">Nace  Zidar</span>, <span class="hlFld-ContribAuthor ">Roberta  Fruttero</span>. </span><span class="cited-content_cbyCitation_article-title">Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2020,</strong> <em>50 </em>, 100682. <a href="https://doi.org/10.1016/j.drup.2020.100682" title="DOI URL">https://doi.org/10.1016/j.drup.2020.100682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2020.100682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2020.100682%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DImprovement%252Bof%252Bconventional%252Banti-cancer%252Bdrugs%252Bas%252Bnew%252Btools%252Bagainst%252Bmultidrug%252Bresistant%252Btumors%26aulast%3DDallavalle%26aufirst%3DSabrina%26date%3D2020%26volume%3D50%26spage%3D100682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhongyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Shubin  Yu</span>, <span class="hlFld-ContribAuthor ">Yanpeng  Xiong</span>, <span class="hlFld-ContribAuthor ">Jiaoyang  Fan</span>, <span class="hlFld-ContribAuthor ">Yansi  Lyu</span>, <span class="hlFld-ContribAuthor ">Zijie  Su</span>, <span class="hlFld-ContribAuthor ">Jiaxing  Song</span>, <span class="hlFld-ContribAuthor ">Shanshan  Liu</span>, <span class="hlFld-ContribAuthor ">Qi  Sun</span>, <span class="hlFld-ContribAuthor ">Desheng  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">CDDO-Me Elicits Anti–Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2020,</strong> <em>373 </em>
                                    (1)
                                     , 149-159. <a href="https://doi.org/10.1124/jpet.119.263434" title="DOI URL">https://doi.org/10.1124/jpet.119.263434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.119.263434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.119.263434%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DCDDO-Me%252BElicits%252BAnti%2525E2%252580%252593Breast%252BCancer%252BActivity%252Bby%252BTargeting%252BLRP6%252Band%252BFZD7%252BReceptor%252BComplex%26aulast%3DZhou%26aufirst%3DLiang%26date%3D2020%26date%3D2020%26volume%3D373%26issue%3D1%26spage%3D149%26epage%3D159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Zuodong  Qin</span>, <span class="hlFld-ContribAuthor ">Wei-Dong  Zhang</span>, <span class="hlFld-ContribAuthor ">Gang  Cheng</span>, <span class="hlFld-ContribAuthor ">Assaraf G.  Yehuda</span>, <span class="hlFld-ContribAuthor ">Charles R.  Ashby</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Xiang-Dong  Cheng</span>, <span class="hlFld-ContribAuthor ">Jiang-Jiang  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2020,</strong> <em>49 </em>, 100681. <a href="https://doi.org/10.1016/j.drup.2020.100681" title="DOI URL">https://doi.org/10.1016/j.drup.2020.100681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2020.100681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2020.100681%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bto%252Bdiscover%252BP-glycoprotein%252Binhibitors%25253A%252BAn%252Bupdate%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2020%26volume%3D49%26spage%3D100681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solomon  Habtemariam</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (6)
                                     , 1426. <a href="https://doi.org/10.3390/molecules25061426" title="DOI URL">https://doi.org/10.3390/molecules25061426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25061426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25061426%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BBerberine%252BInspired%252BAnticancer%252BApproaches%25253A%252BFrom%252BDrug%252BCombination%252Bto%252BNovel%252BFormulation%252BTechnology%252Band%252BDerivatization%26aulast%3DHabtemariam%26aufirst%3DSolomon%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D6%26spage%3D1426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyan  Huang</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Lilin  Liu</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Haonan  Li</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126913. <a href="https://doi.org/10.1016/j.bmcl.2019.126913" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126913%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bapoptosis-related%252Bantiproliferative%252Bactivities%252Bof%252Bchelidonine%252Bderivatives%26aulast%3DHuang%26aufirst%3DXueyan%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose J.G.  Marin</span>, <span class="hlFld-ContribAuthor ">Rocio I.R.  Macias</span>, <span class="hlFld-ContribAuthor ">Elisa  Herraez</span>, <span class="hlFld-ContribAuthor ">Elisa  Lozano</span>, <span class="hlFld-ContribAuthor ">Marta R.  Romero</span>, <span class="hlFld-ContribAuthor ">Silvia  Di Giacomo</span>, <span class="hlFld-ContribAuthor ">Thomas  Efferth</span>, <span class="hlFld-ContribAuthor ">Oscar  Briz</span>. </span><span class="cited-content_cbyCitation_article-title">Liver and gastrointestinal cancers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 197-250. <a href="https://doi.org/10.1016/B978-0-12-816434-1.00007-3" title="DOI URL">https://doi.org/10.1016/B978-0-12-816434-1.00007-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816434-1.00007-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816434-1.00007-3%26sid%3Dliteratum%253Aachs%26atitle%3DLiver%252Band%252Bgastrointestinal%252Bcancers%26aulast%3DMarin%26aufirst%3DJose%2BJ.G.%26date%3D2020%26spage%3D197%26epage%3D250%26pub%3DElsevier%26atitle%3DDrug%252BEfflux%252BPumps%252Bin%252BCancer%252BResistance%252BPathways%25253A%252BFrom%252BMolecular%252BRecognition%252Band%252BCharacterization%252Bto%252BPossible%252BInhibition%252BStrategies%252Bin%252BChemotherapy%26date%3D2020%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haihong  Li</span>, <span class="hlFld-ContribAuthor ">Ke  Wang</span>, <span class="hlFld-ContribAuthor ">Qi  Wan</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives. </span><span class="cited-content_cbyCitation_journal-name">Steroids</span><span> <strong>2019,</strong> <em>141 </em>, 81-95. <a href="https://doi.org/10.1016/j.steroids.2018.11.018" title="DOI URL">https://doi.org/10.1016/j.steroids.2018.11.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.steroids.2018.11.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.steroids.2018.11.018%26sid%3Dliteratum%253Aachs%26jtitle%3DSteroids%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banti-tumor%252Bevaluation%252Bof%252Bnovel%252Bsteroidal%252Bglycoconjugate%252Bwith%252Bfuroxan%252Bderivatives%26aulast%3DLi%26aufirst%3DHaihong%26date%3D2019%26volume%3D141%26spage%3D81%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Manyi  Xu</span>, <span class="hlFld-ContribAuthor ">Na  Bao</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Qixing  Li</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianbo  Sun</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>160 </em>, 1-8. <a href="https://doi.org/10.1016/j.ejmech.2018.10.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BNO-releasing%252Bcelastrol%252Bderivatives%252Bwith%252BHsp90%252Binhibition%252Band%252Bcytotoxic%252Bactivities%26aulast%3DLi%26aufirst%3DNa%26date%3D2018%26volume%3D160%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weizhi  Ge</span>, <span class="hlFld-ContribAuthor ">Xinyi  Chen</span>, <span class="hlFld-ContribAuthor ">Fangzhi  Han</span>, <span class="hlFld-ContribAuthor ">Zhongquan  Liu</span>, <span class="hlFld-ContribAuthor ">Tianpeng  Wang</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>, <span class="hlFld-ContribAuthor ">Yahui  Ding</span>, <span class="hlFld-ContribAuthor ">Quan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cucurbitacin B Derivatives as Potential Anti-Hepatocellular Carcinoma Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3345. <a href="https://doi.org/10.3390/molecules23123345" title="DOI URL">https://doi.org/10.3390/molecules23123345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123345%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BCucurbitacin%252BB%252BDerivatives%252Bas%252BPotential%252BAnti-Hepatocellular%252BCarcinoma%252BAgents%26aulast%3DGe%26aufirst%3DWeizhi%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Rong</span>, <span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Chengli  Yang</span>, <span class="hlFld-ContribAuthor ">Yongzheng  Chen</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Gang  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel nitric oxide-donating podophyllotoxin derivatives as potential antiproliferative agents against multi-drug resistant leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (60)
                                     , 34266-34274. <a href="https://doi.org/10.1039/C8RA06360E" title="DOI URL">https://doi.org/10.1039/C8RA06360E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA06360E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA06360E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bnitric%252Boxide-donating%252Bpodophyllotoxin%252Bderivatives%252Bas%252Bpotential%252Bantiproliferative%252Bagents%252Bagainst%252Bmulti-drug%252Bresistant%252Bleukemia%252Bcells%26aulast%3DZhang%26aufirst%3DLei%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D60%26spage%3D34266%26epage%3D34274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  YAN</span>, <span class="hlFld-ContribAuthor ">Yu-Xuan  DAI</span>, <span class="hlFld-ContribAuthor ">Guo-Long  GU</span>, <span class="hlFld-ContribAuthor ">Miao-Bo  PAN</span>, <span class="hlFld-ContribAuthor ">Shuai-Cong  WU</span>, <span class="hlFld-ContribAuthor ">Yu  CAO</span>, <span class="hlFld-ContribAuthor ">Wen-Long  HUANG</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of novel nitric oxide releasing dehydroandrographolide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Natural Medicines</span><span> <strong>2018,</strong> <em>16 </em>
                                    (10)
                                     , 782-790. <a href="https://doi.org/10.1016/S1875-5364(18)30118-3" title="DOI URL">https://doi.org/10.1016/S1875-5364(18)30118-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1875-5364(18)30118-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1875-5364%2818%2930118-3%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Natural%2520Medicines%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bnitric%252Boxide%252Breleasing%252Bdehydroandrographolide%252Bderivatives%26aulast%3DYAN%26aufirst%3DLin%26date%3D2018%26volume%3D16%26issue%3D10%26spage%3D782%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shen-Zhen  Ren</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Dan  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiao-Hua  Zhu</span>, <span class="hlFld-ContribAuthor ">Fa-Qian  Shen</span>, <span class="hlFld-ContribAuthor ">Song-Yu  Wu</span>, <span class="hlFld-ContribAuthor ">Jin-Jin  Chen</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 909-924. <a href="https://doi.org/10.1016/j.ejmech.2018.08.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bferrocene-pyrazole%252Bderivatives%252Bcontaining%252Bnitric%252Boxide%252Bdonors%252Bas%252BCOX-2%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DRen%26aufirst%3DShen-Zhen%26date%3D2018%26volume%3D157%26spage%3D909%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Cao  Zhang</span>, <span class="hlFld-ContribAuthor ">Huailing  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenlei  Jiang</span>, <span class="hlFld-ContribAuthor ">Jianrun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhijun  Liu</span>, <span class="hlFld-ContribAuthor ">Heru  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 158-172. <a href="https://doi.org/10.1016/j.ejmech.2018.03.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIncorporation%252Bof%252Bnitric%252Boxide%252Bdonor%252Binto%252B1%25252C3-dioxyxanthones%252Bleads%252Bto%252Bsynergistic%252Banticancer%252Bactivity%26aulast%3DLiu%26aufirst%3DJie%26date%3D2018%26volume%3D151%26spage%3D158%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. F.  Khusnutdinova</span>, <span class="hlFld-ContribAuthor ">G. N.  Apryshko</span>, <span class="hlFld-ContribAuthor ">A. V.  Petrova</span>, <span class="hlFld-ContribAuthor ">O. S.  Kukovinets</span>, <span class="hlFld-ContribAuthor ">O. B.  Kazakova</span>. </span><span class="cited-content_cbyCitation_article-title">The Synthesis and Selective Cytotoxicity of New Mannich Bases, Derivatives of 19- and 28-Alkynyltriterpenoids. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>44 </em>
                                    (1)
                                     , 123-127. <a href="https://doi.org/10.1134/S1068162018010090" title="DOI URL">https://doi.org/10.1134/S1068162018010090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1068162018010090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1068162018010090%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Bioorganic%2520Chemistry%26atitle%3DThe%252BSynthesis%252Band%252BSelective%252BCytotoxicity%252Bof%252BNew%252BMannich%252BBases%25252C%252BDerivatives%252Bof%252B19-%252Band%252B28-Alkynyltriterpenoids%26aulast%3DKhusnutdinova%26aufirst%3DE.%2BF.%26date%3D2018%26date%3D2018%26volume%3D44%26issue%3D1%26spage%3D123%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  ZOU</span>, <span class="hlFld-ContribAuthor ">Chang  YAN</span>, <span class="hlFld-ContribAuthor ">Jing-Chao  LIU</span>, <span class="hlFld-ContribAuthor ">Zhang-Jian  HUANG</span>, <span class="hlFld-ContribAuthor ">Jin-Yi  XU</span>, <span class="hlFld-ContribAuthor ">Jin-Pei  ZHOU</span>, <span class="hlFld-ContribAuthor ">Hui-Bin  ZHANG</span>, <span class="hlFld-ContribAuthor ">Yi-Hua  ZHANG</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-hepatocellular carcinoma activity of novel O 2 -vinyl diazeniumdiolate-based nitric oxide-releasing derivatives of oleanolic acid. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Natural Medicines</span><span> <strong>2017,</strong> <em>15 </em>
                                    (12)
                                     , 928-937. <a href="https://doi.org/10.1016/S1875-5364(18)30009-8" title="DOI URL">https://doi.org/10.1016/S1875-5364(18)30009-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1875-5364(18)30009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1875-5364%2818%2930009-8%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Natural%2520Medicines%26atitle%3DSynthesis%252Band%252Banti-hepatocellular%252Bcarcinoma%252Bactivity%252Bof%252Bnovel%252BO%252B2%252B-vinyl%252Bdiazeniumdiolate-based%252Bnitric%252Boxide-releasing%252Bderivatives%252Bof%252Boleanolic%252Bacid%26aulast%3DZOU%26aufirst%3DYu%26date%3D2017%26volume%3D15%26issue%3D12%26spage%3D928%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jorge A.R.  Salvador</span>, <span class="hlFld-ContribAuthor ">Ana S.  Leal</span>, <span class="hlFld-ContribAuthor ">Ana S.  Valdeira</span>, <span class="hlFld-ContribAuthor ">Bruno M.F.  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Daniela P.S.  Alho</span>, <span class="hlFld-ContribAuthor ">Sandra A.C.  Figueiredo</span>, <span class="hlFld-ContribAuthor ">Samuel M.  Silvestre</span>, <span class="hlFld-ContribAuthor ">Vanessa I.S.  Mendes</span>. </span><span class="cited-content_cbyCitation_article-title">Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 95-130. <a href="https://doi.org/10.1016/j.ejmech.2017.07.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOleanane-%25252C%252Bursane-%25252C%252Band%252Bquinone%252Bmethide%252Bfriedelane-type%252Btriterpenoid%252Bderivatives%25253A%252BRecent%252Badvances%252Bin%252Bcancer%252Btreatment%26aulast%3DSalvador%26aufirst%3DJorge%2BA.R.%26date%3D2017%26volume%3D142%26spage%3D95%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo A. M.  Serafim</span>, <span class="hlFld-ContribAuthor ">Filipe G.  Pernichelle</span>, <span class="hlFld-ContribAuthor ">Elizabeth I.  Ferreira</span>. </span><span class="cited-content_cbyCitation_article-title">The latest advances in the discovery of nitric oxide hybrid drug compounds. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2017,</strong> <em>12 </em>
                                    (9)
                                     , 941-953. <a href="https://doi.org/10.1080/17460441.2017.1344400" title="DOI URL">https://doi.org/10.1080/17460441.2017.1344400</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2017.1344400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2017.1344400%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Blatest%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bnitric%252Boxide%252Bhybrid%252Bdrug%252Bcompounds%26aulast%3DSerafim%26aufirst%3DRicardo%2BA.%2BM.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D9%26spage%3D941%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xue</span>, <span class="hlFld-ContribAuthor ">He  Li</span>, <span class="hlFld-ContribAuthor ">Fanxing  Xu</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Gao</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 270-281. <a href="https://doi.org/10.1016/j.ejmech.2017.03.020" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScutellarin%252Bderivatives%252Bas%252Bapoptosis%252Binducers%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DHan%26aufirst%3DTong%26date%3D2017%26volume%3D135%26spage%3D270%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jichao  Chen</span>, <span class="hlFld-ContribAuthor ">Tianyu  Wang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhang</span>, <span class="hlFld-ContribAuthor ">Aijun  Lin</span>, <span class="hlFld-ContribAuthor ">Liang  Wu</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Weijia  Xie</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel antitumor nitric oxide-donating β -elemene hybrids through inhibiting the PI3K/Akt pathway. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>135 </em>, 414-423. <a href="https://doi.org/10.1016/j.ejmech.2017.04.045" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.045%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bantitumor%252Bnitric%252Boxide-donating%252B%2525CE%2525B2%252B-elemene%252Bhybrids%252Bthrough%252Binhibiting%252Bthe%252BPI3K%25252FAkt%252Bpathway%26aulast%3DChen%26aufirst%3DJichao%26date%3D2017%26volume%3D135%26spage%3D414%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhao  Guo</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Gan  Tian</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Shicang  Yu</span>, <span class="hlFld-ContribAuthor ">Zhanjun  Gu</span>. </span><span class="cited-content_cbyCitation_article-title">Near infrared light triggered nitric oxide releasing platform based on upconversion nanoparticles for synergistic therapy of cancer stem-like cells. </span><span class="cited-content_cbyCitation_journal-name">Science Bulletin</span><span> <strong>2017,</strong> <em>62 </em>
                                    (14)
                                     , 985-996. <a href="https://doi.org/10.1016/j.scib.2017.06.010" title="DOI URL">https://doi.org/10.1016/j.scib.2017.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.scib.2017.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.scib.2017.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Bulletin%26atitle%3DNear%252Binfrared%252Blight%252Btriggered%252Bnitric%252Boxide%252Breleasing%252Bplatform%252Bbased%252Bon%252Bupconversion%252Bnanoparticles%252Bfor%252Bsynergistic%252Btherapy%252Bof%252Bcancer%252Bstem-like%252Bcells%26aulast%3DZhang%26aufirst%3DXiao%26date%3D2017%26volume%3D62%26issue%3D14%26spage%3D985%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  MOU</span>, <span class="hlFld-ContribAuthor ">Yan-Lin  JIAN</span>, <span class="hlFld-ContribAuthor ">Tong  CHEN</span>, <span class="hlFld-ContribAuthor ">Zhang-Jian  HUANG</span>, <span class="hlFld-ContribAuthor ">Yi-Xue  QIAO</span>, <span class="hlFld-ContribAuthor ">Si-Xun  PENG</span>, <span class="hlFld-ContribAuthor ">Da-Yong  ZHANG</span>, <span class="hlFld-ContribAuthor ">Hui  JI</span>, <span class="hlFld-ContribAuthor ">Yi-Hua  ZHANG</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 2-cyano-3, 12-dioxooleana-1, 9(11)-en-28-oate-13 β , 28-olide as a potent anti-inflammatory agent for intervention of LPS-induced acute lung injury. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Natural Medicines</span><span> <strong>2017,</strong> <em>15 </em>
                                    (5)
                                     , 347-354. <a href="https://doi.org/10.1016/S1875-5364(17)30055-9" title="DOI URL">https://doi.org/10.1016/S1875-5364(17)30055-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1875-5364(17)30055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1875-5364%2817%2930055-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Natural%2520Medicines%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B2-cyano-3%25252C%252B12-dioxooleana-1%25252C%252B9%25252811%252529-en-28-oate-13%252B%2525CE%2525B2%252B%25252C%252B28-olide%252Bas%252Ba%252Bpotent%252Banti-inflammatory%252Bagent%252Bfor%252Bintervention%252Bof%252BLPS-induced%252Bacute%252Blung%252Binjury%26aulast%3DMOU%26aufirst%3DYi%26date%3D2017%26volume%3D15%26issue%3D5%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jichao  Chen</span>, <span class="hlFld-ContribAuthor ">Tianyu  Wang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Aijun  Lin</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Weijia  Xie</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>132 </em>, 173-183. <a href="https://doi.org/10.1016/j.ejmech.2017.03.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.03.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.03.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bnitric%252Boxide-donating%252Bprotoberberine%252Bderivatives%252Bas%252Bantitumor%252Bagents%26aulast%3DChen%26aufirst%3DJichao%26date%3D2017%26volume%3D132%26spage%3D173%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Ravikumar</span>, <span class="hlFld-ContribAuthor ">Harinath  Chakrapani</span>. </span><span class="cited-content_cbyCitation_article-title">Synergistic Activities of Nitric Oxide and Various Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 293-312. <a href="https://doi.org/10.1016/B978-0-12-809275-0.00012-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-809275-0.00012-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-809275-0.00012-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-809275-0.00012-0%26sid%3Dliteratum%253Aachs%26atitle%3DSynergistic%252BActivities%252Bof%252BNitric%252BOxide%252Band%252BVarious%252BDrugs%26aulast%3DRavikumar%26aufirst%3DGovindan%26date%3D2017%26spage%3D293%26epage%3D312%26pub%3DElsevier%26atitle%3DNitric%252BOxide%252BDonors%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.  Ding</span>, <span class="hlFld-ContribAuthor ">Y.  Ding</span>, <span class="hlFld-ContribAuthor ">H.  Chen</span>, <span class="hlFld-ContribAuthor ">J.  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry and Bioactivity of ent -Kaurene Diterpenoids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 141-197. <a href="https://doi.org/10.1016/B978-0-444-63929-5.00005-X" title="DOI URL">https://doi.org/10.1016/B978-0-444-63929-5.00005-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-63929-5.00005-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-63929-5.00005-X%26sid%3Dliteratum%253Aachs%26atitle%3DChemistry%252Band%252BBioactivity%252Bof%252Bent%252B-Kaurene%252BDiterpenoids%26aulast%3DDing%26aufirst%3DC.%26date%3D2017%26spage%3D141%26epage%3D197%26pub%3DElsevier%26date%3D2017%26volume%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanying  Fang</span>, <span class="hlFld-ContribAuthor ">Rikang  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhen  He</span>, <span class="hlFld-ContribAuthor ">Hesong  Huang</span>, <span class="hlFld-ContribAuthor ">Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Zunhua  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Shilin  Yang</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Nitric oxide-donating derivatives of hederacolchiside A 1 : Synthesis and biological evaluation in vitro and in vivo as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (1)
                                     , 98-101. <a href="https://doi.org/10.1016/j.bmcl.2016.11.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNitric%252Boxide-donating%252Bderivatives%252Bof%252Bhederacolchiside%252BA%252B1%252B%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DFang%26aufirst%3DYuanying%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D98%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi-Bing  Xu</span>, <span class="hlFld-ContribAuthor ">Xiang-Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Jiao  Feng</span>, <span class="hlFld-ContribAuthor ">Jie-Fei  Miao</span>, <span class="hlFld-ContribAuthor ">Ji  Liu</span>, <span class="hlFld-ContribAuthor ">Feng-Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Bi-Xi  Niu</span>, <span class="hlFld-ContribAuthor ">Jin-Yang  Cai</span>, <span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Yanan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong  Ling</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of hybrids of β-carboline and salicylic acid as potential anticancer and apoptosis inducing agents. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep36238" title="DOI URL">https://doi.org/10.1038/srep36238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep36238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep36238%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bhybrids%252Bof%252B%2525CE%2525B2-carboline%252Band%252Bsalicylic%252Bacid%252Bas%252Bpotential%252Banticancer%252Band%252Bapoptosis%252Binducing%252Bagents%26aulast%3DXu%26aufirst%3DQi-Bing%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Ding</span>, <span class="hlFld-ContribAuthor ">Chunyong  Ding</span>, <span class="hlFld-ContribAuthor ">Na  Ye</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Haiying  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher  Wild</span>, <span class="hlFld-ContribAuthor ">Qiang  Shen</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and development of natural product oridonin-inspired anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>122 </em>, 102-117. <a href="https://doi.org/10.1016/j.ejmech.2016.06.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.06.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.06.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bdevelopment%252Bof%252Bnatural%252Bproduct%252Boridonin-inspired%252Banticancer%252Bagents%26aulast%3DDing%26aufirst%3DYe%26date%3D2016%26volume%3D122%26spage%3D102%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Kangtao  Tian</span>, <span class="hlFld-ContribAuthor ">Shuang  Tang</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (17)
                                     , 4191-4196. <a href="https://doi.org/10.1016/j.bmcl.2016.07.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.07.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.07.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bnitric%252Boxide-releasing%252Bspirolactone-type%252Bditerpenoid%252Bderivatives%252Bwith%252Bin%252Bvitro%252Bsynergistic%252Banticancer%252Bactivity%252Bas%252Bapoptosis%252Binducer%26aulast%3DLi%26aufirst%3DDahong%26date%3D2016%26volume%3D26%26issue%3D17%26spage%3D4191%26epage%3D4196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Jie  Liao</span>, <span class="hlFld-ContribAuthor ">Wei  Xiao</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">NO-Releasing Enmein-Type Diterpenoid Derivatives with Selective Antiproliferative Activity and Effects on Apoptosis-Related Proteins. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (9)
                                     , 1193. <a href="https://doi.org/10.3390/molecules21091193" title="DOI URL">https://doi.org/10.3390/molecules21091193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21091193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21091193%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNO-Releasing%252BEnmein-Type%252BDiterpenoid%252BDerivatives%252Bwith%252BSelective%252BAntiproliferative%252BActivity%252Band%252BEffects%252Bon%252BApoptosis-Related%252BProteins%26aulast%3DLi%26aufirst%3DDahong%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D9%26spage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Zhao</span>, <span class="hlFld-ContribAuthor ">Kang-tao  Tian</span>, <span class="hlFld-ContribAuthor ">Ke-guang  Cheng</span>, <span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Da-hong  Li</span>, <span class="hlFld-ContribAuthor ">Zhan-lin  Li</span>, <span class="hlFld-ContribAuthor ">Hui-ming  Hua</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (13)
                                     , 2971-2978. <a href="https://doi.org/10.1016/j.bmc.2016.05.001" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAntiproliferative%252Bactivity%252Band%252Bapoptosis%252Binducing%252Beffects%252Bof%252Bnitric%252Boxide%252Bdonating%252Bderivatives%252Bof%252Bevodiamine%26aulast%3DZhao%26aufirst%3DNan%26date%3D2016%26volume%3D24%26issue%3D13%26spage%3D2971%26epage%3D2978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Yin</span>, <span class="hlFld-ContribAuthor ">Li  Lan</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Ji</span>, <span class="hlFld-ContribAuthor ">Jiangen  Fang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Ji</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a ring-opened derivative of 3-n-butylphthalide bearing NO/H2S-donating moieties as a potential anti-ischemic stroke agent. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 369-380. <a href="https://doi.org/10.1016/j.ejmech.2016.03.044" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.03.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.03.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.03.044%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bring-opened%252Bderivative%252Bof%252B3-n-butylphthalide%252Bbearing%252BNO%25252FH2S-donating%252Bmoieties%252Bas%252Ba%252Bpotential%252Banti-ischemic%252Bstroke%252Bagent%26aulast%3DYin%26aufirst%3DWei%26date%3D2016%26volume%3D115%26spage%3D369%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dahong  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Hu</span>, <span class="hlFld-ContribAuthor ">Tong  Han</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Tingting  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhenzhong  Wang</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhanlin  Li</span>, <span class="hlFld-ContribAuthor ">Huiming  Hua</span>, <span class="hlFld-ContribAuthor ">Wei  Xiao</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2016,</strong> <em>17 </em>
                                    (6)
                                     , 747. <a href="https://doi.org/10.3390/ijms17060747" title="DOI URL">https://doi.org/10.3390/ijms17060747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms17060747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms17060747%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%25252C%252BBiological%252BActivity%25252C%252Band%252BApoptotic%252BProperties%252Bof%252BNO-Donor%25252FEnmein-Type%252Bent-Kauranoid%252BHybrids%26aulast%3DLi%26aufirst%3DDahong%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D6%26spage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan J.  Mathis</span>, <span class="hlFld-ContribAuthor ">Taixing  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">CDDO and Its Role in Chronic Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 291-314. <a href="https://doi.org/10.1007/978-3-319-41342-6_13" title="DOI URL">https://doi.org/10.1007/978-3-319-41342-6_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-41342-6_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-41342-6_13%26sid%3Dliteratum%253Aachs%26atitle%3DCDDO%252Band%252BIts%252BRole%252Bin%252BChronic%252BDiseases%26aulast%3DMathis%26aufirst%3DBryan%2BJ.%26date%3D2016%26date%3D2016%26spage%3D291%26epage%3D314%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DDrug%252BDiscovery%252Bfrom%252BMother%252BNature%26aulast%3DGupta%26aufirst%3DSubash%2BChandra%26date%3D2016%26volume%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of OA and SOADs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Routes of CDDO–Amino Acid–NO Donor Trihybrids <b>4a</b>–<b>p</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) diol, THF, NaH, 0 °C, 15 min; (b) EDCI, DMAP, DCM, rt, 12 h; (c) TFA, DCM, rt, 1 h; (d) acyl chloride of CDDO, TEA, DCM, rt, 12 h.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compounds <b>4a</b>–<b>q</b> inhibit the proliferation of HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with, or without, the indicated compounds at 1 μM for 72 h, and the cell proliferation was measured by MTT. The inhibition (%) of each compound was determined. Data are present as the means (%) ± SD of each compound from three independent experiments. *<i>P</i> < 0.05 vs the CDDO-Me.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of anticancer activity of trihybrid <b>4c</b> with that of <b>5</b>, <b>2a</b>, and an equimolar mixture of <b>5</b> and <b>2a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of NO produced by the target compounds on colon cell proliferation. (A) Variable levels of NO (present as nitrite) produced by the indicated compounds. HCT-8, HCT-8/5-FU, and CCD841 cells were treated in triplicate with individual compounds at 100 μM for 150 min, and the concentrations of intracellular nitrite were determined by Griess assay. The individual values were determined by measuring the absorbance at 540 nm and calculated according to the standard curve. Data are expressed as the mean ± SD of each compound in individual types of cells from three experiments. ***<i>P</i> < 0.001 vs the CCD841 group, #<i>P</i> < 0.05 vs the HCT-8 group. (B) Effects of NO scavenging, carboxy-PTIO (PTIO) on the antiproliferative effect of <b>4c</b>. HCT-8, HCT-8/5-FU, and CCD841 cells were pretreated in triplicate with the indicated concentrations of carboxy-PTIO (0, 6.25, 12.5, 25, or 50 μM) for 1 h and treated with 0.25 μM <b>4c</b> for 24 h. The results are expressed as the percentage of cell growth inhibition relative to control cells without the scavenger. Data are the mean value ± SD obtained from three independent experiments. **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PepT1-mediated cell uptake is important for the antitumor activity of <b>4c</b>. HCT-8 (A) and HCT-8/5-FU (B) cells were pretreated with, or without, Gly-Sar (0.75 or 1.5 μM) for 24 h and treated with the indicated concentrations of <b>4c</b> for 72 h. The inhibition on the proliferation of cancer cells was determined by MTT. (C) Effects of Gly-Sar on the levels of NO (present as nitrite) produced by <b>4c</b>. HCT-8 and HCT-8/5-FU cells were pretreated with, or without, different concentrations of Gly-Sar (0.75, 1.5, 3, 6, 12, 24, 48, 96, and 192 μM) for 150 min and treated with <b>4c</b> at 150 μM for 150 min. The concentrations of intracellular nitrite were determined by Griess assay. Data are expressed as the means ± SD of each concentration of compounds in individual types of cells from three experiments. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the Gly-Sar untreated group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compounds <b>4c</b> and CDDO-Me induce colon cancer cell apoptosis in vitro. HCT-8 (A) and HCT-8/5-FU (B) cells were incubated with the indicated concentrations of <b>4c</b> or CDDO-Me for 24 h, and the percentages of apoptotic cells were determined by flow cytometry after staining them with Annexin V-FITC and propidium iodide (PI). Data are representative charts or expressed as the means ± SD of the percentages of apoptotic cells from three independent experiments. **<i>P</i> < 0.01 vs the CDDO-Me group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of <b>4c</b> and CDDO-Me on the HIF-1α, Stat3, AKT, and ERK signaling in HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with vehicle or the indicated compound for 24 h, and the relative levels of HIF-1α, Stat3, AKT, and ERK expression and phosphorylation were determined by Western blot assays using β-actin as a control. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western blot analysis of the relative levels of HIF-1α, Stat3, AKT, and ERK expression and phosphorylation. (B) Quantitative analysis. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001 vs the vehicle-treated control. <sup>#</sup><i>P</i> < 0.05 vs the CDDO-Me group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Nitration of drug efflux pumps by <b>4c</b> in HCT-8/5-FU cells. (A) Expression of ABC transporters in HCT-8 and HCT-8/5-FU cells. HCT-8 and HCT-8/5-FU cells were treated with, or without, the indicated concentrations of <b>4c</b> or CDDO-Me for 24 h, and the relative levels of Pgp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 to GAPDH were determined by Western blotting. In addition, the nitrated Pgp/ABCB1, MRP1/ABCC1, and BCRP/ABCG2 in the HCT-8/5-FU cell lysates were precipitated by antinitrotyrosine antibody and characterized by Western blotting using individual specific antibodies. Data are representative images and expressed as the means ± SD of each group of cells from three separate experiments. (A) Western analysis of the relative levels of ABC transporter expression. ***<i>P</i> < 0.001 vs the HCT-8 group. (B) Western blot analysis of the levels of nitrated ABC transporters. *<i>P</i> < 0.05, ***<i>P</i> < 0.001 vs the PTIO group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/medium/jm-2014-019302_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Inhibition of <b>4c</b> on the growth of implanted drug-resistant colon tumors in mice. Male BALB/c nude mice were inoculated with HCT-8/5-FU cells, and after establishment of solid tumors, the mice were randomly treated with the indicated doses of <b>4c</b>, CDDO-Me, or vehicle (cremophor-EL/DMSO/PBS (1:1:8)) daily and the tumor volumes were measured every other day through the observation period in a blinded manner. Data are expressed as the mean ± SD from each group of mice (<i>n</i> = 8 per group). **<i>P</i> < 0.01 vs the vehicle-treated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-5/jm5019302/20150306/images/large/jm-2014-019302_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5019302&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 53 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Gottesman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fojo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, S. E.</span><span> </span><span class="NLM_article-title">Multidrug resistance in cancer: role of ATP-dependent transporters</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=11902585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=48-58&author=M.+M.+Gottesmanauthor=T.+Fojoauthor=S.+E.+Bates&title=Multidrug+resistance+in+cancer%3A+role+of+ATP-dependent+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Multidrug resistance in cancer: role of ATP-dependent transporters</span></div><div class="casAuthors">Gottesman, Michael M.; Fojo, Tito; Bates, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-58</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chemotherapeutics are the most effective treatment for metastatic tumors.  However, the ability of cancer cells to become simultaneously resistant to different drugs, a trait known as multidrug resistance, remains a significant impediment to successful chemotherapy.  Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents.  Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRJtnCZv-ZtrVg90H21EOLACvtfcHk0lhfpukj7oJWfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvF2jtL8%253D&md5=ec5284e1fe4a878c5ffc30ee83bccc9d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc706%26sid%3Dliteratum%253Aachs%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26aulast%3DFojo%26aufirst%3DT.%26aulast%3DBates%26aufirst%3DS.%2BE.%26atitle%3DMultidrug%2520resistance%2520in%2520cancer%253A%2520role%2520of%2520ATP-dependent%2520transporters%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2002%26volume%3D2%26spage%3D48%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szak%C3%A1csauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Wilson, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, D. B.</span><span> </span><span class="NLM_article-title">Anti-apoptotic mechanisms of drug resistance in cancer</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.2174%2F156800909788166547" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19442051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=307-319&author=T.+R.+Wilsonauthor=P.+G.+Johnstonauthor=D.+B.+Longley&title=Anti-apoptotic+mechanisms+of+drug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-apoptotic mechanisms of drug resistance in cancer</span></div><div class="casAuthors">Wilson, T. R.; Johnston, P. G.; Longley, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-319</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Resistance to chemotherapy is a major obstacle in the treatment of cancer.  Despite the advent of new chemotherapies and mol.-targeted therapies, approx. 90% of patients with metastatic cancer succumb to their disease.  Drug resistance, either acquired or intrinsic, often prevents tumor cells from undergoing sufficient levels of programmed cell death or apoptosis, resulting in cancer cell survival and treatment failure.  In pre-clin. disease models, agents that target the apoptotic pathway were shown to sensitize tumor cells to chemotherapy and radiotherapy.  Such therapies include small mol. inhibitors and antisense strategies that inhibit the activity of anti-apoptotic proteins, or treatment with recombinant pro-apoptotic proteins or antibodies that can activate the apoptotic pathway.  This review will discuss apoptosis and the mechanisms by which it can become dysregulated in human cancer.  In addn., novel therapeutic strategies that target key components of the apoptotic machinery will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkegczsL_lBrVg90H21EOLACvtfcHk0lhfpukj7oJWfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmslansLo%253D&md5=85b32e7e06a33942779c569f39f19252</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F156800909788166547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156800909788166547%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DT.%2BR.%26aulast%3DJohnston%26aufirst%3DP.%2BG.%26aulast%3DLongley%26aufirst%3DD.%2BB.%26atitle%3DAnti-apoptotic%2520mechanisms%2520of%2520drug%2520resistance%2520in%2520cancer%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2009%26volume%3D9%26spage%3D307%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sarkadi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homolya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szakács, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Váradi, A.</span><span> </span><span class="NLM_article-title">Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">1179</span><span class="NLM_x">–</span> <span class="NLM_lpage">1236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=1179-1236&author=B.+Sarkadiauthor=L.+Homolyaauthor=G.+Szak%C3%A1csauthor=A.+V%C3%A1radi&title=Human+multidrug+resistance+ABCB+and+ABCG+transporters%3A+participation+in+a+chemoimmunity+defense+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSarkadi%26aufirst%3DB.%26aulast%3DHomolya%26aufirst%3DL.%26aulast%3DSzak%25C3%25A1cs%26aufirst%3DG.%26aulast%3DV%25C3%25A1radi%26aufirst%3DA.%26atitle%3DHuman%2520multidrug%2520resistance%2520ABCB%2520and%2520ABCG%2520transporters%253A%2520participation%2520in%2520a%2520chemoimmunity%2520defense%2520system%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26spage%3D1179%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhardwaj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duncan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeley, R.</span><span> </span><span class="NLM_article-title">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1650</span><span class="NLM_x">–</span> <span class="NLM_lpage">1654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1126%2Fscience.1360704" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=1360704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1650-1654&author=S.+Coleauthor=G.+Bhardwajauthor=J.+Gerlachauthor=J.+Mackieauthor=C.+Grantauthor=K.+Almquistauthor=A.+Stewartauthor=E.+Kurzauthor=A.+Duncanauthor=R.+Deeley&title=Overexpression+of+a+transporter+gene+in+a+multidrug-resistant+human+lung+cancer+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line</span></div><div class="casAuthors">Cole, S. P. C.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M. V.; Deeley, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5088</span>),
    <span class="NLM_cas:pages">1650-4</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents.  However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on ATP and is assocd. with multidrug resistance.  CDNA clones corresponding to mRNAs overexpressed in H69AR cells were isolated.  One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells.  Overexpression was assocd. with amplification of the cognate gene located on chromosome 16 at band p13.1.  Reversion to drug sensitivity was assocd. with loss of gene amplification and a marked decrease in mRNA expression.  The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogS-PschUsW7Vg90H21EOLACvtfcHk0ljC6uC22MjfCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXkvFantLc%253D&md5=7002d3f14cd64c4f39e44d938db665f7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1360704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1360704%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%26aulast%3DBhardwaj%26aufirst%3DG.%26aulast%3DGerlach%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DC.%26aulast%3DAlmquist%26aufirst%3DK.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DKurz%26aufirst%3DE.%26aulast%3DDuncan%26aufirst%3DA.%26aulast%3DDeeley%26aufirst%3DR.%26atitle%3DOverexpression%2520of%2520a%2520transporter%2520gene%2520in%2520a%2520multidrug-resistant%2520human%2520lung%2520cancer%2520cell%2520line%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1650%26epage%3D1654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Uchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imamura, M.</span><span> </span><span class="NLM_article-title">Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1168</span><span class="NLM_x">–</span> <span class="NLM_lpage">1173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fsj.bjc.6690186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=10098753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A280%3ADyaK1M7ps1eruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1999&pages=1168-1173&author=S.+Uchidaauthor=Y.+Shimadaauthor=G.+Watanabeauthor=Z.+G.+Liauthor=T.+Hongauthor=M.+Miyakeauthor=M.+Imamura&title=Motility-related+protein+%28MRP-1%2FCD9%29+and+KAI1%2FCD82+expression+inversely+correlate+with+lymph+node+metastasis+in+oesophageal+squamous+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma</span></div><div class="casAuthors">Uchida S; Shimada Y; Watanabe G; Li Z G; Hong T; Miyake M; Imamura M</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1168-73</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">Although the mechanisms of action of the transmembrane superfamilies, motility-related protein-1 (MRP-1/CD9) and KAI1/CD82, are not well known, they are reported to suppress the metastasis of several kinds of cancers.  The suppression of cell motility by MRP-1/CD9 may cause suppression of the metastasis.  As we could not find any reports concerning the expression of MRP-1/CD9 and KAI1/CD82 in oesophageal cancers we investigated their expression in oesophageal specimens.  We conducted immunohistochemical staining for MRP1/CD9 against 108 cases of oesophageal squamous cell carcinoma using anti-MRP-1/CD9 monoclonal antibody M31-15, and for KAI1/CD82 against 104 cases using anti-KAI1/CD82 monoclonal antibody C33.  To investigate the gradual expression of MRP-1/CD9 and KAI1/CD82, 24 oesophageal dysplasias were immunohistochemically stained using the same method and then investigated.  The expression of both MRP-1/CD9 and KAI1/CD82 were positive on the cell membranes of normal oesophageal epithelial cells, but reduced or negative in the cancer cells.  Reduced MRP-1/CD9 expressions significantly correlated to tumour depth (P = 0.0009).  We found a significantly greater number of reduced or negative expression of MRP-1/CD9 and KAI1/CD82 in lymph node metastatic cases (P = 0.0003 and P= 0.0129, respectively), but not in distant metastatic cases.  The 5-year survival rate of MRP-1/CD9-negative and reduced patients was significantly worse than those of positive patients (n = 108, curative cases, RO).  Few cases remained KAI1/CD82-positive (9.6%; 10/104) in oesophageal cancer.  Twenty (83.3%) and twenty-two (91.7%) cases out of 24 dysplasias were defined as KAI1/CD82-positive and MRP1/CD9-positive, respectively.  The decrease in MRP-1/CD9 and KAI1/CD82 expression may facilitate lymph node metastasis in oesophageal squamous cell carcinomas.  Knowing the status of the expression of MRP-1/CD9 appears helpful in predicting the prognosis for each patient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0HVn8r3Ac0YhLSh9fo81bfW6udTcc2eYRkzH4l1FGq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7ps1eruw%253D%253D&md5=2ec1da90bf54cf62b063ce1d4c316d3d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6690186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6690186%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DS.%26aulast%3DShimada%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%2BG.%26aulast%3DHong%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DImamura%26aufirst%3DM.%26atitle%3DMotility-related%2520protein%2520%2528MRP-1%252FCD9%2529%2520and%2520KAI1%252FCD82%2520expression%2520inversely%2520correlate%2520with%2520lymph%2520node%2520metastasis%2520in%2520oesophageal%2520squamous%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1999%26volume%3D79%26spage%3D1168%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Doyle, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abruzzo, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krogmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rishi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D.</span><span> </span><span class="NLM_article-title">A multidrug resistance transporter from human MCF-7 breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">15665</span><span class="NLM_x">–</span> <span class="NLM_lpage">15670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1073%2Fpnas.95.26.15665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=9861027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=15665-15670&author=L.+A.+Doyleauthor=W.+Yangauthor=L.+V.+Abruzzoauthor=T.+Krogmannauthor=Y.+Gaoauthor=A.+K.+Rishiauthor=D.+Ross&title=A+multidrug+resistance+transporter+from+human+MCF-7+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A multidrug resistance transporter from human MCF-7 breast cancer cells</span></div><div class="casAuthors">Doyle, L. Austin; Yang, Weidong; Abruzzo, Lynne V.; Krogmann, Tammy; Gao, Yongming; Rishi, Arun K.; Ross, Douglas D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15665-15670</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">MCF-7/AdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent redn. in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein.  RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in MCF-7/AdrVp cells relative to parental MCF-7 cells.  The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP).  Enforced expression of the full-length BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123 in the cloned transfected cells.  BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7/AdrVp human breast cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowbckt6jTJYLVg90H21EOLACvtfcHk0lgI_56HeRw3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFeitQ%253D%253D&md5=ef3e4ddd772833b363ba458401e3331a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.26.15665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.26.15665%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DL.%2BA.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DAbruzzo%26aufirst%3DL.%2BV.%26aulast%3DKrogmann%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DRishi%26aufirst%3DA.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DA%2520multidrug%2520resistance%2520transporter%2520from%2520human%2520MCF-7%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D15665%26epage%3D15670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Eckford, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharom, F. J.</span><span> </span><span class="NLM_article-title">ABC efflux pump-based resistance to chemotherapy drugs</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2989</span><span class="NLM_x">–</span> <span class="NLM_lpage">3011</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr9000226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=2989-3011&author=P.+D.+Eckfordauthor=F.+J.+Sharom&title=ABC+efflux+pump-based+resistance+to+chemotherapy+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ABC Efflux Pump-Based Resistance to Chemotherapy Drugs</span></div><div class="casAuthors">Eckford, Paul D. W.; Sharom, Frances J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2989-3011</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over 1 million new cases of all types of cancer are diagnosed each year in the United States alone, and 559, 650 cancer-related deaths were expected to occur in 2007.  Chemotherapeutic treatment of cancers is an important tool to combat this devastating disease.  However, chemotherapy can fail due to the development of tumor cell resistance to multiple drugs, a phenomenon known as multidrug resistance (MDR), and essentially all cancer-related deaths are considered to be a result of chemotherapy failure.  MDR can have many causes, but one important mechanism of drug resistance is the expression of active drug efflux pumps in the membranes of cancer cells.  The efflux pump proteins mediating MDR in human cancers belong to the ATP-Binding Cassette (ABC) superfamily of proteins.  This is a diverse group of (primarily) active membrane transporters and is one of the largest known protein families.  Its members include proteins that mediate a variety of transport processes, in both prokaryotes (e.g., membrane-embedded importers for sugars and amino acids, and drug exporters) and eukaryotes, where only ABC exporters are known.  The 49 ABC proteins identified in the human genome (there appear to be 48 functional proteins) are involved in the efflux of substrates such as phospholipids, sterols, bile salts, and amphipathic drugs.  While as many as 15 ABC transporters have been obsd. to export chemotherapy drugs using in vitro exptl. systems, only 3 transporters have thus far been implicated as major contributors to MDR in cancer.  Discovered over 30 years ago, P-glycoprotein (Pgp; MDR1; ABCB1), was the first mammalian ABC protein to be identified.  Multidrug resistance-assocd. protein 1 (MRP1 or ABCC1) and more recently ABCG2 (also termed the breast cancer resistance protein, BCRP, or mitoxantrone resistance protein, MXR) also appear to function as clin. relevant drug efflux pumps.  All three proteins were discovered as factors over-expressed in MDR cell lines in culture, and they have since been detected in MDR tumors in patients.  Considerable effort has been made to understand the structure and function of these three drug pumps, which possess a unique ability to recognize and transport a broad array of structurally diverse compds. out of the cell.  The development of compds. known as modulators, which are able to reverse MDR by blocking or inhibiting the ATP-dependent transport function of these proteins, is also an important goal of researchers in this field.  This review will summarize our understanding of the substrate specificity of the mammalian drug efflux pumps, their structure, the mol. mechanisms by which they exert their function, and the progress made to date in reversing pump-mediated MDR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZIkwCqe_qg7Vg90H21EOLACvtfcHk0lgI_56HeRw3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlslSmtbg%253D&md5=5009e7a7cac6977a296fd5bbf97d7df7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fcr9000226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9000226%26sid%3Dliteratum%253Aachs%26aulast%3DEckford%26aufirst%3DP.%2BD.%26aulast%3DSharom%26aufirst%3DF.%2BJ.%26atitle%3DABC%2520efflux%2520pump-based%2520resistance%2520to%2520chemotherapy%2520drugs%26jtitle%3DChem.%2520Rev.%26date%3D2009%26volume%3D109%26spage%3D2989%26epage%3D3011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Szakacs, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth-Genthe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesman, M. M.</span><span> </span><span class="NLM_article-title">Targeting multidrug resistance in cancer</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=219-234&author=G.+Szakacsauthor=J.+K.+Patersonauthor=J.+A.+Ludwigauthor=C.+Booth-Gentheauthor=M.+M.+Gottesman&title=Targeting+multidrug+resistance+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSzakacs%26aufirst%3DG.%26aulast%3DPaterson%26aufirst%3DJ.%2BK.%26aulast%3DLudwig%26aufirst%3DJ.%2BA.%26aulast%3DBooth-Genthe%26aufirst%3DC.%26aulast%3DGottesman%26aufirst%3DM.%2BM.%26atitle%3DTargeting%2520multidrug%2520resistance%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D219%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tannock, I. F.</span><span> </span><span class="NLM_article-title">Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1007%2Fs10555-012-9402-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=23093326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFWit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=211-227&author=M.+Yuauthor=A.+Ocanaauthor=I.+F.+Tannock&title=Reversal+of+ATP-binding+cassette+drug+transporter+activity+to+modulate+chemoresistance%3A+why+has+it+failed+to+provide+clinical+benefit%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?</span></div><div class="casAuthors">Yu, Man; Ocana, Alberto; Tannock, Ian F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">211-227</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Enhanced drug extrusion from cells due to the overexpression of the ATP-binding cassette (ABC) drug transporters inhibits the cytotoxic effects of structurally diverse and mechanistically unrelated anticancer agents and is a major cause of multidrug resistance (MDR) of human malignancies.  Multiple compds. can suppress the activity of these efflux transporters and sensitize resistant tumor cells, but despite promising preclin. and early clin. data, they have yet to find a role in oncol. practice.  Based on the knowledge of the structure, function, and distribution of MDR-related ABC transporters and the results of their preclin. and clin. evaluation, we discuss probable reasons why these inhibitors have not improved the outcome of therapy for cancer patients.  We also outline new MDR-reversing strategies that directly target ABC transporters or circumvent relevant signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBAZK6a3syH7Vg90H21EOLACvtfcHk0lgI_56HeRw3mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFWit78%253D&md5=76bbcfcf06b4b4274310f9f48a8cf3cd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2Fs10555-012-9402-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-012-9402-8%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DM.%26aulast%3DOcana%26aufirst%3DA.%26aulast%3DTannock%26aufirst%3DI.%2BF.%26atitle%3DReversal%2520of%2520ATP-binding%2520cassette%2520drug%2520transporter%2520activity%2520to%2520modulate%2520chemoresistance%253A%2520why%2520has%2520it%2520failed%2520to%2520provide%2520clinical%2520benefit%253F%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2013%26volume%3D32%26spage%3D211%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">The role of nitric oxide in tumour progression</span> <span class="citation_source-journal">Nature Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc1910" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16794635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=521-534&author=D.+Fukumuraauthor=S.+Kashiwagiauthor=R.+K.+Jain&title=The+role+of+nitric+oxide+in+tumour+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The role of nitric oxide in tumour progression</span></div><div class="casAuthors">Fukumura, Dai; Kashiwagi, Satoshi; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">521-534</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nitric oxide (NO) and nitric oxide synthases are ubiquitous in malignant tumors and are known to exert both pro- and anti-tumor effects.  We summarize our current understanding of the role of NO in tumor progression, esp. in relation to angiogenesis and vascular functions.  We also discuss potential strategies for cancer treatment that modulate NO prodn. and/or its downstream signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorTlzSMm-9dbVg90H21EOLACvtfcHk0lhmqFcrt4u8dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7Y%253D&md5=ee546d1b8e37e216ef373374ba15209c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1910%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520nitric%2520oxide%2520in%2520tumour%2520progression%26jtitle%3DNature%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D521%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bonavida, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baritaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huerta-Yepez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeung, K.</span><span> </span><span class="NLM_article-title">Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases</span> <span class="citation_source-journal">Nitric Oxide</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=152-157&author=B.+Bonavidaauthor=S.+Baritakiauthor=S.+Huerta-Yepezauthor=M.+I.+Vegaauthor=D.+Chatterjeeauthor=K.+Yeung&title=Novel+therapeutic+applications+of+nitric+oxide+donors+in+cancer%3A+roles+in+chemo-+and+immunosensitization+to+apoptosis+and+inhibition+of+metastases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonavida%26aufirst%3DB.%26aulast%3DBaritaki%26aufirst%3DS.%26aulast%3DHuerta-Yepez%26aufirst%3DS.%26aulast%3DVega%26aufirst%3DM.%2BI.%26aulast%3DChatterjee%26aufirst%3DD.%26aulast%3DYeung%26aufirst%3DK.%26atitle%3DNovel%2520therapeutic%2520applications%2520of%2520nitric%2520oxide%2520donors%2520in%2520cancer%253A%2520roles%2520in%2520chemo-%2520and%2520immunosensitization%2520to%2520apoptosis%2520and%2520inhibition%2520of%2520metastases%26jtitle%3DNitric%2520Oxide%26date%3D2008%26volume%3D19%26spage%3D152%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miraglia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viarisio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costamagna, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pescarmona, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghigo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span> </span><span class="NLM_article-title">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">516</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=15695394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=516-525&author=C.+Rigantiauthor=E.+Miragliaauthor=D.+Viarisioauthor=C.+Costamagnaauthor=G.+Pescarmonaauthor=D.+Ghigoauthor=A.+Bosia&title=Nitric+oxide+reverts+the+resistance+to+doxorubicin+in+human+colon+cancer+cells+by+inhibiting+the+drug+efflux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux</span></div><div class="casAuthors">Riganti, Chiara; Miraglia, Erica; Viarisio, Daniele; Costamagna, Costanzo; Pescarmona, Gianpiero; Ghigo, Dario; Bosia, Amalia</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) is a phenomenon by which cancer cells evade the cytotoxic effects of chemotherapeutic agents.  It may occur through different mechanisms, but it often correlates with the overexpression of integral membrane transporters, such as P-glycoprotein (Pgp) and MDR-assocd. proteins (MRPs), with resulting decrease of drug accumulation and cellular death.  Doxorubicin is a substrate of Pgp; it has been suggested that its ability to induce synthesis of nitric oxide (NO) could explain, at least in part, its cytotoxic effects.  Culturing the human epithelial colon cell line HT29 in the presence of doxorubicin, we obtained a doxorubicin-resistant (HT29-dx) cell population: these cells accumulated less intracellular doxorubicin, were less sensitive to the cytotoxic effects of doxorubicin and cisplatin, overexpressed Pgp and MRP3, and exhibited a lower NO prodn. (both under basal conditions and after doxorubicin stimulation).  The resistance to doxorubicin could be reversed when HT29-dx cells were incubated with inducers of NO synthesis (cytokines mix, atorvastatin).  Some NO donors increased the drug accumulation in HT29-dx cells in a guanosine-3':5'-cyclic monophosphate-independent way; this effect was assocd. with a marked redn. of doxorubicin efflux rate in HT29 and HT29-dx cells, and tyrosine nitration in the MRP3 protein.  Our results suggest that onset of MDR and impairment of NO synthesis are related; this finding could point to a new strategy to reverse doxorubicin resistance in human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTu2bqm5O1DbVg90H21EOLACvtfcHk0lhmqFcrt4u8dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqtQ%253D%253D&md5=e0e7757d954680c9b9eb3470a1758da6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DMiraglia%26aufirst%3DE.%26aulast%3DViarisio%26aufirst%3DD.%26aulast%3DCostamagna%26aufirst%3DC.%26aulast%3DPescarmona%26aufirst%3DG.%26aulast%3DGhigo%26aufirst%3DD.%26aulast%3DBosia%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520reverts%2520the%2520resistance%2520to%2520doxorubicin%2520in%2520human%2520colon%2520cancer%2520cells%2520by%2520inhibiting%2520the%2520drug%2520efflux%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D516%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Sullivan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, C. H.</span><span> </span><span class="NLM_article-title">Chemosensitization of cancer by nitric oxide</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1113</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.2174%2F138161208784246225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=18473858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslKrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1113-1123&author=R.+Sullivanauthor=C.+H.+Graham&title=Chemosensitization+of+cancer+by+nitric+oxide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Chemosensitization of cancer by nitric oxide</span></div><div class="casAuthors">Sullivan, Richard; Graham, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1113-1123</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent evidence from exptl. and clin. studies links the development of intratumoral hypoxia and oxidative stress with malignant progression.  Cellular adaptation induced by these environmental stresses is also assocd. with the emergence of drug resistant populations.  This adaptation is most likely a multifactorial process involving coordination of various stress-induced signaling pathways, including those regulated by hypoxia-inducible factor-1 (HIF-1) and nuclear factor κB (NF-κB) together with their down-stream targets linked to resistance mechanisms.  Exptl. data suggest that treatment of human cancer cells with nitric oxide (NO) and NO mimetic agents can effectively restore the sensitivity of resistant populations to the cytotoxic effects of chemotherapeutics both in vitro and in vivo.  Furthermore, preliminary results from Phase II clin. trials evaluating NO as an adjuvant to chemotherapy are promising.  The present review highlights the significance of intratumoral hypoxia and oxidative stress in the emergence of multidrug resistance, and summarizes the latest data demonstrating the chemosensitizing ability of NO.  To date, the specific mechanisms through which NO restores sensitivity to anticancer agents are not clearly understood.  However, the data suggest that chemosensitization is likely to involve NO-mediated activities assocd. with both prevention and inhibition of cellular drug resistance mechanisms.  Potential mechanisms contributing to the chemosensitizing activity of NO include vascular changes that promote increased blood delivery and tumor oxygenation, antioxidant effects and down-regulation of the glutathione detoxification/redox buffering system, inhibition of key transcription factors such as HIF-1 and NF-κB, as well as inhibition of drug efflux transporters and DNA repair enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgKEY49it3dbVg90H21EOLACvtfcHk0liFSUb9X5Nj9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslKrsrw%253D&md5=e0a4aa6a7c684d5e8cc68e2c88dffe09</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F138161208784246225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784246225%26sid%3Dliteratum%253Aachs%26aulast%3DSullivan%26aufirst%3DR.%26aulast%3DGraham%26aufirst%3DC.%2BH.%26atitle%3DChemosensitization%2520of%2520cancer%2520by%2520nitric%2520oxide%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1113%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ning, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oronsky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, S. J.</span><span> </span><span class="NLM_article-title">Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">447</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=447&publication_year=2014&pages=537-542&author=S.+Ningauthor=M.+Bednarskiauthor=B.+Oronskyauthor=J.+Scicinskiauthor=S.+J.+Knox&title=Novel+nitric+oxide+generating+compound+glycidyl+nitrate+enhances+the+therapeutic+efficacy+of+chemotherapy+and+radiotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNing%26aufirst%3DS.%26aulast%3DBednarski%26aufirst%3DM.%26aulast%3DOronsky%26aufirst%3DB.%26aulast%3DScicinski%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DS.%2BJ.%26atitle%3DNovel%2520nitric%2520oxide%2520generating%2520compound%2520glycidyl%2520nitrate%2520enhances%2520the%2520therapeutic%2520efficacy%2520of%2520chemotherapy%2520and%2520radiotherapy%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D447%26spage%3D537%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hutchens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manevich, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend, D. M.</span><span> </span><span class="NLM_article-title">Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO</span> <span class="citation_source-journal">Invest. New Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">719</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=719-729&author=S.+Hutchensauthor=Y.+Manevichauthor=L.+Heauthor=K.+D.+Tewauthor=D.+M.+Townsend&title=Cellular+resistance+to+a+nitric+oxide+releasing+glutathione+S-transferase+P-activated+prodrug%2C+PABA%2FNO"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutchens%26aufirst%3DS.%26aulast%3DManevich%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DTew%26aufirst%3DK.%2BD.%26aulast%3DTownsend%26aufirst%3DD.%2BM.%26atitle%3DCellular%2520resistance%2520to%2520a%2520nitric%2520oxide%2520releasing%2520glutathione%2520S-transferase%2520P-activated%2520prodrug%252C%2520PABA%252FNO%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2011%26volume%3D29%26spage%3D719%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Aguirre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boiani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerecetto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernández, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">González, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">León, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arredondo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacheco, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basombrío, M. A.</span><span> </span><span class="NLM_article-title">Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=54-59&author=G.+Aguirreauthor=M.+Boianiauthor=H.+Cerecettoauthor=M.+Fern%C3%A1ndezauthor=M.+Gonz%C3%A1lezauthor=E.+Le%C3%B3nauthor=C.+Pintosauthor=S.+Raymondoauthor=C.+Arredondoauthor=J.+P.+Pachecoauthor=M.+A.+Basombr%C3%ADo&title=Furoxan+derivatives+as+cytotoxic+agents%3A+preliminary+in+vivo+antitumoral+activity+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAguirre%26aufirst%3DG.%26aulast%3DBoiani%26aufirst%3DM.%26aulast%3DCerecetto%26aufirst%3DH.%26aulast%3DFern%25C3%25A1ndez%26aufirst%3DM.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DM.%26aulast%3DLe%25C3%25B3n%26aufirst%3DE.%26aulast%3DPintos%26aufirst%3DC.%26aulast%3DRaymondo%26aufirst%3DS.%26aulast%3DArredondo%26aufirst%3DC.%26aulast%3DPacheco%26aufirst%3DJ.%2BP.%26aulast%3DBasombr%25C3%25ADo%26aufirst%3DM.%2BA.%26atitle%3DFuroxan%2520derivatives%2520as%2520cytotoxic%2520agents%253A%2520preliminary%2520in%2520vivo%2520antitumoral%2520activity%2520studies%26jtitle%3DPharmazie%26date%3D2006%26volume%3D61%26spage%3D54%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9343</span><span class="NLM_x">–</span> <span class="NLM_lpage">9356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500613m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9343-9356&author=M.+Liuauthor=X.+Chenauthor=Y.+Huangauthor=P.+Fengauthor=Y.+Guoauthor=G.+Yangauthor=Y.+Chen&title=Hybrids+of+phenylsulfonylfuroxan+and+coumarin+as+potent+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm500613m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500613m%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DHybrids%2520of%2520phenylsulfonylfuroxan%2520and%2520coumarin%2520as%2520potent%2520antitumor%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9343%26epage%3D9356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riganti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzarato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolando, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span> </span><span class="NLM_article-title">Nitric oxide donor doxorubicins accumulate into doxorubicin-resistant human colon cancer cells inducing cytotoxicity</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">494</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100302t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=494-497&author=K.+Chegaevauthor=C.+Rigantiauthor=L.+Lazzaratoauthor=B.+Rolandoauthor=S.+Guglielmoauthor=I.+Campiaauthor=R.+Frutteroauthor=A.+Bosiaauthor=A.+Gasco&title=Nitric+oxide+donor+doxorubicins+accumulate+into+doxorubicin-resistant+human+colon+cancer+cells+inducing+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml100302t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100302t%26sid%3Dliteratum%253Aachs%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DRiganti%26aufirst%3DC.%26aulast%3DLazzarato%26aufirst%3DL.%26aulast%3DRolando%26aufirst%3DB.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DCampia%26aufirst%3DI.%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DBosia%26aufirst%3DA.%26aulast%3DGasco%26aufirst%3DA.%26atitle%3DNitric%2520oxide%2520donor%2520doxorubicins%2520accumulate%2520into%2520doxorubicin-resistant%2520human%2520colon%2520cancer%2520cells%2520inducing%2520cytotoxicity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D494%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fruttero, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegaev, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panaro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colabufo, N. A.</span><span> </span><span class="NLM_article-title">Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5467</span><span class="NLM_x">–</span> <span class="NLM_lpage">5475</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100066y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5467-5475&author=R.+Frutteroauthor=M.+Crosettiauthor=K.+Chegaevauthor=S.+Guglielmoauthor=A.+Gascoauthor=F.+Berardiauthor=M.+Nisoauthor=R.+Perroneauthor=M.+A.+Panaroauthor=N.+A.+Colabufo&title=Phenylsulfonylfuroxans+as+modulators+of+multidrug-resistance-associated+protein-1+and+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm100066y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100066y%26sid%3Dliteratum%253Aachs%26aulast%3DFruttero%26aufirst%3DR.%26aulast%3DCrosetti%26aufirst%3DM.%26aulast%3DChegaev%26aufirst%3DK.%26aulast%3DGuglielmo%26aufirst%3DS.%26aulast%3DGasco%26aufirst%3DA.%26aulast%3DBerardi%26aufirst%3DF.%26aulast%3DNiso%26aufirst%3DM.%26aulast%3DPerrone%26aufirst%3DR.%26aulast%3DPanaro%26aufirst%3DM.%2BA.%26aulast%3DColabufo%26aufirst%3DN.%2BA.%26atitle%3DPhenylsulfonylfuroxans%2520as%2520modulators%2520of%2520multidrug-resistance-associated%2520protein-1%2520and%2520P-glycoprotein%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5467%26epage%3D5475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4834</span><span class="NLM_x">–</span> <span class="NLM_lpage">4838</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800167u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4834-4838&author=L.+Chenauthor=Y.+Zhangauthor=X.+Kongauthor=E.+Lanauthor=Z.+Huangauthor=S.+Pengauthor=D.+L.+Kaufmanauthor=J.+Tian&title=Design%2C+synthesis%2C+and+antihepatocellular+carcinoma+activity+of+nitric+oxide+releasing+derivatives+of+oleanolic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800167u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800167u%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DLan%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DKaufman%26aufirst%3DD.%2BL.%26aulast%3DTian%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antihepatocellular%2520carcinoma%2520activity%2520of%2520nitric%2520oxide%2520releasing%2520derivatives%2520of%2520oleanolic%2520acid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4834%26epage%3D4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Han, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Novel hybrids of (phenylsulfonyl)furoxan and anilinopyrimidine as potent and selective epidermal growth factor receptor inhibitors for intervention of non-small-cell lung cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4738</span><span class="NLM_x">–</span> <span class="NLM_lpage">4748</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400463q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4738-4748&author=C.+Hanauthor=Z.+Huangauthor=C.+Zhengauthor=L.+Wanauthor=L.+Zhangauthor=S.+Pengauthor=K.+Dingauthor=H.+Jiauthor=J.+Tianauthor=Y.+Zhang&title=Novel+hybrids+of+%28phenylsulfonyl%29furoxan+and+anilinopyrimidine+as+potent+and+selective+epidermal+growth+factor+receptor+inhibitors+for+intervention+of+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400463q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400463q%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DC.%26aulast%3DWan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DNovel%2520hybrids%2520of%2520%2528phenylsulfonyl%2529furoxan%2520and%2520anilinopyrimidine%2520as%2520potent%2520and%2520selective%2520epidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520for%2520intervention%2520of%2520non-small-cell%2520lung%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4738%26epage%3D4748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Tang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of nitric oxide-releasing DDB derivatives as potential Pgp-mediated MDR reversal agents in MCF-7/Adr cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=801-805&author=X.+Tangauthor=X.+Guauthor=H.+Aiauthor=G.+Wangauthor=H.+Pengauthor=Y.+Laiauthor=Y.+Zhang&title=Synthesis+and+evaluation+of+nitric+oxide-releasing+DDB+derivatives+as+potential+Pgp-mediated+MDR+reversal+agents+in+MCF-7%2FAdr+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DX.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520nitric%2520oxide-releasing%2520DDB%2520derivatives%2520as%2520potential%2520Pgp-mediated%2520MDR%2520reversal%2520agents%2520in%2520MCF-7%252FAdr%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D801%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Gu, X.; Huang, Z.; Ren, Z.; Tang, X.; Peng, S.; Peng, H.; Lu, B.; Tian, J.; Zhang, Y.</span><span> </span><span class="NLM_article-title">Discovery of novel nitric oxide-donating DDB derivatives as potential anti-tumor agents against multidrug resistant leukemia</span>. J. Med. Chem. (submitted).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Gu%2C+X.%3B+Huang%2C+Z.%3B+Ren%2C+Z.%3B+Tang%2C+X.%3B+Peng%2C+S.%3B+Peng%2C+H.%3B+Lu%2C+B.%3B+Tian%2C+J.%3B+Zhang%2C+Y.+Discovery+of+novel+nitric+oxide-donating+DDB+derivatives+as+potential+anti-tumor+agents+against+multidrug+resistant+leukemia.+J.+Med.+Chem.+%28submitted%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520nitric%2520oxide-donating%2520DDB%2520derivatives%2520as%2520potential%2520anti-tumor%2520agents%2520against%2520multidrug%2520resistant%2520leukemia%26jtitle%3DJ.%2520Med.%2520Chem." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liby, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yore, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopchuk, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span> </span><span class="NLM_article-title">New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span></span><div class="citationLinks">[<a href="/doi/10.1021/np100826q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2011&pages=537-545&author=M.+B.+Spornauthor=K.+T.+Libyauthor=M.+M.+Yoreauthor=L.+Fuauthor=J.+M.+Lopchukauthor=G.+W.+Gribble&title=New+synthetic+triterpenoids%3A+potent+agents+for+prevention+and+treatment+of+tissue+injury+caused+by+inflammatory+and+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">New Synthetic Triterpenoids: Potent Agents for Prevention and Treatment of Tissue Injury Caused by Inflammatory and Oxidative Stress</span></div><div class="casAuthors">Sporn, Michael B.; Liby, Karen T.; Yore, Mark M.; Fu, Liangfeng; Lopchuk, Justin M.; Gribble, Gordon W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">537-545</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">We review the original rational for the development and the chem. of a series of new synthetic oleanane triterpenoids (SO), based on oleanolic acid (I) as a starting material.  Many of the new compds. that have been made, such as 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ["CDDO", (II; R = H)], are highly potent (activities found at levels below 1 nM) anti-inflammatory agents, as measured by their ability to block the cellular synthesis of the enzyme inducible nitric oxide synthase (iNOS) in activated macrophages.  Details of the org. synthesis of new SO and their chem. mechanisms of biol. activity are reviewed, as is formation of biotin conjugates for investigation of protein targets.  Finally, we give a brief summary of important biol. activities of SO in many organ systems in numerous animal models.  Clin. investigation of a new SO [Me 2-cyano-3,12-dioxooleana-1,9(11)dien-28-oate, "CDDO-Me", bardoxolone Me, (II; R = Me)] is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXWMDf2Fxc3LVg90H21EOLACvtfcHk0lh70n4VDi_Big"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvVWisrg%253D&md5=a6b2efe5faaba6151472b0f5f654940e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fnp100826q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp100826q%26sid%3Dliteratum%253Aachs%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DLopchuk%26aufirst%3DJ.%2BM.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DNew%2520synthetic%2520triterpenoids%253A%2520potent%2520agents%2520for%2520prevention%2520and%2520treatment%2520of%2520tissue%2520injury%2520caused%2520by%2520inflammatory%2520and%2520oxidative%2520stress%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2011%26volume%3D74%26spage%3D537%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rounds, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favaloro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span> </span><span class="NLM_article-title">Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4233</span><span class="NLM_x">–</span> <span class="NLM_lpage">4246</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002230" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4233-4246&author=T.+Hondaauthor=B.+V.+Roundsauthor=L.+Boreauthor=H.+J.+Finlayauthor=F.+G.+Favaloroauthor=N.+Suhauthor=Y.+Wangauthor=M.+B.+Spornauthor=G.+W.+Gribble&title=Synthetic+oleanane+and+ursane+triterpenoids+with+modified+rings+A+and+C%3A+a+series+of+highly+active+inhibitors+of+nitric+oxide+production+in+mouse+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0002230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002230%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DRounds%26aufirst%3DB.%2BV.%26aulast%3DBore%26aufirst%3DL.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DFavaloro%26aufirst%3DF.%2BG.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26atitle%3DSynthetic%2520oleanane%2520and%2520ursane%2520triterpenoids%2520with%2520modified%2520rings%2520A%2520and%2520C%253A%2520a%2520series%2520of%2520highly%2520active%2520inhibitors%2520of%2520nitric%2520oxide%2520production%2520in%2520mouse%2520macrophages%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4233%26epage%3D4246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favaloro, F. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Place, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span> </span><span class="NLM_article-title">A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1027-1030&author=T.+Hondaauthor=Y.+Hondaauthor=F.+G.+Favaloroauthor=G.+W.+Gribbleauthor=N.+Suhauthor=A.+E.+Placeauthor=M.+H.+Rendiauthor=M.+B.+Sporn&title=A+novel+dicyanotriterpenoid%2C+2-cyano-3%2C12-dioxooleana-1%2C9%2811%29-dien-28-onitrile%2C+active+at+picomolar+concentrations+for+inhibition+of+nitric+oxide+production"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DHonda%26aufirst%3DY.%26aulast%3DFavaloro%26aufirst%3DF.%2BG.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSuh%26aufirst%3DN.%26aulast%3DPlace%26aufirst%3DA.%2BE.%26aulast%3DRendi%26aufirst%3DM.%2BH.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DA%2520novel%2520dicyanotriterpenoid%252C%25202-cyano-3%252C12-dioxooleana-1%252C9%252811%2529-dien-28-onitrile%252C%2520active%2520at%2520picomolar%2520concentrations%2520for%2520inhibition%2520of%2520nitric%2520oxide%2520production%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1027%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">DDQ-promoted dehydrogenation from natural rigid polycyclic acids or flexible alkyl acids to generate lactones by a radical ion mechanism</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9495</span><span class="NLM_x">–</span> <span class="NLM_lpage">9497</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=9495-9497&author=Y.+Dingauthor=Z.+Huangauthor=J.+Yinauthor=Y.+Laiauthor=S.+Zhangauthor=Z.+Zhangauthor=L.+Fangauthor=S.+Pengauthor=Y.+Zhang&title=DDQ-promoted+dehydrogenation+from+natural+rigid+polycyclic+acids+or+flexible+alkyl+acids+to+generate+lactones+by+a+radical+ion+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDDQ-promoted%2520dehydrogenation%2520from%2520natural%2520rigid%2520polycyclic%2520acids%2520or%2520flexible%2520alkyl%2520acids%2520to%2520generate%2520lactones%2520by%2520a%2520radical%2520ion%2520mechanism%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D9495%26epage%3D9497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells</span> <span class="citation_source-journal">Food Chem. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.fct.2013.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=24211866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFyksb3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=38-47&author=Z.+Zhangauthor=C.+Zhangauthor=Y.+Dingauthor=Q.+Zhaoauthor=L.+Yangauthor=J.+Lingauthor=L.+Liuauthor=H.+Jiauthor=Y.+Zhang&title=The+activation+of+p38+and+JNK+by+ROS%2C+contribute+to+OLO-2-mediated+intrinsic+apoptosis+in+human+hepatocellular+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The activation of p38 and JNK by ROS, contribute to OLO-2-mediated intrinsic apoptosis in human hepatocellular carcinoma cells</span></div><div class="casAuthors">Zhang, Zhenzhen; Zhang, Chao; Ding, Ye; Zhao, Qian; Yang, Lifang; Ling, Jingjing; Liu, Ling; Ji, Hui; Zhang, Yihua</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-47</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, we describe that a novel synthesized compd., olean-28,13β-olide 2 (OLO-2), exhibits selective cytotoxic activity via inducing apoptosis in human hepatocellular carcinoma (HCC) cell lines but not normal human hepatic cells in vitro.  Exposure of human HCC HepG2 cells to OLO-2 results in significant loss of mitochondrial transmembrane potential (ΔΨm), the release of cytochrome c, the recruitment of B-cell lymphoma 2 (Bcl-2) assaciated X protein (Bax) and the downregulation of Bcl-2.  The apoptosis induced by OLO-2 is assocd. with the activation of caspase-3/9 and the nuclear translocation of apoptosis inducing factor (AIF).  Moreover, the increase of phosphorylated p38 and c-Jun N-terminal kinase (JNK) is obsd.  OLO-2-induced the externalization of phosphatidyl-serine (PS) and the loss of ΔΨm are blocked by p38 inhibitor SB203580 or JNK inhibitor SP600125.  In addn., OLO-2 provokes the generation of reactive oxygen species (ROS) in HepG2 cells, while the antioxidant N-acetyl cysteine (NAC) almost completely blocks OLO-2-induced apoptosis and the activation of p38 and JNK.  Taken together, the present study demonstrates that OLO-2 exhibits its cytotoxic activity through intrinsic apoptosis via ROS generation and the activation of p38 and JNK.  Its potential to be a candidate of anti-cancer agent is worth being further investigated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXRBGw2Zdia7Vg90H21EOLACvtfcHk0lhsHm5nQ249OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFyksb3F&md5=5362d1e3697281c504adfc9b39b7d195</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2013.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2013.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLing%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DThe%2520activation%2520of%2520p38%2520and%2520JNK%2520by%2520ROS%252C%2520contribute%2520to%2520OLO-2-mediated%2520intrinsic%2520apoptosis%2520in%2520human%2520hepatocellular%2520carcinoma%2520cells%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2014%26volume%3D63%26spage%3D38%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Liby, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yore, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span> </span><span class="NLM_article-title">Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer</span> <span class="citation_source-journal">Nature Rev. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">357</span><span class="NLM_x">–</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1038%2Fnrc2129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=17446857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=357-369&author=K.+T.+Libyauthor=M.+M.+Yoreauthor=M.+B.+Sporn&title=Triterpenoids+and+rexinoids+as+multifunctional+agents+for+the+prevention+and+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer</span></div><div class="casAuthors">Liby, Karen T.; Yore, Mark M.; Sporn, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">357-369</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Synthetic oleanane triterpenoids and rexinoids are two new classes of multifunctional drugs.  They are neither conventional cytotoxic agents, nor are they monofunctional drugs that uniquely target single steps in signal transduction pathways.  Synthetic oleanane triterpenoids have profound effects on inflammation and the redox state of cells and tissues, as well as being potent anti-proliferative and pro-apoptotic agents.  Rexinoids are ligands for the nuclear receptor transcription factors known as retinoid X receptors.  Both classes of agents can prevent and treat cancer in exptl. animals.  These drugs have unique mol. and cellular mechanisms of action and might prove to be synergistic with std. anti-cancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpngXAsiGtLhrVg90H21EOLACvtfcHk0lhCmG4zRy0caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFSiu7g%253D&md5=70f20e84e8ad6d4bbe03316432bb5b97</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrc2129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2129%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%2BT.%26aulast%3DYore%26aufirst%3DM.%2BM.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26atitle%3DTriterpenoids%2520and%2520rexinoids%2520as%2520multifunctional%2520agents%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520cancer%26jtitle%3DNature%2520Rev.%2520Cancer.%26date%3D2007%26volume%3D7%26spage%3D357%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Braga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayres-Saraiva, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gattass, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capella, M. A. M.</span><span> </span><span class="NLM_article-title">Oleanolic acid inhibits the activity of the multidrugresistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): possible use in cancer chemotherapy</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.canlet.2006.06.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16889888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=2007&pages=147-152&author=F.+Bragaauthor=D.+Ayres-Saraivaauthor=C.+R.+Gattassauthor=M.+A.+M.+Capella&title=Oleanolic+acid+inhibits+the+activity+of+the+multidrugresistance+protein+ABCC1+%28MRP1%29+but+not+of+the+ABCB1+%28P-glycoprotein%29%3A+possible+use+in+cancer+chemotherapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy</span></div><div class="casAuthors">Braga, F.; Ayres-Saraiva, D.; Gattass, C. R.; Capella, M. A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-152</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of oleanolic acid (OA) on ABCB1 and ABCC1 activities were studied in a cell line constitutively expressing both proteins.  It was obsd. that OA did not alter ABCB1 activity, but inhibited the activity of ABCC1 protein.  This inhibition was reversible and only occurred in the presence of OA.  In addn., OA did not alter the expression of ABCC1 mRNA.  These results suggest that OA could be a good choice in the treatment of MDR tumors, either as a chemotherapy itself in tumors bearing ABCB1, or as an adjuvant in the chemotherapy of ABCC1 expressing tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtV1rl85BULVg90H21EOLACvtfcHk0lhCmG4zRy0caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVWmu7Y%253D&md5=6a5c8b351bb5dfd598b367de6ee8111f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2006.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2006.06.008%26sid%3Dliteratum%253Aachs%26aulast%3DBraga%26aufirst%3DF.%26aulast%3DAyres-Saraiva%26aufirst%3DD.%26aulast%3DGattass%26aufirst%3DC.%2BR.%26aulast%3DCapella%26aufirst%3DM.%2BA.%2BM.%26atitle%3DOleanolic%2520acid%2520inhibits%2520the%2520activity%2520of%2520the%2520multidrugresistance%2520protein%2520ABCC1%2520%2528MRP1%2529%2520but%2520not%2520of%2520the%2520ABCB1%2520%2528P-glycoprotein%2529%253A%2520possible%2520use%2520in%2520cancer%2520chemotherapy%26jtitle%3DCancer%2520Lett.%26date%3D2007%26volume%3D248%26spage%3D147%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Paszel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubiś, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarczyk-Cwynar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaprutko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaczmarek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybczyńska, M.</span><span> </span><span class="NLM_article-title">Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1</span> <span class="citation_source-journal">Pharmacol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1500</span><span class="NLM_x">–</span> <span class="NLM_lpage">1517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2FS1734-1140%2811%2970714-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=22358098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC38Xot1yjs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1500-1517&author=A.+Paszelauthor=B.+Rubi%C5%9Bauthor=B.+Bednarczyk-Cwynarauthor=L.+Zaprutkoauthor=M.+Kaczmarekauthor=J.+Hofmannauthor=M.+Rybczy%C5%84ska&title=Oleanolic+acid+derivative+methyl+3%2C11-dioxoolean-12-en-28-olate+targets+multidrug+resistance+related+to+ABCB1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid derivative methyl 3,11-dioxoolean-l2-en-28-olate targets multidrug resistance related to ABCB1</span></div><div class="casAuthors">Paszel, Anna; Rubis, Blazej; Bednarczyk-Cwynar, Barbara; Zaprutko, Lucjusz; Kaczmarek, Mariusz; Hofmann, Johann; Rybczynska, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1500-1517</span>CODEN:
                <span class="NLM_cas:coden">PRHEDU</span>;
        ISSN:<span class="NLM_cas:issn">1734-1140</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Multidrug resistance (MDR) in leukemia patients is a great incentive to the development of new drugs.  In a search for potential multidrug resistance modulators we tested a group of oleanolic acid (OA) analogs modified at C-3, C-11, C-12 and C-28 using an exptl. model consisting of three human acute lymphoblastic leukemia cell lines (CCRF-CEM and the multidrug resistant sublines CCRF-VCR1000 and CCRF-ADR5000).  The most effective compd., Me 3,11-dioxoolean-12-en-28-olate (DIOXOL) was more potent in cell viability inhibition than its precursor - OA, and showed similar or even higher activity in the drug resistant than in the wild-type cells.  Resistance factor (RF) values obtained for CCRF-VCR1000 and CCRF-ADR-5000 cells using MTT assay were 0.7 and 0.8 (24 h of treatment) and after 72 h of treatment 0.9 and 1.1, resp.  Moreover, 5 μM DIOXOL significantly reduced the expression of the ABCB1 gene in MDR cells by around 30%, and also decreased the level of P-gp protein.  Compared to untreated control cells, DIOXOL treatment resulted in a significant P-gp decrease (30% in CCRF-ADR5000 and 50% in CCRF-VCR1000), that was detected by western blot and confirmed by flow cytometry anal.  Moreover, DIOXOL (at 10 μM) significantly inhibited P-gp transport function by more than twofold comparing to control, untreated cells that was demonstrated using rhodamine 123-based functional test.  The compd. exhibited synergistic activity with ABCB1 substrate - adriamycin in CCRF-VCR1000 cells, indicating partial but significant MDR reversing ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopKNB6BK_Xi7Vg90H21EOLACvtfcHk0lhCmG4zRy0caw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xot1yjs7k%253D&md5=4f50a0ae9fd29e151011925208833e48</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1734-1140%2811%2970714-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1734-1140%252811%252970714-9%26sid%3Dliteratum%253Aachs%26aulast%3DPaszel%26aufirst%3DA.%26aulast%3DRubi%25C5%259B%26aufirst%3DB.%26aulast%3DBednarczyk-Cwynar%26aufirst%3DB.%26aulast%3DZaprutko%26aufirst%3DL.%26aulast%3DKaczmarek%26aufirst%3DM.%26aulast%3DHofmann%26aufirst%3DJ.%26aulast%3DRybczy%25C5%2584ska%26aufirst%3DM.%26atitle%3DOleanolic%2520acid%2520derivative%2520methyl%25203%252C11-dioxoolean-12-en-28-olate%2520targets%2520multidrug%2520resistance%2520related%2520to%2520ABCB1%26jtitle%3DPharmacol.%2520Rep.%26date%3D2011%26volume%3D63%26spage%3D1500%26epage%3D1517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Terada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, K.</span><span> </span><span class="NLM_article-title">Recent advances in structural biology of peptide transporters</span> <span class="citation_source-journal">Curr. Top. Membr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2FB978-0-12-394316-3.00008-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotFeisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2012&pages=257-274&author=T.+Teradaauthor=K.+Inui&title=Recent+advances+in+structural+biology+of+peptide+transporters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in structural biology of peptide transporters</span></div><div class="casAuthors">Terada, Tomohiro; Inui, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Membranes</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">Co-Transport Systems</span>),
    <span class="NLM_cas:pages">257-274</span>CODEN:
                <span class="NLM_cas:coden">CTMEET</span>;
        ISSN:<span class="NLM_cas:issn">1063-5823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Peptide transporters localized at brush-border membranes of intestinal and renal epithelial cells mediate the membrane transport of di- and tripeptides, and play important roles in protein absorption and the conservation of peptide-bound amino nitrogen.  Peptide-like drugs that show structural similarities to di- and tripeptides are also recognized by peptide transporters.  The energy for transport of small peptides and peptide-like drugs is provided by the proton gradient across the cell membrane.  Since the cloning of H+/peptide cotransporter (PEPT1, SLC15A1), there have been advances in the mol. biol., biochem., biophysics and structural detn. of PEPT1.  By integrating these advances, much effort has been made to understand the relationship between structure and function.  In silico exptl. strategies are classified as (1) construction of kinetic models, (2) computer modeling of PEPT1 structure and (3) homol. modeling of PEPT1 with crystal structures of bacterial transporters.  The hypotheses regarding the structure-function relationship produced by these strategies have been confirmed by in vitro mutagenesis including cysteine-scanning mutagenesis.  Recently, the crystal structure of PepTSo, a functionally similar prokaryotic homolog of the mammalian peptide transporters from Shewanella oneidensis, was classified, and the previous hypotheses regarding the structure-function relationship of PEPT1 have been re-evaluated.  This review highlights the recent advances in our knowledge of the structural biol. of PEPT1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHja7umCppMLVg90H21EOLACvtfcHk0ljrTRrwDHbfSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotFeisbk%253D&md5=5cee6ce36a7db3feb34fd5139b988d11</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-394316-3.00008-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-394316-3.00008-9%26sid%3Dliteratum%253Aachs%26aulast%3DTerada%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520structural%2520biology%2520of%2520peptide%2520transporters%26jtitle%3DCurr.%2520Top.%2520Membr.%26date%3D2012%26volume%3D70%26spage%3D257%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Meredith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sword, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, P. D.</span><span> </span><span class="NLM_article-title">Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">3723</span><span class="NLM_x">–</span> <span class="NLM_lpage">3728</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1046%2Fj.1432-1327.2000.01405.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=10848990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVKgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=3723-3728&author=D.+Meredithauthor=C.+S.+Templeauthor=N.+Guhaauthor=C.+J.+Swordauthor=C.+A.+Boydauthor=I.+D.+Collierauthor=K.+M.+Morganauthor=P.+D.+Bailey&title=Modified+amino+acids+and+peptides+as+substrates+for+the+intestinal+peptide+transporter+PepT1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1</span></div><div class="casAuthors">Meredith, David; Temple, Catherine S.; Guha, Nishan; Sword, Corinna J.; Boyd, C. A. Richard; Collier, Ian D.; Morgan, Keith M.; Bailey, Patrick D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3723-3728</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The binding affinities of a no. of amino-acid and peptide derivs. by the mammalian intestinal peptide transporter PepT1 were investigated, using the Xenopus laevis expression system.  A series of blocked amino acids, namely N-acetyl-Phe (Ac-Phe), Phe-amide (Phe-NH2), N-acetyl-Phe-amide (Ac-Phe-NH2) and the parent compd. Phe, was compared for efficacy in inhibiting the uptake of the peptide [3H]-D-Phe-L-Gln.  In an equiv. set of expts., the blocked peptides Ac-Phe-Tyr, Phe-Tyr-NH2 and Ac-Phe-Tyr-NH2 were compared with the parent compd. Phe-Tyr.  Comparing amino acids and derivs., only Ac-Phe was an effective inhibitor of peptide uptake (Ki = 1.81 ± 0.37 mM).  Ac-Phe-NH2 had a very weak interaction with PepT1 (Ki = 16.8 ± 5.64 mM); neither Phe nor Phe-NH2 interacted with PepT1 with measurable affinity.  With the dipeptide and derivs., unsurprisingly the highest affinity interaction was with Phe-Tyr (Ki = 0.10 ± 0.04 mM).  The blocked C-terminal peptide Phe-Tyr-NH2 also interacted with PepT1 with a relatively high affinity (Ki = 0.94 ± 0.38 mM).  Both Ac-Phe-Tyr and Ac-Phe-Tyr-NH2 interacted weakly with PepT1 (Ki = 8.41 ± 0.11 and 9.97 ± 4.01 mM, resp.).  The results suggest that the N-terminus is the primary binding site for both dipeptides and tripeptides.  Addnl. expts. with four stereoisomers of Ala-Ala-Ala support this conclusion, and lead us to propose that a histidine residue is involved in binding the C-terminus of dipeptides.  In addn., a substrate binding model for PepT1 is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ_S7-o5ew37Vg90H21EOLACvtfcHk0ljrTRrwDHbfSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVKgtb8%253D&md5=247bbe953d9fa273ff1494b41c59c15b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01405.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01405.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeredith%26aufirst%3DD.%26aulast%3DTemple%26aufirst%3DC.%2BS.%26aulast%3DGuha%26aufirst%3DN.%26aulast%3DSword%26aufirst%3DC.%2BJ.%26aulast%3DBoyd%26aufirst%3DC.%2BA.%26aulast%3DCollier%26aufirst%3DI.%2BD.%26aulast%3DMorgan%26aufirst%3DK.%2BM.%26aulast%3DBailey%26aufirst%3DP.%2BD.%26atitle%3DModified%2520amino%2520acids%2520and%2520peptides%2520as%2520substrates%2520for%2520the%2520intestinal%2520peptide%2520transporter%2520PepT1%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D3723%26epage%3D3728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Nielsen, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frokjaer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taub, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffansen, B.</span><span> </span><span class="NLM_article-title">Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2001&pages=129-138&author=C.+U.+Nielsenauthor=R.+Andersenauthor=B.+Brodinauthor=S.+Frokjaerauthor=M.+E.+Taubauthor=B.+Steffansen&title=Dipeptide+model+prodrugs+for+the+intestinal+oligopeptide+transporter.+Affinity+for+and+transport+via+hPepT1+in+the+human+intestinal+Caco-2+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DC.%2BU.%26aulast%3DAndersen%26aufirst%3DR.%26aulast%3DBrodin%26aufirst%3DB.%26aulast%3DFrokjaer%26aufirst%3DS.%26aulast%3DTaub%26aufirst%3DM.%2BE.%26aulast%3DSteffansen%26aufirst%3DB.%26atitle%3DDipeptide%2520model%2520prodrugs%2520for%2520the%2520intestinal%2520oligopeptide%2520transporter.%2520Affinity%2520for%2520and%2520transport%2520via%2520hPepT1%2520in%2520the%2520human%2520intestinal%2520Caco-2%2520cell%2520line%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2001%26volume%3D76%26spage%3D129%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gonzalez, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covitz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrsny, R. J.</span><span> </span><span class="NLM_article-title">An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1998&pages=519-525&author=D.+E.+Gonzalezauthor=K.+M.+Covitzauthor=W.+Sadeeauthor=R.+J.+Mrsny&title=An+oligopeptide+transporter+is+expressed+at+high+levels+in+the+pancreatic+carcinoma+cell+lines+AsPc-1+and+Capan-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez%26aufirst%3DD.%2BE.%26aulast%3DCovitz%26aufirst%3DK.%2BM.%26aulast%3DSadee%26aufirst%3DW.%26aulast%3DMrsny%26aufirst%3DR.%2BJ.%26atitle%3DAn%2520oligopeptide%2520transporter%2520is%2520expressed%2520at%2520high%2520levels%2520in%2520the%2520pancreatic%2520carcinoma%2520cell%2520lines%2520AsPc-1%2520and%2520Capan-2%26jtitle%3DCancer%2520Res.%26date%3D1998%26volume%3D58%26spage%3D519%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, A.</span><span> </span><span class="NLM_article-title">Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4118</span><span class="NLM_x">–</span> <span class="NLM_lpage">4122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4118-4122&author=T.+Nakanishiauthor=I.+Tamaiauthor=Y.+Saiauthor=T.+Sasakiauthor=A.+Tsuji&title=Carrier-mediated+transport+of+oligopeptides+in+the+human+fibrosarcoma+cell+line+HT1080"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DTamai%26aufirst%3DI.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DTsuji%26aufirst%3DA.%26atitle%3DCarrier-mediated%2520transport%2520of%2520oligopeptides%2520in%2520the%2520human%2520fibrosarcoma%2520cell%2520line%2520HT1080%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4118%26epage%3D4122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tai, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.</span><span> </span><span class="NLM_article-title">Expression profile and functional activity of peptide transporters in prostate cancer cells</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">487</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp300364k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=477-487&author=W.+Taiauthor=Z.+Chenauthor=K.+Cheng&title=Expression+profile+and+functional+activity+of+peptide+transporters+in+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Expression Profile and Functional Activity of Peptide Transporters in Prostate Cancer Cells</span></div><div class="casAuthors">Tai, Wanyi; Chen, Zhijin; Cheng, Kun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">477-487</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptide transporters are expressed predominantly in intestinal and renal epithelial cells.  The functional expression of peptide transporters is also identified in other types of tissues, such as glia cells, macrophages, and the epithelia of the bile duct, the lungs, and the mammary glands.  However, their presence and role are poorly understood in carcinomas.  We explored the expression profile and functional activity of peptide transporters in the prostate cancer cell lines LNCaP, PC-3, and DU145.  Quant. real time RT-PCR (qRT-PCR) and Western blot were used to evaluate the expression profile of peptide transporter 1 (PEPT1), peptide transporter 2 (PEPT2), peptide histidine transporter 1 (PHT1), and peptide histidine transporter 2 (PHT2) in these cells.  LNCaP expresses high levels of PEPT2 and PHT1, while PC-3 demonstrates strong expression of PEPT1 and PHT1.  DU145 shows only weak expression of PEPT1 and PHT1.  Functional activities were studied in these cell lines using radiolabeled glycylsarcosine ([3H]Gly-Sar) and l-histidine ([3H]-l-histidine).  The uptake of [3H]Gly-Sar and [3H]-l-histidine was time- and pH-dependent.  A kinetic study showed that the uptake of Gly-Sar and l-histidine is saturable over the tested concn. range.  The binding affinity (Km) and the maximal velocity (Vmax) exhibited in the three cell lines were consistent with the expression profiles we obsd. in qRT-PCR and Western blot anal.  A competitive inhibition study revealed that peptide transporters in prostate cancer cells exhibited broad substrate specificity with a preference for hydrophobic dipeptides, such as Leu-Leu.  Fluorescence microscopy study revealed that the fluorescent dipeptide probe d-Ala-Lys-AMCA (a substrate of peptide transporters) specifically accumulated in the cytoplasm of LNCaP and PC-3, but not DU145 cells.  Inhibiting the peptide transporter activity by Gly-Sar suppressed the growth of LNCaP and PC-3 cells.  Our study indicated that PC-3 cells can be established as a new cell culture model for PEPT1 study, and LNCaP can be used as a model for PEPT2 study.  Moreover, our results suggested that peptide transporters are overexpressed in prostate cancer cells and can be adopted as a promising target for tumor-specific drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobyrL-hsv-GLVg90H21EOLACvtfcHk0ljrTRrwDHbfSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlSmtrrN&md5=b637c4df34fcb8e0b1f6258645119f32</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fmp300364k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300364k%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DK.%26atitle%3DExpression%2520profile%2520and%2520functional%2520activity%2520of%2520peptide%2520transporters%2520in%2520prostate%2520cancer%2520cells%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D477%26epage%3D487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Endter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francombe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbleton, M.</span><span> </span><span class="NLM_article-title">RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">591</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1211%2Fjpp.61.05.0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19405996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVemsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=583-591&author=S.+Endterauthor=D.+Francombeauthor=C.+Ehrhardtauthor=M.+Gumbleton&title=RT-PCR+analysis+of+ABC%2C+SLC+and+SLCO+drug+transporters+in+human+lung+epithelial+cell+models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">RT-PCR analysis of ABC, SLC and SLCO drug transporters in human lung epithelial cell models</span></div><div class="casAuthors">Endter, Sibylle; Francombe, Danielle; Ehrhardt, Carsten; Gumbleton, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">583-591</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Press</span>)
        </div><div class="casAbstract">Carrier-mediated transport mechanisms play crucial roles in drug absorption and elimination processes, as well as in the transport of endogenous mols. affecting cellular regulation and function.  In this study the authors used RT-PCR anal. to characterize the mRNA transcript expression of a wide range of membrane carrier transporters in several in-vitro lung epithelial cell models.  Transporters studied included: 11 ATP-binding cassette (ABC) transporters, 11 solute carrier (SLC) transporters and 9 solute carrier org. anion (SLCO) transporters.  The cell culture models included both established cell lines (A549, Calu-3, 16HBE14o-, BEAS-2B) and freshly isolated lung epithelial cells in primary culture (human bronchial and alveolar epithelial cells).  The expression profiles of several clin. relevant drug transporters were characterized using RT-PCR anal.  The authors' results showed differential transporter expression in cell culture models from different regions of the lung and also highlighted disparities when comparing lung cell lines with primary cell culture models.  Differences in transporter expression between cell models of pulmonary and gastrointestinal origin were also noted.  The information will guide and validate the use of in-vitro lung epithelial cell lines in the study of pulmonary administered drugs and candidate mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri1P0ptS20-rVg90H21EOLACvtfcHk0lg5clS-LPerGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVemsg%253D%253D&md5=18353b05e3c635c257a5baf95429202b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1211%2Fjpp.61.05.0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252Fjpp.61.05.0006%26sid%3Dliteratum%253Aachs%26aulast%3DEndter%26aufirst%3DS.%26aulast%3DFrancombe%26aufirst%3DD.%26aulast%3DEhrhardt%26aufirst%3DC.%26aulast%3DGumbleton%26aufirst%3DM.%26atitle%3DRT-PCR%2520analysis%2520of%2520ABC%252C%2520SLC%2520and%2520SLCO%2520drug%2520transporters%2520in%2520human%2520lung%2520epithelial%2520cell%2520models%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2009%26volume%3D61%26spage%3D583%26epage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kouodom, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celegato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dou, Q. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldinucci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formaggio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fregona, D.</span><span> </span><span class="NLM_article-title">Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2212</span><span class="NLM_x">–</span> <span class="NLM_lpage">2226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2212-2226&author=M.+N.+Kouodomauthor=L.+Ronconiauthor=M.+Celegatoauthor=C.+Nardonauthor=L.+Marchioauthor=Q.+P.+Douauthor=D.+Aldinucciauthor=F.+Formaggioauthor=D.+Fregona&title=Toward+the+selective+delivery+of+chemotherapeutics+into+tumor+cells+by+targeting+peptide+transporters%3A+tailored+gold-based+anticancer+peptidomimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKouodom%26aufirst%3DM.%2BN.%26aulast%3DRonconi%26aufirst%3DL.%26aulast%3DCelegato%26aufirst%3DM.%26aulast%3DNardon%26aufirst%3DC.%26aulast%3DMarchio%26aufirst%3DL.%26aulast%3DDou%26aufirst%3DQ.%2BP.%26aulast%3DAldinucci%26aufirst%3DD.%26aulast%3DFormaggio%26aufirst%3DF.%26aulast%3DFregona%26aufirst%3DD.%26atitle%3DToward%2520the%2520selective%2520delivery%2520of%2520chemotherapeutics%2520into%2520tumor%2520cells%2520by%2520targeting%2520peptide%2520transporters%253A%2520tailored%2520gold-based%2520anticancer%2520peptidomimetics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D2212%26epage%3D2226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, F.</span><span> </span><span class="NLM_article-title">Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs</span> <span class="citation_source-journal">J. Med, Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401634d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1116-1120&author=L.+Fangauthor=M.+Wangauthor=S.+Gouauthor=X.+Liuauthor=H.+Zhangauthor=F.+Gao&title=Combination+of+amino+acid%2Fdipeptide+with+nitric+oxide+donating+oleanolic+acid+derivatives+as+PepT1+targeting+antitumor+prodrugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Combination of Amino Acid/Dipeptide with Nitric Oxide Donating Oleanolic Acid Derivatives as PepT1 Targeting Antitumor Prodrugs</span></div><div class="casAuthors">Fang, Lei; Wang, Meng; Gou, Shaohua; Liu, Xuying; Zhang, Huan; Cao, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1116-1120</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By taking advantage of the cytotoxic effect of nitric oxide (NO) and PepT1 for mol.-targeted drug delivery, a series of amino acid/dipeptide diester prodrugs of NO-donating oleanolic acid derivs. were designed and synthesized.  Two prodrugs 6a and 8a showed potent cytotoxcity, which is probably due to their high PepT1 affinity and NO-releasing ability.  Furthermore, the aq. soly. of the prodrugs was also significantly enhanced because of the hydrophilic amino acid/dipeptide promoiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9pR7AdIqo7Vg90H21EOLACvtfcHk0lg5clS-LPerGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVKitw%253D%253D&md5=34d4a03853bb2b0bc6400f85c885ff4c</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm401634d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401634d%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGou%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DF.%26atitle%3DCombination%2520of%2520amino%2520acid%252Fdipeptide%2520with%2520nitric%2520oxide%2520donating%2520oleanolic%2520acid%2520derivatives%2520as%2520PepT1%2520targeting%2520antitumor%2520prodrugs%26jtitle%3DJ.%2520Med%252C%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1116%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Tsume, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. l.</span><span> </span><span class="NLM_article-title">Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp800008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFSkurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=717-727&author=Y.+Tsumeauthor=J.+M.+Hilfingerauthor=G.+l.+Amidon&title=Enhanced+cancer+cell+growth+inhibition+by+dipeptide+prodrugs+of+floxuridine%3A+increased+transporter+affinity+and+metabolic+stability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability</span></div><div class="casAuthors">Tsume, Yasuhiro; Hilfinger, John M.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">717-727</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dipeptide monoester prodrugs of floxuridine were synthesized, and their chem. stability in buffers, resistance to glycosidic bond metab., affinity for PEPT1, enzymic activation and permeability in cancer cells were detd. and compared to those of mono amino acid monoester floxuridine prodrugs.  Prodrugs contg. glycyl moieties were the least stable in pH 7.4 buffer (t1/2 < 100 min).  The activation of all floxuridine prodrugs was 2- to 30-fold faster in cell homogenates than their hydrolysis in buffer, suggesting enzymic action.  The enzymic activation of dipeptide monoester prodrugs contg. arom. promoieties in cell homogenates was 5- to 20-fold slower than that of other dipeptide and most mono amino acid monoester prodrugs (t1/2 ∼ 40 to 100 min).  All prodrugs exhibited enhanced resistance to glycosidic bond metab. by thymidine phosphorylase compared to parent floxuridine.  In general, the 5'-O-dipeptide monoester floxuridine prodrugs exhibited higher affinity for PEPT1 than the corresponding 5'-O-mono amino acid ester prodrugs.  The permeability of dipeptide monoester prodrugs across Caco-2 and Capan-2 monolayers was 2- to 4-fold higher than the corresponding mono amino acid ester prodrug.  Cell proliferation assays in AsPC-1 and Capan-2 pancreatic ductal cell lines indicated that the dipeptide monoester prodrugs were equally as potent as mono amino acid prodrugs.  The transport and enzymic profiles of 5'-L-phenylalanyl-L-tyrosyl-floxuridine, 5'-L-phenylalanyl-L-glycyl-floxuridine, and 5'-L-isoleucyl-L-glycyl-floxuridine suggest their potential for increased oral uptake, delayed enzymic bioconversion and enhanced resistance to metab. to 5-fluorouracil, as well as enhanced uptake and cytotoxic activity in cancer cells, attributes that would facilitate prolonged systemic circulation for enhanced therapeutic action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqALEnhYGvnZrVg90H21EOLACvtfcHk0lg5clS-LPerGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFSkurc%253D&md5=9646d4140b600e263fb95a76152e5631</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fmp800008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp800008c%26sid%3Dliteratum%253Aachs%26aulast%3DTsume%26aufirst%3DY.%26aulast%3DHilfinger%26aufirst%3DJ.%2BM.%26aulast%3DAmidon%26aufirst%3DG.%2Bl.%26atitle%3DEnhanced%2520cancer%2520cell%2520growth%2520inhibition%2520by%2520dipeptide%2520prodrugs%2520of%2520floxuridine%253A%2520increased%2520transporter%2520affinity%2520and%2520metabolic%2520stability%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2008%26volume%3D5%26spage%3D717%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landowski, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vig, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilfinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amidon, G. L.</span><span> </span><span class="NLM_article-title">Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp049888e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlKgtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=157-167&author=X.+Songauthor=P.+L.+Lorenziauthor=C.+P.+Landowskiauthor=B.+S.+Vigauthor=J.+M.+Hilfingerauthor=G.+L.+Amidon&title=Amino+acid+ester+prodrugs+of+the+anticancer+agent+gemcitabine%3A+synthesis%2C+bioconversion%2C+metabolic+bioevasion%2C+and+hPEPT1-mediated+transport"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Amino Acid Ester Prodrugs of the Anticancer Agent Gemcitabine: Synthesis, Bioconversion, Metabolic Bioevasion, and hPEPT1-Mediated Transport</span></div><div class="casAuthors">Song, Xueqin; Lorenzi, Philip L.; Landowski, Christopher P.; Vig, Balvinder S.; Hilfinger, John M.; Amidon, Gordon L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gemcitabine, a clin. effective nucleoside anticancer agent, is a polar drug with low membrane permeability and is administered i.v.  Further, extensive degrdn. of gemcitabine by cytidine deaminase to an inactive metabolite in the liver affects its activity adversely.  Thus, strategies that provide both enhanced transport and high metabolic bioevasion would potentially lead to oral alternatives that may be clin. useful.  The objective of this study was to evaluate whether amino acid ester prodrugs of gemcitabine would (a) facilitate transport across intestinal membranes or across cells that express hPEPT1 and (b) provide resistance to deamination by cytidine deaminase.  3'-Monoester, 5'-monoester, and 3',5'-diester prodrugs of gemcitabine utilizing aliph. (L-valine, D-valine, and L-isoleucine) and arom. (L-phenylalanine and D-phenylalanine) amino acids as promoieties were synthesized and evaluated for their affinity and direct hPEPT1-mediated transport in HeLa/hPEPT1 cells.  All prodrugs exhibited enhanced affinity (IC50: 0.14-0.16 mM) for the transporter.  However, only the 5'-L-valyl and 5'-L-isoleucyl monoester prodrugs exhibited (a) increased uptake (11.25- and 5.64-fold, resp.) in HeLa/hPEPT1 cells compared to HeLa cells and (b) chem. stability in buffers, that were comparable to valacyclovir, a com. marketed oral amino acid ester prodrug.  The widely disparate enzymic bioconversion profiles of the 5'-L-valyl and 5'-L-isoleucyl prodrugs in Caco-2 cell homogenates along with their significant resistance to deamination by cytidine deaminase suggest that the disposition of gemcitabine following oral administration would be controlled by the rate of bioconversion following transport across the intestinal epithelial membrane.  The combined results also suggest that it may be possible to modulate these characteristics by the choice of the amino acid moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5aZvHr6U9tbVg90H21EOLACvtfcHk0lizEU7sOfpgxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlKgtr4%253D&md5=c53342f57966396d26c6ded0daa46321</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fmp049888e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp049888e%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DX.%26aulast%3DLorenzi%26aufirst%3DP.%2BL.%26aulast%3DLandowski%26aufirst%3DC.%2BP.%26aulast%3DVig%26aufirst%3DB.%2BS.%26aulast%3DHilfinger%26aufirst%3DJ.%2BM.%26aulast%3DAmidon%26aufirst%3DG.%2BL.%26atitle%3DAmino%2520acid%2520ester%2520prodrugs%2520of%2520the%2520anticancer%2520agent%2520gemcitabine%253A%2520synthesis%252C%2520bioconversion%252C%2520metabolic%2520bioevasion%252C%2520and%2520hPEPT1-mediated%2520transport%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2005%26volume%3D2%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Z.</span><span> </span><span class="NLM_article-title">Synthesis, transport and pharmacokinetics of 5′-amino acid ester prodrugs of 1-β-<span class="smallcaps smallerCapital">d</span>-arabinofuranosylcytosine</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp800200a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFM%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=315-325&author=Y.+Sunauthor=J.+Sunauthor=S.+Shiauthor=Y.+Jingauthor=S.+Yinauthor=Y.+Chenauthor=G.+Liauthor=Y.+Xuauthor=Z.+He&title=Synthesis%2C+transport+and+pharmacokinetics+of+5%E2%80%B2-amino+acid+ester+prodrugs+of+1-%CE%B2-d-arabinofuranosylcytosine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Transport and Pharmacokinetics of 5'-Amino Acid Ester Prodrugs of 1-β-D-Arabinofuranosylcytosine</span></div><div class="casAuthors">Sun, Yongbing; Sun, Jin; Shi, Shiliang; Jing, Yongkui; Yin, Shiliang; Chen, Ying; Li, Gang; Xu, Youjun; He, Zhonggui</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">315-325</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cytarabine (1-β-D-arabinofuranosylcytosine, ara-C, 1) suffers from low oral bioavailability due to low intestinal membrane permeability and poor metabolic stability, and i.v. infusion is usually adopted as the clin. std. dosing administration.  To develop an oral alternative for 1 and utilize the intestinal oligopeptide transporter 1 (PepT1), a series of 5'-amino acid ester derivs. of 1 was synthesized to clarify which modification was the most suitable to increase the oral bioavailability of 1.  Their apical-to-basolateral permeability across Caco-2 cells and the antiproliferative activity with HL-60 cells were screened. 5'-Valyl prodrug 2 demonstrated the highest permeability and was selected for further study.  Glycylsarcosine (gly-sar, a typical substrate of PepT1) uptake by Caco-2 cells can be inhibited by 2 in a concn.-dependent manner, and IC50 for 2 was 2.18 ± 0.12 mM.  The uptake of 2 was markedly increased in the long-term leptin-treated Caco-2 cells compared with the control Caco-2 cells, and was significantly inhibited by the excess of gly-sar, but not by L-valine.  A dose-proportional pharmacokinetics was obsd. in rats when 5, 15, 30 mg/kg doses of 2 (calcd. as 1) were orally administered.  The oral abs. bioavailability of 1 was 60.0% and 21.8% after 2 and 1 were orally administered to rats 30 mg/kg, resp.  Following oral administration of 15 mg/kg, the absorption and bioactivation of 2 were extensive and rapid, over 98% of prodrug hydrolysis occurring before appearance in the portal vein.  The in vivo dispositions of 1-β-D-arabinofuranosyluracil (ara-U), a deaminated product of 1, were investigated.  Oral administration of 2 resulted in an increased 1/ara-U ratio (2.76) in the blood, much higher than that (1.25) after 1 orally taken.  Overall, these results demonstrated that the PepT1-mediated absorption of 2 and the increased metabolic stability resulted in a dramatic increase in the oral bioavailability of 1 in rats and further corroborated the thought that prodrug design strategy targeting intestinal PepT1 was an important and promising strategy to improve oral bioavailability of poorly absorbed drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-MXf_lWyLGbVg90H21EOLACvtfcHk0lizEU7sOfpgxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFM%253D&md5=b0c0eb744c81107c794d9f2f7d4077af</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fmp800200a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp800200a%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DS.%26aulast%3DJing%26aufirst%3DY.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHe%26aufirst%3DZ.%26atitle%3DSynthesis%252C%2520transport%2520and%2520pharmacokinetics%2520of%25205%25E2%2580%25B2-amino%2520acid%2520ester%2520prodrugs%2520of%25201-%25CE%25B2-d-arabinofuranosylcytosine%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D315%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span> </span><span class="NLM_article-title">Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells</span> <span class="citation_source-journal">Neoplasia.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=287-297&author=H.+Xiongauthor=Z.+Zhangauthor=X.+Tianauthor=D.+Sunauthor=Q.+Liangauthor=Y.+Zhangauthor=R.+Luauthor=Y.+Chenauthor=J.+Fang&title=Inhibition+of+JAK1%2C+2%2FSTAT3+signaling+induces+apoptosis%2C+cell+cycle+arrest%2C+and+reduces+tumor+cell+invasion+in+colorectal+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520JAK1%252C%25202%252FSTAT3%2520signaling%2520induces%2520apoptosis%252C%2520cell%2520cycle%2520arrest%252C%2520and%2520reduces%2520tumor%2520cell%2520invasion%2520in%2520colorectal%2520cancer%2520cells%26jtitle%3DNeoplasia.%26date%3D2008%26volume%3D10%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derijard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabandhu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hueber, A. O.</span><span> </span><span class="NLM_article-title">Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.canlet.2014.08.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=25199763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGgsLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2014&pages=355-364&author=L.+Zhuauthor=B.+Derijardauthor=K.+Chakrabandhuauthor=B.+S.+Wangauthor=H.+Z.+Chenauthor=A.+O.+Hueber&title=Synergism+of+PI3K%2FAkt+inhibition+and+Fas+activation+on+colon+cancer+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism of PI3K/Akt inhibition and Fas activation on colon cancer cell death</span></div><div class="casAuthors">Zhu, Liang; Derijard, Benoit; Chakrabandhu, Krittalak; Wang, Bing-Shun; Chen, Hong-Zhuan; Hueber, Anne-Odile</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">354</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Fas and PI3K/Akt signaling pathways pivotally impact on cancer cell death and survival resp. and are considered as promising targets for innovative anticancer therapies.  To better characterize the combination effect of PI3K/Akt inhibitors and Fas agonists and understand the profile of the interaction between PI3K/Akt and Fas signaling, we qual. and quant. evaluated the combination effect of PI3K/Akt inhibitors LY294002, Akt inhibitor VIII and FasL.  At the concn. that can block cell cycle progression and DNA synthesis but not elicit apoptosis, these inhibitors potentiate FasL to induce apoptosis.  At higher concns., when the PI3K/Akt inhibitors induce apoptosis, they synergize FasL to induce apoptosis.  In addn., PI3K/Akt inhibition significantly facilitates the Fas-mediated apoptotic signaling.  Understanding the combination effects between PI3K/Akt inhibition and Fas activation not only leads to rational design of effective combination therapy of PI3K/Akt inhibitors but also improve our knowledge about the impact of PI3K-Akt pathway on Fas signaling and the potential modulation of innate immune system by PI3K-Akt-targeting drugs in anticancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5zxVgOhhPALVg90H21EOLACvtfcHk0ljAtyyPCy1JlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGgsLjL&md5=25fe3dfa7ed997777c59217e1556dea9</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.08.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.08.038%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DDerijard%26aufirst%3DB.%26aulast%3DChakrabandhu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%2BS.%26aulast%3DChen%26aufirst%3DH.%2BZ.%26aulast%3DHueber%26aufirst%3DA.%2BO.%26atitle%3DSynergism%2520of%2520PI3K%252FAkt%2520inhibition%2520and%2520Fas%2520activation%2520on%2520colon%2520cancer%2520cell%2520death%26jtitle%3DCancer%2520Lett.%26date%3D2014%26volume%3D354%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sheffer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob-Hirsch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechavi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domany, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Givol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Orazi, G.</span><span> </span><span class="NLM_article-title">Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1191</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1191-1202&author=M.+Shefferauthor=A.+J.+Simonauthor=J.+Jacob-Hirschauthor=G.+Rechaviauthor=E.+Domanyauthor=D.+Givolauthor=G.+D%E2%80%99Orazi&title=Genome-wide+analysis+discloses+reversal+of+the+hypoxia-induced+changes+of+gene+expression+in+colon+cancer+cells+by+zinc+supplementation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSheffer%26aufirst%3DM.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DJacob-Hirsch%26aufirst%3DJ.%26aulast%3DRechavi%26aufirst%3DG.%26aulast%3DDomany%26aufirst%3DE.%26aulast%3DGivol%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Orazi%26aufirst%3DG.%26atitle%3DGenome-wide%2520analysis%2520discloses%2520reversal%2520of%2520the%2520hypoxia-induced%2520changes%2520of%2520gene%2520expression%2520in%2520colon%2520cancer%2520cells%2520by%2520zinc%2520supplementation%26jtitle%3DOncotarget%26date%3D2011%26volume%3D2%26spage%3D1191%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Liby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voong, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risingsong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Royce, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sporn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letterio, J. J.</span><span> </span><span class="NLM_article-title">The synthetic triterpenoid CDDO-imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4288</span><span class="NLM_x">–</span> <span class="NLM_lpage">4293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1158%2F1078-0432.CCR-06-0215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=16857804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSmsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4288-4293&author=K.+Libyauthor=N.+Voongauthor=C.+R.+Williamsauthor=R.+Risingsongauthor=D.+B.+Royceauthor=T.+Hondaauthor=G.+W.+Gribbleauthor=M.+B.+Spornauthor=J.+J.+Letterio&title=The+synthetic+triterpenoid+CDDO-imidazolide+suppresses+STAT+phosphorylation+and+induces+apoptosis+in+myeloma+and+lung+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthetic Triterpenoid CDDO-Imidazolide Suppresses STAT Phosphorylation and Induces Apoptosis in Myeloma and Lung Cancer Cells</span></div><div class="casAuthors">Liby, Karen; Voong, Nga; Williams, Charlotte R.; Risingsong, Renee; Royce, Darlene B.; Honda, Tadashi; Gribble, Gordon W.; Sporn, Michael B.; Letterio, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14, Pt. 1</span>),
    <span class="NLM_cas:pages">4288-4293</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Excessive activity of the transcription factors known as signal transducers and activators of transcription (STAT) contributes to the development and progression of malignancy in many organs.  It is, therefore, important to develop new drugs to control the STATs, particularly their phosphorylation state, which is required for their transcriptional activity.  Myeloma and lung cancer cells were treated with the new synthetic triterpenoid CDDO-Imidazolide, and STAT phosphorylation and apoptosis were evaluated by immunoblotting and fluorescence-activated cell sorting anal.  We now report that CDDO-Imidazolide, previously shown to be a potent agent for control of inflammation, cell proliferation, and apoptosis, rapidly (within 30-60 min) and potently (at nanomolar levels) suppresses either constitutive or interleukin-6-induced STAT3 and STAT5 phosphorylation in human myeloma and lung cancer cells.  Furthermore, in these cells, CDDO-Imidazolide also up-regulates crit. inhibitors of STATs, such as suppressor of cytokine signaling-1 and SH2-contg. phosphatase-1 (a tyrosine phosphatase).  Moreover, gene array studies reported here show that CDDO-Imidazolide potently regulates the transcription of important genes that are targets of the STATs.  Our new data thus show that CDDO-Imidazolide is a potent suppressor of STAT signaling and provide a further mechanistic basis for future clin. use of this agent to control inflammation or cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl7ur0Wz3rJbVg90H21EOLACvtfcHk0ljAtyyPCy1JlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSmsLY%253D&md5=2bac90a0068414beb2af3af3a4577d18</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0215%26sid%3Dliteratum%253Aachs%26aulast%3DLiby%26aufirst%3DK.%26aulast%3DVoong%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DC.%2BR.%26aulast%3DRisingsong%26aufirst%3DR.%26aulast%3DRoyce%26aufirst%3DD.%2BB.%26aulast%3DHonda%26aufirst%3DT.%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DSporn%26aufirst%3DM.%2BB.%26aulast%3DLetterio%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520synthetic%2520triterpenoid%2520CDDO-imidazolide%2520suppresses%2520STAT%2520phosphorylation%2520and%2520induces%2520apoptosis%2520in%2520myeloma%2520and%2520lung%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4288%26epage%3D4293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeb, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbab, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divine, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dulchavsky, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gautam, S. C.</span><span> </span><span class="NLM_article-title">Prevention of prostate cancer with oleanane synthetic triterpenoid CDDO-Me in the TRAMP mouse model of prostate cancer</span> <span class="citation_source-journal">Cancers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">3353</span><span class="NLM_x">–</span> <span class="NLM_lpage">3369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=3353-3369&author=X.+Gaoauthor=D.+Deebauthor=Y.+Liuauthor=A.+S.+Arbabauthor=G.+W.+Divineauthor=S.+A.+Dulchavskyauthor=S.+C.+Gautam&title=Prevention+of+prostate+cancer+with+oleanane+synthetic+triterpenoid+CDDO-Me+in+the+TRAMP+mouse+model+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DX.%26aulast%3DDeeb%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DArbab%26aufirst%3DA.%2BS.%26aulast%3DDivine%26aufirst%3DG.%2BW.%26aulast%3DDulchavsky%26aufirst%3DS.%2BA.%26aulast%3DGautam%26aufirst%3DS.%2BC.%26atitle%3DPrevention%2520of%2520prostate%2520cancer%2520with%2520oleanane%2520synthetic%2520triterpenoid%2520CDDO-Me%2520in%2520the%2520TRAMP%2520mouse%2520model%2520of%2520prostate%2520cancer%26jtitle%3DCancers%26date%3D2011%26volume%3D3%26spage%3D3353%26epage%3D3369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Qi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, W.</span><span> </span><span class="NLM_article-title">Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">2399</span><span class="NLM_x">–</span> <span class="NLM_lpage">2406</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=24604140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptlyru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=2399-2406&author=R.+Qiauthor=W.+Jinauthor=J.+Wangauthor=Q.+Yiauthor=M.+Yuauthor=S.+Xuauthor=W.+Jin&title=Oleanolic+acid+enhances+the+radiosensitivity+of+tumor+cells+under+mimetic+hypoxia+through+the+reduction+in+intracellular+GSH+content+and+HIF-1%CE%B1+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression</span></div><div class="casAuthors">Qi, Rongxin; Jin, Wenwen; Wang, Juan; Yi, Qiyi; Yu, Maohu; Xu, Shiguo; Jin, Wensen</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2399-2406</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">We previously found that oleanolic acid (OA), a naturally pentacyclic triterpenoid, enhances the radiosensitizing effect on tumor cells.  However, it is unclear whether or not OA enhances the radiosensitivity of hypoxic cells.  Therefore, the aim of the present study was to further observe the influence of OA on hypoxic tumor cells, and the relative mechanism was also investigated.  The radiosensitivity of rat glioma C6 cells and human lung cancer A549 cells with different treatments, under mimetic hypoxia, was evaluated by clonogenic assay.  A micronucleus (MN) test, meanwhile, was utilized to observe the alteration in intracellular DNA damage.  For detg. the mechanism involved in the OA influence on the radiosensitivity of hypoxic cells, we detd. the levels of intracellular reduced glutathione (GSH) using the glutathione reductase/5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) recycling assay.  Simultaneously, the activities of γ-glutamylcysteine synthetase (γ-GCS) and GSH synthase (GSS), both enzymes for GSH synthesis, were tested using appropriate methods.  Due to the involvement of hypoxia inducible factor-1α (HIF-1α) in the resistence of hypoxic cells to radiation damage, its levels were also obsd. by western blot method.  The results from this study demonstrated that the clonogenic growth of irradiated cells was increased under mimetic hypoxia while the refractory effect of hypoxic cells to radiation was decreased following OA treatment.  Moreover, the (MN) frequencies in the hypoxic cells treated with OA were augmented after irradn. compared with the cells without OA treatment.  In the subsequent expt., OA significantly reduced the biosynthesis of intracellular GSH via the attenuation of γ-GCS activity.  Addnl., there was an obvious redn. in HIF-1α expression in irradiated cells treated with OA at different concns.  In conclusion, OA significantly enhanced the radiosensitivity of tumor cells under mimetic hypoxia, through the redn. in intracellular GSH content and HIF-1α expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx09I9pwrcnLVg90H21EOLACvtfcHk0ljAtyyPCy1JlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptlyru7o%253D&md5=0f56c48b3c9b0840ea1cd7afa953e023</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DR.%26aulast%3DJin%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYi%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DW.%26atitle%3DOleanolic%2520acid%2520enhances%2520the%2520radiosensitivity%2520of%2520tumor%2520cells%2520under%2520mimetic%2520hypoxia%2520through%2520the%2520reduction%2520in%2520intracellular%2520GSH%2520content%2520and%2520HIF-1%25CE%25B1%2520expression%26jtitle%3DOncol.%2520Rep.%26date%3D2014%26volume%3D31%26spage%3D2399%26epage%3D2406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Dixit, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koul, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishra, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sen, E.</span><span> </span><span class="NLM_article-title">Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5019302&amp;key=10.1016%2Fj.freeradbiomed.2009.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5019302&amp;key=19409983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=364-374&author=D.+Dixitauthor=V.+Sharmaauthor=S.+Ghoshauthor=N.+Koulauthor=P.+K.+Mishraauthor=E.+Sen&title=Manumycin+inhibits+STAT3%2C+telomerase+activity%2C+and+growth+of+glioma+cells+by+elevating+intracellular+reactive+oxygen+species+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generation</span></div><div class="casAuthors">Dixit, Deobrat; Sharma, Vivek; Ghosh, Sadashib; Koul, Nitin; Mishra, Prakash Kumar; Sen, Ellora</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">364-374</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The poor prognosis of glioblastoma multiforme and lack of effective therapy have necessitated the identification of new treatment strategies.  The authors have previously reported that elevation of oxidative stress induces apoptosis of glioma cells.  Because the farnesyltransferase inhibitor manumycin is known to induce reactive oxygen species (ROS) generation, the authors evaluated the effects of manumycin on glioma cells.  Manumycin induced glioma cell apoptosis by elevating ROS generation.  Treatment with the ROS inhibitor N-acetylcysteine blocked manumycin-induced apoptosis, caspase-3 activity, and PARP expression, indicating the involvement of increased ROS in the proapoptotic activity of manumycin.  This heightened ROS level was accompanied by a concurrent decrease in antioxidants such as superoxide dismutase (SOD-1) and thioredoxin (TRX-1).  SOD-1 overexpression protects glioma cells from manumycin-induced apoptosis.  In addn., small interfering RNA-mediated knockdown of SOD-1 and TRX-1 expression also increased ROS generation and sensitivity of glioma cells to manumycin-induced cell death.  Interestingly, suppressing ROS generation prevented manumycin-induced Ras inhibition.  This study reports for the first time that Ras inhibition by manumycin is due to heightened ROS levels.  The authors also report for the first time that manumycin inhibits the phosphorylation of signal transducer and activator of transcription 3 and telomerase activity in a ROS-dependent manner, which plays a crucial role in glioma resistance to apoptosis.  In addn. manumycin (i) induced the DNA-damage repair response, (ii) affected cell-cycle-regulatory mols., and (iii) impaired the colony-forming ability of glioma cells in a ROS-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprefJOXA98SrVg90H21EOLACvtfcHk0lheWji3HuqEaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotl2lsbs%253D&md5=2425f2472440ceae2551b5d7d2e2c37e</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2009.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2009.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DDixit%26aufirst%3DD.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DKoul%26aufirst%3DN.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSen%26aufirst%3DE.%26atitle%3DManumycin%2520inhibits%2520STAT3%252C%2520telomerase%2520activity%252C%2520and%2520growth%2520of%2520glioma%2520cells%2520by%2520elevating%2520intracellular%2520reactive%2520oxygen%2520species%2520generation%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2009%26volume%3D47%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span> </span><span class="NLM_article-title">Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo</span> <span class="citation_source-journal">Cell Death Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1191&author=C.+Fanauthor=W.+Zhengauthor=X.+Fuauthor=X.+Liauthor=Y.+S.+Wongauthor=T.+Chen&title=Enhancement+of+auranofin-induced+lung+cancer+cell+apoptosis+by+selenocystine%2C+a+natural+inhibitor+of+TrxR1+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DY.%2BS.%26aulast%3DChen%26aufirst%3DT.%26atitle%3DEnhancement%2520of%2520auranofin-induced%2520lung%2520cancer%2520cell%2520apoptosis%2520by%2520selenocystine%252C%2520a%2520natural%2520inhibitor%2520of%2520TrxR1%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">He, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">You, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, C. M.</span><span> </span><span class="NLM_article-title">A cancer-targeted nanosystem for delivery of gold(III) complexes: enhanced selectivity and apoptosis-inducing efficacy of a gold(III) porphyrin complex</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">12532</span><span class="NLM_x">–</span> <span class="NLM_lpage">12536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5019302&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCisrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=12532-12536&author=L.+Heauthor=T.+Chenauthor=Y.+Youauthor=H.+Huauthor=W.+Zhengauthor=W.+L.+Kwongauthor=T.+Zouauthor=C.+M.+Che&title=A+cancer-targeted+nanosystem+for+delivery+of+gold%28III%29+complexes%3A+enhanced+selectivity+and+apoptosis-inducing+efficacy+of+a+gold%28III%29+porphyrin+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A Cancer-Targeted Nanosystem for Delivery of Gold(III) Complexes: Enhanced Selectivity and Apoptosis-Inducing Efficacy of a Gold(III) Porphyrin Complex</span></div><div class="casAuthors">He, Lizhen; Chen, Tianfeng; You, Yuanyuan; Hu, Hao; Zheng, Wenjie; Kwong, Wai-Lun; Zou, Taotao; Che, Chi-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">12532-12536</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Construction of delivery systems for anticancer gold complexes to decrease their toxicity while maintaining efficacy is a key strategy to optimize and develop anticancer gold medicines.  Herein, we describe cancer-targeted mesoporous silica nanoparticles (MSN) for delivery of a gold(III) porphyrin complex (Au-1 <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d0b1909d839e">[email protected]</a>(R)) to enhance its anticancer efficacy and selectivity between cancer and normal cells.  Encapsulation of Au-1 a within mesoporous silica nanoparticles amplifies its inhibitory effects on thioredoxin reductase (TrxR), resulting in a loss of redox balance and overprodn. of reactive oxygen species (ROS).  Elevated cellular oxidative stress activates diversified downstream ROS-mediated signaling pathways, leading to enhanced apoptosis-inducing efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk2JVwDP2syrVg90H21EOLACvtfcHk0lheWji3HuqEaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCisrjP&md5=311dbf02f970ea5792601738b9d33cb5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DYou%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DKwong%26aufirst%3DW.%2BL.%26aulast%3DZou%26aufirst%3DT.%26aulast%3DChe%26aufirst%3DC.%2BM.%26atitle%3DA%2520cancer-targeted%2520nanosystem%2520for%2520delivery%2520of%2520gold%2528III%2529%2520complexes%253A%2520enhanced%2520selectivity%2520and%2520apoptosis-inducing%2520efficacy%2520of%2520a%2520gold%2528III%2529%2520porphyrin%2520complex%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D12532%26epage%3D12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm5019302">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02278"></div></div></div></div></div><hr /></hr><p class="last">Preparative procedures and spectral data for compound <b>5</b> and HPLC spectra for the purities of compounds <b>4a</b>–<b>q</b> (PEF and CSV). This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019302/suppl_file/jm5019302_si_001.pdf">jm5019302_si_001.pdf (807.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5019302/suppl_file/jm5019302_si_002.csv">jm5019302_si_002.csv (3.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5019302&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5019302%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-5%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5019302" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0afab4c931923","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
